Final Exam Flashcards

1
Q

Care
- Hospice (3)
- Palliative (3)

A

Hospice
- death expected within 6 months
- comfort care at end of life
- done once curative treatment stopped

Palliative Care
- offered at any point of illness starting at diagnosis through bereavement
- Includes bereavement care b-c palliative care encompasses family care
- concurrent with curative treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Goals of Palliative Care (4)

A
  • Improve quality of life (better relief of symptoms esp. Pain, Dyspnea, N/V, Fever and Infection, Edema, Anxiety, Delirium, Comfort) – does not mean pt does not want any treatments
  • Allow client to experience a “good death”– doing what patients wishes and desires are to promote peaceful and meaningful death
  • Avoiding a Bad death: not following patient’s wishes; isolation, pain; death w/o dignity
  • holistic care for all needs of patient and family
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common problems in Critical Care (Anxiety)

  • S/s (4)
  • Risk
  • Treatment
A

s/s: agitation/restlessness, verbal expression, BP and HR increase, dyspnea

Risk: Anxiety and agitation can complicate recovery of ICU patient

Treatment: benzos (antianxiety meds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Common Problems in Critical Care (Pain)

  • Assessment Variations (3)
  • Risk
  • Treatment
A

Assessment
- may need alternate scales (Behavioral pain scale
Critical care pain observation scale)
- give elderly vertical scales and time to respond
- may need alt communication methods or utilize family

Risk
- triggers anxiety and anxiety can worsen pain

Treatment
- opioids or nonopioids (Ketorolac)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Benzodiazepine (ex. diazepam (Valium), midazolam (Versed), and lorazepam (Ativan))

Side effects (3)
Risks (3)

A

Side effects
- Delirium
- dose related respiratory depression
- dose related hypotension

Risk
- Temazepam (Restoril) and other benzos have opposite effects in geriatric i.e. agitation
- Not recommended for sedation of mechanically ventilated
- abrupt withdrawal can induce seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sleep Pattern Disturbance in ICU

Medical Management (2)
Nursing Care (4)

A

Medical Management
- hypnotic benzodiazepine (Temazepam(Restoril))- avoid if elderly
- manage any pain

Nursing Interventions
- Limit interruptions and cluster care to provide uninterrupted rest periods (use DND signs)
- Minimize awakenings and noise (limit staff conversations; do not slam doors)
- Drapes and blinds open at day; dim lights at night
- Provide earplugs and eye masks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Benzodiazepine (ex. diazepam (Valium), midazolam (Versed), and lorazepam (Ativan))

Purpose (2)
Use (2)
Antidote

A

Purpose
- Sedative-hypnotics with amnesic propertie
- no analgesic properties

Uses
- Versed/midazolam IV push for short term agitation
- Valium and Ativan for long term agitation (Ex. DT)

Antidote: Flumazenil (Romazicon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Propofol (Diprivan)

Purpose (3)
Use (2)
Route
Composition
Contraindication (2)

A

Purpose
- Powerful sedative and respiratory depressant
- no analgesic properties
- unreliable amnesic

Use
- sedation in mechanically ventilated in ICU
- Ideal for quick awakening or spontaneous breathing trials

Route: IV continuous b-c rapid onset (30 seconds) and Short half-life (2–4-minute half life)

Composition: High lipid content (looks like milk and quickly crosses cell membranes including blood-brain barrier)

Contraindication: allergy to soy or eggs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Propofol (Diprivan)

Side effects (4)
Care (2)

A

Side effects:
- green urine (benign)
- Propofol-related infusion syndrome (metabolic acidosis, rhabdomyolysis, myoglobinuria, AKI, dysrhythmias) – due to use of > 5 mg/kg/hr for > 48 hrs r/t fat-emulsion
- Hyperlipidemia and hypertriglyceridemia
- Acute pancreatitis

Care
- change tubing q12h b-c high lipid = risk for bacteria growth
- look at Triglyceride level (may change to Versed/midazolam if high Triglyceride)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Prevention of Sedation Dependence: Daily Sedation Interruption

Process (4)

A
  • Turn off medication (propofol wears off fast; Versed/midazolam wears off slow) once a day
  • Assess LOC and neurologic function of patient after awareness attained
  • if agitated, change in VS, dysrhythmias, restart to prevent complications – MONITORING = VERY important to prevent harm during withdrawal
  • After interruption, determine next plan of care (may reduce dose to avoid dependence; may discontinue sedation if able to be off > 4 hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute Confusion/Delirium

Definition
Manifestation (2)
Medical management and risk

A

Definition: Sudden onset of global Impairment in patient cognitive processes leads to inappropriate behavior, disorientation, impaired short-term memory, alt sensory perception and thought processes

Manifestation
- Hypoactive (somnolent, withdrawn, unaware, quiet, extreme fatigue)-> Loss of consciousness
- Hyperactive (picking at lines/tubes, agitation, restless, psychosis)

Medical Management
- Drug of choice: Haloperidol (Haldol)– risk for prolonged QT (> 0.44 sec) -> ventricular dysrhythmia (torsades de pointes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advance Directives

Components (2)
Notes (4)

A

Components
- Living will (Identifies what pt would want if near death i.e. CPR, ventilation, artificial nutrition and hydration)
- Health care power of attorney (Follows patient’s values, wishes, values; Reduces family conflict;

Notes
- HC POA does not make decisions until pt lacks capacity
- Should be updated regularly
- Pt should be asked about written advance directive upon hospital admission per Patient Self-Determination Act
- If no AD, give info on value of AD and opportunity to complete state-required forms in ED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

End of life issues
- CPR (3)
- DNR or DNI (3)
- withdrawal or withholding of treatment (2)

A

CPR
- Family presence is important to facilitate closure during CPR or invasive procedures
- Done for everyone unless DNR
- Can be painful, unsuccessful or result in worsened condition

DNR or DNI
- DNR does not mean stop caring for patient or stop all life sustaining treatment
- DNI (do not intubate)-may still want CPR
- Must be signed by HCP

Withdrawal or withholding of treatment
- Prepare family for what to expect
- implement comfort orders prior to treatment withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Care for Changes r/t Approaching Death

Speech
Circulation (2)
Respirations (3)

A

Speech
- talk to pt as you normally would b-c hearing is last sense to go

Circulation
- apply blanket
- no electric blankets or heat packs

Respiration
- Positioning ( Elevate HOB, turn head to side)
- give anticholinergics or scopolamine to decrease secretions
- oral suctioning not helpful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Old categories (4)

A
  • Young old (65-74)
  • Middle old (75-84)
  • Old old (85-99) - Fastest growing; described as frail (geriatric syndrome w/ unintentional weight loss; weakness and exhaustion and slowed physical activity in older adults)
  • Elite old (100+)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Older Adult: General Physiological Changes (6)

A
  • Decreased adaptability
  • Impaired organ function
  • Decreased reaction time
  • Impaired memory of recent events
  • visual changes: presbyopia (farsighted r/t age), glaucoma (may need meds or surgery), cataracts (may need surgery), macular degeneration, diabetic retinopathy
  • impaired hearing (presbycusis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Older Adults: ADL Changes (4)

A
  • Greater risk for functional decline (Need assistance w/ 2+ ADLs prior to admission)
  • Loss of autonomy and increased dependence r/t mental and physical changes of aging or illness
  • inability to drive (increased MVA)– can decrease independence
  • mobility concerns (increased sleep; need for cane or walker; increased falls)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Older Adults: Psychosocial changes (5)

A
  • Impaired stress response
  • ageism (discrimination r/t age)
  • impaired socialization r/t loss of significant others
  • increased elderly individuals in prison or homeless
  • increased drug usage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Older Adults: Diet/ nutritional changes (7)

A
  • Dietary fat < 30% of calories (<10% from saturated fat)
  • Increase calcium to b/w 1000-1500 mg daily
  • Daily vitamin D supplement or 10-15 min sun exposure
  • Increased vitamin C and A
  • Reduce total calories if sedentary lifestyle
  • Drink 2 L of fluid a day (may need Colon cocktail: prune juice, applesauce, psyllium to prevent constipation)
  • 35-50 g of fiber each day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Health Protecting behavior for Older Adults (6)

A
  • Yearly physical and eye exam
  • vaccinations (Influenza, shingles, Pneumococcal, Tetanus (booster every 10 yr))
  • Drink ETOH in moderation (<1/day) or not at all
  • Avoid smoking
  • Create a hazard-free environment (No scatter rugs, waxed floors; Grab bars in bathroom; Install smoke detectors/sprinklers in home)
  • Exert autonomy and control as much as possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Older Adults: Inadequate or Decreased Nutrition

Contributing factors (8)

A
  • Diminished sense of taste, smell (Results in loss of desire for food)
  • Inappropriate/unbalanced foods (fast foods)
  • Excess meds and OTC drugs (can decrease appetite, affect food tolerance and absorption, and lead to constipation)
  • Tooth decay, tooth loss, poorly fitting dentures (r/t inadequate dental care and calcium loss)- may lead to avoidance of nutritious foods
  • reduced income
  • Chronic disease/ Fatigue
  • Decreased ability to perform ADLs
  • Loneliness, depression and boredom (may lead to lack of eating and weight loss)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Older adults: Inadequate or Decreased Hydration

Contributing factors (3)
Care (4)

A

Risk factors
- less body water
- decreased thirst sensation
- Limiting fluid intake in evening due to decreased mobility, diuretics, and urinary incontinence

Care
- Incontinence increases w/ dehydration b-c concentrated urine irritates bladder
- Drink 2 L of water a day plus other fluids
- Avoid excess caffeine and alcohol
- Know s/s of dehydration (dark urine, weight loss, poor skin turgor, dry mucus membranes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Older Adults and Hospital Patients: Inadequate or Decreased Nutrition

Care for inadequate nutrition (7)

A
  • Perform nutritional screenings on the 1st day of pt. admission (include Nutritional hx, wt., ht., and BMI)
  • Do an oral exam to understand why patient may only eat soft/low fiber foods
  • Collaborate w/ RDN about the patient’s nutritional status
  • Collaborate w/ SLP about problems swallowing or chewing
  • Encourage to use herbs instead of salt and sugar b-c may overuse them
  • Get social work involved for food bank programs
  • manage symptoms that may impair nutrition (pain w/ analgesic; NV w/ antiemetic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Older adults: Decreased Mobility

Care (5)

A
  • Assess older adults in any setting about hx of exercise and any health concerns
  • Teach importance of physical activity 3-5x a week for at least 30 minutes
  • Encourage sedentary adults to slowly start their exercise programs
  • If patient is homebound, focus is performing ADLs
  • walking and swimming are good choices (walking is best because it is weight bearing and can help prevent osteoporosis and build bones)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Accidents: Falls in Older Adults

Risk factors for falls (8)
Fall risk Assessment (3)

A

Risk factors
- Hx of falling (most important predictor of falls)
- Multiple illnesses
- Generalized weakness or decreased mobility
- Changes in sensory perception (r/t age or drugs)
- impaired body orientation r/t decreased sense of touch -> decreased reaction time
- Urinary incontinence or nocturia
- Communication impairment (disorientation, confusion)
- Alcohol/substance abuse

Assessment (fall risk assessment)
- Observation of Gait (wobbly?); Footwear (closed toe? Sturdy?); assistive devices (cane? Walker? Glasses?)—Do they use them?
- Past medical hx (Diabetic neuropathy?, arthritis?, peripheral neuropathy?)
- Drug assessment (Drug side effects?) i.e. Antihypertensives and orthostatic hypotension; Opioids and CNS depressant effects of drowsiness and acute confusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Accidents: falls

Impact of falls (2)
Prevention (8)

A

Impact of falls: fractures and fallphobia (esp if osteoporosis)

Prevention
- Ensure hydration b-c dehydration can cause incontinence due to bladder irritation
- RN communicate hazards on their health literacy level
- Safeguards (handrails, grab bars, slip proof rugs, adequate lighting)
- No scatter rugs, slippery floors, clutter
- Pt avoids going out on bad weather days (slippery or icy)
- ask for help when needed esp. toileting
- use assistive devices i.e hearing aids, glasses, walker, cane,
- keep bed low and locked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Older Adults: Drug Use

Concerns (3)

A
  • Intolerance to standard drug dosages (use “Start low and go slow” policy)
  • Opioid Use (increased due to use for acute and chronic conditions w/ persistent pain)
  • increased risk of adverse drug events due to polymedicine/polypharmacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Older adults: Age-related changes of Pharmacotherapy

  • Metabolism (3)
  • Excretion (3)
A

Metabolism (monitor liver function tests)
- Decreased liver size
- Decreased liver blood flow
- Decreased serum liver enzyme activity

Excretion (get renal function test esp. Crt clearance)
- Increased BUN and Crt
- Reduced renal blood flow
- Reduced GFR and creatine clearance (leads to slower excretion; decreases by 6.5 mL/min per decade of life)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Older adults: Age-related changes of Pharmacotherapy

  • Absorption (3)
  • Distribution (4)
A

Absorption
- Decreased GI motility
- Decreased GI blood flow
- Increased gastric pH

Distribution
- Smaller amount of total body water
- Decreased albumin level
- Increased ratio of adipose tissue to lean body mass (leads to increased storage of lipid-soluble drugs in tissue vs plasma)
- Decreased cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Older adults: Factors for improper self-administration of drugs (7)

A
  • Poor communication with HCP r/t poor explanations due to educational limits, language barriers or difficulty hearing and vision
  • Make errors (Forget to take; Duplication (think 2 is better than 1); use wrong drugs
  • Take OTC drugs that interact with prescribed drugs (Ex. Clopidogrel, aspirin, warfarin for anticoagulation, ibuprofen for arthritis and garlic for hypertension = bleeding risk)
  • Discontinue drug therapy due to cost, fear of dependency or side effects)
  • use leftover drugs from previous illness
  • Borrow from others
  • Use more than one pharmacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Older adults: Medication assessment and health teaching (6)

A
  • Obtain complete drug list (OTC, prescribed, herbs, supplements)
  • Highlight all drugs that are part of Beers criteria ( drugs where harm > benefit for elderly (ex. Benadryl, ketorolac)
  • Assess for duplicate drugs (Ex. Warfarin from two pharmacies)
  • Give verbal and written information at appropriate knowledge level
  • Encourage to take drugs exactly as prescribed (do not share or borrow drugs)
  • Be Aware of common adverse drug events (ADEs) (Hypotension from HTN drugs; Edema; Syncope; Dehydration from diuretics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Beer’s Criteria Drugs

A
  • meperidine
  • oxycodone
  • cyclobenzaprine
  • digoxin (Should not exceed 0.125 mg daily except for a-fib)
  • Ticlopidine
  • fluoxetine
  • amitriptyline
  • diazepam
  • promethazine
  • diphenhydramine
  • ketorolac
  • short-acting nifedipine
  • ferrous sulfate (Should not exceed 325 mg daily)
  • chlorpropamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Older adults: Tips for better drug self-administration (5)

A
  • Encourage use of pill boxes or associating pills w/ daily events
  • Use large print on drug label for poor vision
  • Write drug regimen on bottle
  • Colored labels
  • Easy to open bottle caps for limited hand mobility and strength
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Older Adults: Depression

Assessment
Treatment (3)

A

Assessment
- Geriatric Depression Scale (15 yes or no questions; > 10 = possible depression)

Treatment
- SSRI (takes 2-3 weeks to start working)
- TCAs have anticholinergic properties and should not be used (side effects: acute confusion, severe constipation, urinary retention or incontinence)
- Nonpharmacological: psychotherapy; reminiscence, music therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Older Adults: Dementia

What is it?
Prevention (4)

A
  • Slow, progressive and chronic global impairment of intellectual function

Prevention of cognitive changes in older adults
- Cognitive training (learning new skill)
- Physical and mental activity
- Social engagement
- Proper nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Older Adults: Alcohol Use

CAGE Screening (4)

A
  • Have you ever tried to cut down on your drinking?
  • Have people annoyed you by criticizing your drinking?
  • Have you ever felt bad or guilty about your drinking?
  • Have you ever had a drink first thing in the morning to settle your nerves? (eye-opener)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

SPICES

What does it stand for?
Risks of SPICES (3)

A

SPICES or geriatric vital signs
* Sleep disorders
* Problems with eating or feeding
* Incontinence
* Confusion
* Evidence of falls
* Skin breakdown

Risks: longer hospital stays, higher medical cost, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Older adults: Skin breakdown

Two problems
Care (5)

A

Two problems
- Skin breakdown (esp. pressure ulcers)
- Skin tears esp. the old-old and those on chronic steroid therapy b-c increased capillary fragility)

Care
- Prevention of pressure ulcers ( Nutritional support (protein), turn, reposition q2h, mobility/activity plan of care, moisture barriers, good hygiene)
- Use the Braden scale daily
- Coordinate w/ RDN and WOCN
- Assess skin q8h for reddened areas that do not blanch and report any open areas (Encourage UAP to report any reddened areas so RN can assess)
- Use a gentle touch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

ABGs: Age-related changes (4)

A
  • CO2 does not change with age
  • PaO2 decreases w/ age r/t V/Q matching changes (Expected value = 80 mm Hg minus 1 mm Hg for every year > 60)
  • Reduced size and function of the kidneys (Loss of nephrons; Decreased renal blood flow)
  • Underlying conditions that may result as one ages Ex. COPD (respiratory acidosis), DKA (metabolic acidosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

ABGs: Normal values (4)

A
  • pH 7.35-7.45
  • CO2 35-45 (Ventilatory failure if > 50)
  • HCO3- 22-26
  • PaO2 80-100 mm Hg (never should be < 40)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

ABGs: Compensation equations (3)

A
  • ph abnormal + one abn. value = uncompensated
  • ph abnormal + two abn. values = partial compensation
  • ph normal + two abn. values = full compensation (determine primary disorder by seeing if pH on acidic (7.35-7.4) or alkalinic side (7.4-7.45) of normal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Head and Neck Cancer

What is it?
Progression (4)

A
  • slow growing squamous cell carcinoma

Progression
- Begins with mucosa that is chronically irritated
- mucosa becomes tougher and thicker from irritation and genes for cell growth damaged
- metastasis to Lymph nodes, muscles, bone i.e. nearby structural areas
- fatal when metastasis to organs (lungs, liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Head and Neck Cancer

  • Prognosis (3)
  • Consequences (4)
A

Prognosis
- dependent on location and extent of tumor
- curable when treated early
- fatal in 2 yrs if not treated due to airway obstruction

Consequences
- impaired gas exchange (inability to breath)
- impaired nutrition (inability to eat)
- impaired self-image (impaired facial appearance)
- impaired communication (inability to speak)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Head and Neck Cancer: Risk Factors

Main (2)
Others (8)
What is not a risk factor?

A

Main: tobacco and alcohol (worse when together)

Others
- men more than women
- > 60 yrs
- poor oral hygiene
- chronic laryngitis
- voice abuse
- chemical or dust exposure
- long-term GERD
- oral infection w/ HPV

FAMILY HISTORY IS NOT A RISK FACTOR FOR HEAD AND NECK CANCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Head and Neck Cancer: warning signs (12)

A
  • Pain
  • Lumps in mouth, throat, neck
  • Color changes in mouth or tongue (leukoplakia (white, patchy); Erythroplakia (red, velvety); black; gray; dark brown)
  • Oral lesion or sore that does not heal in 2 weeks (may have burning sensation from hot liquids or citrus juice
  • Persistent/unexplained oral bleeding
  • Numbness of mouth, lips, or face
  • Change in denture fit
  • Hoarseness or change in voice quality
  • Persistent, unilateral ear pain
  • Persistent/recurrent sore throat or difficulty swallowing
  • Shortness of breath
  • Anorexia and weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Head and Neck Cancer: Diagnostics

Labs (5)
Diagnostic tests (4)

A

Labs
- chronic alcohol use or poor nutrition (low albumin)
- metastasis to liver (increased AST, ALT)
- metastasis to kidney (increased BUN, Crt)
- CBC, Bleeding times, and blood chemistries
- Urinalysis

Diagnostics
- direct and indirect laryngoscopy OR bronchoscopy under anesthesia to define extent of tumor
- Biopsy to confirm diagnosis, tumor type, cell features, location, and stages
- X-ray of skull, sinuses, neck, and chest
- CT and MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Head and Neck Cancer: Treatments (3)

A
  • Radiation
  • chemo
  • surgery (laryngectomy– requires trach)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Laryngectomy: Potential complications (5)

A
  • Airway obstruction (priority)- s/s: restlessness
  • Hemorrhage (esp. if wound exposes carotid artery)– call RRT if blood leaking and do not touch b-c can rupture carotid artery; apply continuous pressure if carotid artery ruptures
  • wound breakdown (Risks: poor nutrition, long smoking hx, chronic alcohol use, wound contamination, radiation therapy prior to surgery)
  • Tumor recurrence
  • nutritional deficiencies (may have taste changes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Total Laryngectomy: Speech and Language Rehabilitation

Options for Speech (3)

A
  • Electronic devices (picture board, smart phone, computer)
  • Mechanical device (sound vibrates air inside mouth and throatwhile patient moves lips and tongue; produces robotic sound)
  • esophageal speech (patient burps swallowed air to produce speech; produces monotone sound)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Laryngectomy Care: Monitoring for hemorrhage and wound breakdown (4)

A
  • Suture line of stoma care q1-2h during first few days post-op then q4h
  • Surgical drain collects blood and drainage for 72 hrs post-op
  • Monitor and record amount and character of drainage; cap refill; and activity of major BVs in region (Secretions blood tinged for 1-2 days)
  • Report sudden increase or decrease of drainage to surgeon (may be clot if sudden stoppage of drainage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Laryngectomy care: Promoting adequate nutrition (6)

A
  • feeding tube usually for 7-10 days post-op and removed when swallowing is safe per Swallow study
  • PEG > NGT to prevent aspiration
  • give diet high in protein and calories
  • small amounts of food at a time
  • may need thickened liquids
  • collaborate w/ RDN and SLP b-c at risk for aspiration, speech, and nutritional problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Prevention of Aspiration

Care (5)

A
  • tuck chin when swallowing
  • use supraglottic swallowing (Valsalva maneuver and swallow twice to clear food that may pool in pharynx; exaggeration of normal protective mechanisms)
  • observe for aspiration or aspiration pneumonia and report immediately (aspiration not possible after total laryngectomy b-c airway totally separated from esophagus)
  • NO oral intake until swallow study done
  • collab w/ SLP and RDN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Laryngectomy: Self-Management Education (7)

A
  • Avoid swimming
  • Lean forward and cover stoma when coughing, sneezing (may need to cover when laughing and crying as well)
  • Wear stoma guard or loose clothing to cover stoma to prevent water from entering airway when showering
  • Clean stoma with mild soap and water
  • Lubricate stoma with non-oil based ointment
  • use alt communication methods
  • use MedicAlert bracelet and emergency card for life-threatening situations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

7 Nursing Care for patient w/ chest tube

A
  • Inspect insertion site( eyelets of tube should not be visible; s/s of infection (redness, purulent drainage, excess bleeding))
  • Palpate Insertion Site (may have subQ emphysema if puffiness or crackling
  • Ensure Intact Dressing at Site
  • Assess/reassess Respiratory Status (breathing, pulse ox, breath sounds)
  • Observe Trachea (tension pneumothorax if shifted)
  • Assess/reassess Pain (give meds and reposition)
  • Encourage Cough, Deep Breathing, Incentive Spirometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

9 Nursing Care for chest tube system

A
  • Avoid kinks, Occlusions, or Loose Connections (should be straight)
  • Do NOT Strip/Milk Tubing
  • Keep Drainage System Below Level of Chest
  • Assess for “Tidaling” (water level rises inhalation and fall exhalation) - if not present, may be obstruction
  • bubbling seen on exhalation, forceful cough, position changes (EXCESS BUBBLING = air leak)
  • Always have at least 2 cm of water to prevent air from returning to patient in water seal chamber
  • Limit clamping of a chest tube b-c will increase pressure in pleural space and may cause tension pneumothorax
  • No need to disconnect chest tube for transport
  • never let drainage come in contact w/ tubes (can cause tension pneumothorax)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

8 emergency situations w/ chest tubes

A
  • Tracheal deviation from midline
  • Sudden onset or increased intensity of dyspnea
  • O2 sat <90%
  • Drainage greater than 100 mL/hr, fresh blood, sudden increase in drainage
  • Visible eyelets on chest tube
  • Chest tube falls out of the patient’s chest
    (cover the area with dry, sterile gauze; leave one side out so air can continue to escape chest and prevent tension pneumothorax)
  • Chest tube disconnects from the drainage system (put end of tube in a container of sterile water and keep below the level of the patient’s chest)
  • Drainage in tube stops (in the first 24 hours)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Older Adults: Age-related changes in Gas exchange (9)

A
  • Sarcopenia (age-related muscle atrophy) and weakened respiratory muscles
  • Decreased chest wall movement (stiffens) and size
  • Air trapping = increased residual volume causing thinned and enlarged alveoli
  • Reduced sensitivity to hypoxia and hypercarbia
  • Decreased pulmonary reserve
  • Decreased pulmonary perfusion capacity
  • increase Dyspnea
  • Difficulty coughing up secretions r/t decreased cilia beat frequency in airways
  • Decrease in ability to protect against environmental injury and infection (r/t decreased T-cell, nutrition, swallowing ability, and mucociliary clearance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Bronchoscopy

Minor complications (4)
Major complications (4)

A

Minor complications: Laryngospasm/Bronchospasm, fever, vomiting, epistaxis

Major complications
- anaphylaxis
- Cardiac (hypotension, arrhythmias, hemorrhage, CODING/ cardiopulmonary arrest)
- respiratory (respiratory failure, hypoxemia, pneumothorax)
- infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Ventilation-perfusion (V/Q) scan

Indication
Process (2)
Results (2)
Complications (3)

A

Indications: Diagnosis (determine if occlusion of pulmonary artery, respiratory or perfusion problems esp. PE)

Process
- Ventilation: radiolabeled gas inhaled via mask into lungs
- Perfusion: radioisotope injected into veins and travels to lung tissue

Results
- Normal= perfusion scan is normal
- V/Q mismatch i.e. diminished radioactivity on perfusion scan indicates obstruction i.e pulmonary embolus

Complications
- Bleeding at injection site
- infection at site
- Allergy to injection dye (anaphylaxis)– rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Bronchoscopy

Indication (2)
Post procedure care (2)

A

Indications (at bedside by HCP)
- Diagnosis (r/t hemoptysis; post-chest trauma; chest or face burn; post-aspiration; difficult intubation; airway obstruction)
- therapeutic (reverse aspiration, help w/ difficult intubation; removal of secretions or growths; atelectasis)

Post procedure Care
- Observe sputum for hemorrhage (Expected: slightly bloody due to trauma)
- Ensure gag reflex returns and anesthesia wears off before patient eats or drinks (about 2 hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Bronchoscopy

Pre procedure Care (4)
Pre procedure meds (5)

A

Pre procedure Care
- Chest x-ray
- Clotting studies (PT, aPTT, Platelet)
- ABGs (oxygen during procedure if hypoxemic)
- No oral intake for 6-8 hrs to prevent aspiration

Pre-op meds
- Topical anesthetic
- Benzo for sedation
- Opioid for pain
- Atropine to reduce vasovagal response and secretions
- IM Codeine to reduce cough reflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Tension Pneumothorax: Clinical Manifestations (6)

A
  • Tracheal deviation (away from affected due to compression of heart)
  • Respiratory distress (dyspneic, cyanotic
  • Reduced or Absence of breath sounds on affected side (hyperresonance)
  • Distended neck veins
  • Hypotension
  • Hemodynamic instability (cyanotic, sudden chest pain, tachycardia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Hemothorax

  • Causes (2)
  • Classifications (2)
  • Interventions (3)
A

Causes
- Blunt or penetrating trauma
- Lesser trauma if tendency to bleed (i.e. on anticoagulants)

Classifications
- Simple: < 1L blood loss (May not exhibit manifestations)
- Massive: > 1L blood loss

Interventions for massive (simple may resolve on own)
- chest tube to remove blood and prevent infection
- Fluids
- Open thoracotomy if massive or persistent bleeding at 150-200 mL/hr over 3-4 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Hemothorax: Clinical Manifestations (7)

A
  • Respiratory distress (dyspnea, cyanosis, tachypnea)
  • Blood visible on chest x-ray
  • Hypovolemia
  • Decreased breath sounds (no extra sounds)
  • Shock possible (tachycardia)
  • Dull to percussion
  • Chest pain r/t hypoxia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Flail Chest: Clinical manifestations (7)

A
  • Respiratory failure (dyspnea, cyanosis,) r/t intrathoracic injury and inadequate diaphragmatic movement
  • Shock (decreased BP, increased HR)
  • Paradoxical movement of the chest (Inspiration: in; Expiration: out) leads to increased work of breathing
  • severe Pain and anxiety
  • Decreased chest expansion leads to decreased ventilation
  • Risk for hemothorax or pneumothorax
  • chest deformity and crepitation over fractured ribs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Flail Chest

Description (2)
Care (6)

A

Description
- Fractures of at least two neighboring ribs in two or more places or separation of rib from cartilage
- Result of blunt chest trauma

Care
- Oxygen (or mechanical ventilation if respiratory failure or shock)
- PEEP if severe hypoxemia and hypercarbia
- Pain and anxiety management (talk slow, explain everything)
- Promote lung expansion via deep breathing and positioning
- Secretion clearance via coughing and tracheal suctioning
- Monitor VS, ABG, f/e balance, vital capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Acute Lung Failure

Definition (3)
Labs/Diagnostics (5)

A

Definition
- Physiologically defined condition w/ inadequate exchange of O2 & CO2
- Body is not able to meet the need for O2 at rest
- most common organ failure in ICU

Labs/Diagnostics
- ABG analysis– most specific indicator for evaluating effectiveness of therapy (PaO2 < 60 mm Hg; Hypercapnia (HCO2 > 45))
- Blood/sputum cultures (may be done via bronchoscopy)
- Electrolytes, urinalysis, CBC
- Cardiac- 12 lead EKG; Pulmonary artery catheter if severe (all hemodynamic factors)
- Thoracic CT and Chest x-ray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Acute Lung Failure: Clinical Manifestations

  • CNS (4)
  • Cardiac (5)
  • Pulmonary (5)
A

CNS
- Restless
- Headache
- Decreased LOC (confused, drowsy)
- ischemic-anoxic encephalopathy

Cardiac
- Decreased cardiac output (hypotensive, systolic HTN)
- Dysrhythmias
- Chest pain
- palpitations
- VTE (Prevent: SCDs, heparin)

Pulmonary
- respiratory distress (retractions, nasal flaring)
- Rapid shallow breathing and Dyspnea/SOB
- Tripod position
- Active abdominal movement
- Cyanosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Acute Lung Failure: Clinical Manifestations

  • GI (6)
  • Renal
  • Skin
A

GI
- Decreased GI blood flow
- Ascites and Abdominal distention
- Anorexia
- NV
- Constipation
- Stress ulcers (Prevent: H2 antagonists, PPIS)

Renal (Impaired renal blood flow (decreased urine output)

Skin (Cool, clammy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Acute Lung Failure: Oxygen (4)

A
  • Delivery system should be tolerated by patient AND lowest FiO2 to maintain O2 sat > 90%
  • Use positive pressure ventilation if intrapulmonary shunting present
  • Noninvasive okay unless rapid deterioration
  • Use A/C mode
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Acute Lung Failure: Drug Therapy (6)

A
  • Relief of bronchospasm via smooth muscle relaxation (bronchodilators)
  • Reduction of airway inflammation (corticosteroids)
  • Reduction of pulmonary congestion (diuretics)
  • Treatment of pulmonary infections (antibiotics)
  • Reduction of severe anxiety, pain, and agitation (sedatives, analgesics, neuromuscular paralysis)
  • Sodium bicarbonate if metabolic acidosis severe (pH < 7.2), dysrhythmias, or refractory to therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Acute Respiratory Distress Syndrome

Definition (2)
Pathophysiology (3)

A

Definition
- sudden progressive form of acute respiratory failure
- pulmonary manifestation of MODS

Patho
- Alveolar capillary membrane becomes damaged and more permeable to intravascular fluid
- Alveoli fill with fluid and collapse causing noncardiac pulmonary edema
- Lung compliance drops and they become stiff

Timing: within 1 week of problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

ARDS: Diagnostics (3)

A
  • chest x-ray (whited out, bilateral infiltrates)
  • ABGs (low PaO2 (refractory hypoxemia even w/ O2 administration) OR low PCO2 (due to hyperventilation then increases w/ fatigue)
  • PaO2/FiO2 ratio: < 200 due to poor lung function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

ARDS: Early Signs (5)

A
  • respiratory distress (tachypnea, dyspnea, use of accessory muscles, suprasternal retractions
  • cough
  • restless, apprehension
  • scattered crackles
  • weight gain or loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

ARDS: Late signs (7)

A
  • Tachycardia to bradycardia
  • Hypo to hypertension
  • Diaphoresis
  • Cyanosis
  • Pallor
  • changes in sensorium with decreased mentation (somnolence, agitation)
  • Extracardiac sounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

ARDS: Medical Management (5)

A
  • drugs to regulate and increase BP (norepinephrine)
  • PRBCs for hemodynamic support
  • Fluid restriction and diuretics for pulmonary HTN
  • Treat underlying infection and trauma (i.e. sepsis)
  • Sedation and analgesia that balance both comfort and desired ventilatory status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

ARDS: Ventilation Management (4)

A
  • suction PRN for secretion clearance
  • give lowest oxygen (< 0.5 to maintain sat O2 > 90%)
  • Low tidal volume (6 mL/kg) to limit barotrauma and volutrauma
  • Use PEEP (positive end expiratory pressure) – 10-15 cm H2O adequate – risk for barotrauma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

ARDS: Prone Positioning

Use (4)
Contraindications (3)

A

Uses
- Improves V/Q matching
- Improves oxygenation in patients with ARDS b-c Good lung down to the ground ( least damaged lung in dependent position)
- Reduces aspiration risk via mobilization of secretions
- Decreases intrapulmonary shunting

Contraindications
- increased ICP or spinal cord injury
- hemodynamic instability
- recent abdominal surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

ARDS: Rotation Therapy

Use (2)
Types (2)
Complications (3)

A

Use
- Helps with V/Q matching to improve oxygenation
- Prevents further pulmonary complications r/t mechanical ventilation and bedrest

Types
- Kinetic therapy (> 40 degree continuous rotation)- Decreases VAP incidence
- Continuous lateral rotation therapy (CLRT)– <40 degree continuous rotation

Complications
- Dislodgment or obstruction of tubes/lines/drains
- Pressure injuries (NURSE must still turn pt q2h)
- Hemodynamic instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

ARDS: Prone Positioning

Complications (6)

A
  • tube/drain obstruction (care: move out of way)
  • Hemodynamic instability
  • Massive facial edema
  • Pressure injuries (care: continue to turn as needed)
  • Aspiration
  • corneal ulcerations (care: lubricate and close eyes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

ARDS: Treatment Complications (5 and prevention)

A
  • Hospital-acquired pneumonia
    Prevention: HOB elevate, hand hygiene
  • Barotrauma (r/t rupture of overextended alveoli from excess pressure)–s/s: subQ emphysema, sternal pain, clicking sound over heart, friction rub
    Prevention: smaller volumes of PEEP
  • Volutrauma (r/t too much volume ventilating non compliant lungs)
    Prevention: smaller tidal volumes
  • Stress ulcers r/t decreased GI blood flow
    Prevention: PPIs, H2 antagonists, enteral nutrition
  • Renal failure r/t decreased renal blood flow, hypotension, hypoxemia, hypercapnia
    Prevention: limit nephrotoxic antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Artificial Airway: Oral Care (5)

A
  • q2h and as needed b-c increased bacteria r/t decreased saliva, poor mucosal status and dental plaque
  • Brush teeth and stimulate gums and tongue w/ swab
  • No glycerin, alcohol, hydrogen peroxide because drying effects
  • deep oropharyngeal suctioning for pooled secretions (painful for subglottic secretions so give pain meds or sedation)
  • 2% chlorhexidine q4-6h
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Artificial Airway: Skin Care (4)

A
  • Pad pressure points if s/s of irritation
  • Lubricate nares, face, lip w/ nonpetroleum cream to prevent drying effect
  • Maintain cuff pressure (Low-pressure, high volume
  • Monitor cuff pressure every shift to maintain within 20-30 cm H2O (< 20 = increased risk of aspiration; > 30 = decreased blood flow to capillaries in tracheal wall (report to HCP))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Artificial Airway: Suctioning (sterile)

Complications (7)

A
  • Hypoxemia r/t disconnected oxygen
    Care: stop suctioning if O2 < 90%
  • Atelectasis r/t suction catheter > ½ diameter of ETT and excessive negative pressure or prolonged suctioning
  • Bronchospasms r/t stimulation of airway w/ catheter
    Care: Give bronchodilator
  • Dysrhythmias (bradycardia, heart block, v-tach) r/t vagal stimulation
    Care: Stop suctioning and hyperoxygenate
  • Increased ICP
  • Airway trauma r/t impact of catheter in airways and excessive negative pressure
  • Infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Artificial airway: suctioning

Care (5)

A
  • Hyperoxygenate with 100% oxygen for 30-60 sec prior to suctioning and 60 seconds after suctioning
  • Use < 150 mm HG of suction to reduce hypoxemia, atelectasis and airway trauma
  • Limit number of times patient is suctioned
  • Suction 10-15 secs continuously on the way out to reduce hypoxemia, airway trauma, cardiac dysrhythmias (Intermittent suction during withdrawal leads to secretion dropping)
  • Suction mouth or nose after suctioning artificial airway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Artificial Airway: Suctioning

Indications (6)

A
  • Rhonchi or wheezes (usually not for crackles)
  • Coughing
  • visible secretions in airway or indicated by dyspnea
  • Sawtooth pattern on flow-volume loop on ventilatory
  • Increased peak airway pressure on ventilator
  • Acute respiratory distress (increased RR (indicates hypoxia), HR; restless; decreased O2 sat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Mechanical Ventilation

Definition
Indications (4)
Types (2)

A

Definition: process of using an apparatus to facilitate transport of O2 and CO2 b/w atmosphere and alveoli to enhance pulmonary gas exchange

Indications: Ventilation, oxygenation, airway and lung protection, secretions

Types of ventilators
- Positive-pressure: intubated and on machine via ETT or Trach; mechanical drive to force air into lungs
- Negative-pressure: on machine but via mask; decrease atmospheric pressure around thorax to initiate inspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Basic Ventilator Settings

  • Modes (3)
  • Rate
  • Tidal Volume
  • PEEP (2)
  • FiO2 (2)
A

Mode of ventilation
- Assist Control (AC)
- Synchronized Intermittent Mandatory Ventilation (SIMV)
- Continuous Positive Airway Pressure (CPAP)

Rate: respiratory rate (6-30 breaths/min)

Tidal volume (VT): volume or size of the breath (6-10 mL/kg (4-8 mL/kg in ARDS)

Positive-end expiratory pressure (PEEP)
- amount of pressure remaining in the lung at the END of the expiratory phase; keeps alveoli from collapsing (3-5 cm H2O)
- Risks of too much PEEP: barotrauma, decreased venous return

FiO2
- fraction of inspired oxygen (Range: 21%-100%)
- prefer <50% to maintain O2 sat > 92% and PaO2 > 60 mm Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Ventilator Modes: Assist/Control (Continuous mandatory ventilation)

  • How it works? (2)
  • Indications (2)
  • Care (2)
A

How it works
- Delivers a “machine breath” every time, whether the pt. triggers the breath or the ventilator initiates the breath (time-triggered)
- patient cannot generate spontaneous volume or flow rate

Indications
- Volume controlled AC if weak respiratory muscles but spontaneous breathing (Risk for volutrauma)
- Pressure controlled AC if decreased lung compliance, increased airway resistance or risk for Volutrauma (Risk for hypercapnia)

Care
- Hyperventilation risk if patient increases their respiratory rate
- Sedation may be needed to limit # of spontaneous breaths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Ventilator Modes: Synchronized Intermittent Mandatory Ventilation (SIMV)

  • How it works? (3)
  • Indications (3)
  • Risk
A

How it works
- Delivers a pre-set number of breaths at a set volume or pressure and flow rate.
- Allows the patient to generate spontaneous breaths, volumes, and flow rates between the set breaths.
- Detects a patient’s spontaneous breath attempt and doesn’t initiate a ventilatory breath – prevents breath stacking (A/C does not prevent breath stacking)

Indications
- Volume controlled if weak respiratory muscles but spontaneous breathing
- Pressure controlled if decreased lung compliance, increased airway resistance or risk for Volutrauma (Risk for hypercapnia)
- used for weaning

Risk
- May increase work of breathing and promote respiratory muscle fatigue when used for weaning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Ventilator Modes: Pressure Support

How it works? (2)
Use
Risk
Pros (3)

A

How it works?
- Positive pressure applied only on patient- initiated breaths on inhalation to augment efforts (similar to PEEP but only on inhalation vs. expiration)
- Patient’s lung mechanics and efforts controls rate, inspiratory flow, and tidal volume

Use: for pt w/ stable respiratory drive to overcome mechanical resistance

Risk: Hypercapnia

Pros
- Reduces work of breathing
- increases ventilatory synchrony
- Can be used with SIMV or CPAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Ventilator Modes: Continuous Positive Airway Pressure (CPAP)

How it works? (3)
Indication (3)

A

How it works?
- Positive pressure applied during spontaneous breaths (no ventilator breaths in PEEP or CPAP mode)
- Pt controls rate, inspiratory flow, tidal volume
- Similar to pressure support but without the additional inspiratory pressure

Indication
- used with masks for sleep apnea (negative pressure)
- used with ventilator (positive pressure)
- used for weaning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Mechanical Ventilation: Respiratory Complications (5)

A
  • Increased secretions (care: Suction PRN)
  • Oxygen toxicity (Continuous oxygen > 50% for > 24-48 hrs may injure lung and reduce tissue integrity) –Care: notify HCP if PaO2 > 90 mm Hg
  • Respiratory muscle weakness
  • Ventilator-Associated Pneumonia
  • Ventilator induced lung injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Mechanical Ventilation: Complications

CNS
GI (3)
Cardiac
Psychological (2)

A

CNS
- Increased ICP r/t decreased cerebral venous return

GI (prevent: NGT decompression, appropriate cuff inflation)
- Gastric distention r/t air leaks around ETT or trach cuff and overcomes resistance of lower esophageal sphincter
- Vomiting r/t pharyngeal stimulation from artificial airway
- Hypomotility and constipation r/t immobility and paralytic agents, analgesics, sedatives

Cardiovascular compromise
- Decreased Cardiac Output r/t decreased venous return to right side of heart

Psychological complications
- need for alternative communication
- Patient ventilator dyssynchrony (Risks: auto-PEEP, psychological distress, decreased effectiveness)
Care: ventilator accommodates patient’s spontaneous breathing pattern OR patient is sedated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Mechanical Ventilation: Oxygen Toxicity

Early signs (4)
Late signs (5)
Care

A

Early s/s: dyspnea, nonproductive cough, sternal chest pain, GI upset, crackles

Late s/s: decreased vital capacity and compliance; hypoxemia, pulmonary edema, hemorrhage, hyaline membrane formation and atelectasis

Care: notify HCP if paO2 > 90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Ventilator-induced Lung Injury

Causes (4)
Care (3)

A

Causes
- Barotrauma r/t too much PEEP
- Volutrauma r/t too much tidal volume
- Atelectrauma r/t shearing r/t repeated opening and closing of alveoli
- biotrauma r/t inflammatory-immune response (Leads to ARDS)

Care
- keep pressure at 32 or below cm H2O
- use PEEP
- tidal volume of 6-10 ml/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Mechanical Ventilation: ABCDE

A

Awakening
Breathing Coordination
Delirium monitoring
Early mobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Ventilator Assessment (4)

A
  • Assess settings and do they correlate with presentation (any desynchrony?)
  • High pressure alarms = airway obstruction b-c patient ventilatory desynchrony, airway resistance or kinked tubing
  • Low pressure alarm = leak or oxygen not connected
  • If vent malfunctions, disconnect patient from vent and Ambu bag patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Ventilator-Associated pneumonia

Definition
Risk factors (5)

A

Development of pneumonia 48-72 hrs after endotracheal or other artificial airway insertion intubation b-c tube bypasses normal defense mechanisms of lung

Risk factors
- severe illness
- increased age
- presence of ARDS or malnutrition
- naso intubation b-c promotes aspiration
- Gastric alkalization by enteral feeds and meds b-c promotes bacterial growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Prevention of VAP (7)

A
  • Hand hygiene
  • Elevation of HOB (30-45 degrees) to prevent GER and aspiration
  • Daily “sedation vacations” and assessment of readiness to extubate
  • Stress ulcer prophylaxis
  • DVT prophylaxis
  • Daily oral care (teeth, gums, and tongue) with chlorhexidine q2h
  • Adequate endotracheal tube cuff pressure (Keep at 20cm H20-decreases aspiration)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Prevention of Sedation Dependence: Daily Sedation Interruption

Contraindications (5)

A
  • hemodynamic instability
  • increased ICP
  • ongoing agitation or seizures
  • alcohol withdrawal
  • use of neuromuscular blocking agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Mechanical Ventilation: Drug Therapy

  • mucolytics
  • bronchodilators
  • steroids
  • sedatives (2)
  • paralytics (Nimbex/cisatracurium besilate) (3)
A

Mucolytics (Liquefy secretions to help with their removal)

Bronchodilators (beta 2 agonists and anticholinergics)
- Relax smooth muscles when air flow limitations

Steroids (Reduce airway inflammation)

Sedatives
- provide comfort
- Decrease work of breathing and prevent ventilator fighting

Neuromuscular paralysis (Nimbex-Cisatracurium besilate)
- Decreases oxygen consumption:
- sedate and explain all procedures to patient if giving paralytic b-c they do not inhibit pain or awareness
- risk for immobility complications so prevent skin breakdown, DVT, and atelectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Aspiration: Risk factors (4)

A
  • surgical changes in upper respiratory tract w/ laryngectomy
  • NGT
  • Difficulty swallowing r/t tracheostomy tube fixing larynx in place and cuff interfering with passage of food via esophagus
  • cuff pressure < 20 on trach tube (may partially deflate for easier swallowing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

QT Prolongation

Causes (5)
Risk
Treatment (4)

A

Causes
- electrolyte imbalance (hypokalemia, hypomagnesemia, hypocalcemia)
- bradycardia
- heart blocks
- PVC
- meds (antidysrhythmic (i.e. amiodarone), antibiotics, anesthetics, antidepressants, antiemetics, antipsychotics, opioids, sedatives)

Risk: torsades de pointes (v-tach)

Treatment: pacemaker, increase HR, stop meds, correct electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

ST Segment

How many boxes is it deviated?
NSTEMI (3)
STEMI (3)

A
  • deviated 3 small boxes up or down

Non-ST elevation MI (NSTEMI)
- No ST elevation
- T waves may be tall and symmetric
- troponin is elevated

ST elevation MI (STEMI)
- ST elevation in 2 or more consecutive leads
- T wave inversion
- troponin elevated as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Ventricular Dysrhythmias: Characteristics (3)

A
  • widened QRS complexes (> 0.12)
  • impulses from sinus and atrial nodes fail
  • lead to decreased perfusion and potential for cardiac arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Premature ventricular complexes (PVC)

What is it?
Causes (5)

A
  • Early ventricular contraction/irritability (misfiring in heart outside of SA node; unable to see P wave)

Causes
- electrolytes (hypokalemia, hypomagnesemia,
- drugs (smoking, caffeine, alcohol,,
- stress (infection or invasive procedure (cardiac cath, surgery))
- respiratory problems (hypoxemia, acidosis, COPD)
- heart problems (cardiomyopathy, ventricular aneurysms, CHF, MI, sympathomimetic drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Premature ventricular complexes (PVC)

Multifocal vs. unifocal
Repetitive Waves (4)

A

Multifocal vs. Unifocal
- Multifocal looks different and occur in different areas (more serious)
- Unifocal look the same and occurring in same place of heart

Repetitive Waves
- 2 PVCs- Couplets (two consecutive PVC)
- Bigeminy (after every normal beat)
- Trigeminy (after every two normal beats)
- 3 or more PVC’s in a row = Nonsustained run of V-tach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

PVCs: Nursing care (5)

A
  • if new or symptomatic, call HCP
  • If > 3 in a row, call MRT and give amiodarone or beta blockers
  • Check labs for hypokalemia or hypomagnesemia
  • check perfusion (HR, BP, palpitations, decreased peripheral pulses)
  • request 12-lead EKG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

V-tach: Characteristics (4)

A
  • most common ventricular dysrhythmia
  • Repetitive ventricular firing greater than 140 beats/min
  • no P waves
  • Nonsustained V-tach = < 30 seconds (sustained can progress to v-fib)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

V-Tach/v-fib: Causes (4)

A
  • Cardiac (MI, HF, Dig toxicity,valvular dysfunction, cardiomyopathy, hypotension, SVT)
  • Electrolytes (hypokalemia, hypomagnesemia)
  • Meds (steroids, antidysrhythmic drugs which prolong QT)
  • Drugs(cocaine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

V-tach: Care w/ carotid pulse (4)

A
  • slow pulse with amiodarone (alt: diltiazem, digoxin, lidocaine, procainamide)
  • use cardioversion (call HCP; can be elective or emergent)
  • give oxygen
  • Get informed consent and hold digoxin 48 hrs prior to elective cardioversion b-c increases risk of VF from shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

V-tach: Care w/o carotid pulse (4)

Note: same care for V-fib

A
  • Implement Code Blue/ ACLS Protocol
  • Defibrillate (priority after everyone clear and oxygen off)
  • CPR if no defibrillation and after defibrillation
  • Epinephrine q3 min if no HR and no pulse after IV established
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

V-fib: characteristics (4)

A
  • Total chaos in ventricle with no discernible waves or complexes
  • Ventricles quiver and no forward flow of blood which consumes oxygen
  • Non-perfusing rhythm (no BP, no HR, apnea; potential for seizures and acidosis)
  • fatal if not terminated in 3-5 min
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Myocardial Infarction: Priority Meds (4)

A
  • Morphine: For pain, anxiety, fear, reduces preload and afterload
  • Oxygen: To maintain >90% O2 sat
  • Nitroglycerin sublingual (vasodilation and increase cardiac output)–Risk for hypotension (hold if systolic <90 OR PDE5 inhibitor (sildenafil) in hx for erectile dysfunction or pulmonary HTN)
  • Aspirin (ASA): Prevents clumping of platelets and reduces mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Myocardial Infarction: Areas from outer to inner

Area of ischemia (2)
Area of Injury (2)
Area of Infarction (3)

A

Ischemia
- transient and reversible due to O2 deprivation
- Seen on ECG as T-wave inversion and ST depression

Injury
- injured but potentially viable tissue if circulation adequate
- Seen on ECG as ST elevation

Infarction (irreversible)
- Area of dead muscle (necrosis) in the myocardium which becomes scar tissue
- Delayed treatment = increased damage/area of infarction
- Seen on ECG as pathologic Q waves (deeper and wider than normal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

MI: Clinical Manifestations (7)

A
  • Angina (abrupt and not relieved by NTG); may be crushing, tightness, radiating
  • systolic murmur or S3/S4 sounds (r/t papillary muscle rupture, HF, pulmonary edema)
  • Pulmonary (dyspnea, tachypnea, crackles, wheezes)
  • Skin (diaphoresis)
  • Decreased cardiac outout) (tachycardia, hypotension, slow cap refill
  • Neuro (syncope, denial)
  • Muscular (weakness)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Diagnostics for MI (3)

A
  • Cardiac monitoring (12 lead EKG within 10 min of arrival to determine where MI is in the heart)
  • daily chest x-ray
  • echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Labs for MI (4)

A
  • troponin (q6-8h b-c not elevated immediately but elevated for 7-10 days)
  • Metabolic panel
  • CBC
  • B type natriuretic peptide (BNP) (Rule out heart failure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

MI: Other Drugs Purposes

  • Beta Blocker (2)
  • ACE Inhibitor and ARBs
  • Anticoagulant (2)
A

Beta Blocker
- Decrease mortality from ventricular dysrhythmias; lower BP, prevent reinfarction
- Hold if in cardiogenic shock, heart failure, heart block (PR >0.24) or active asthma

ACE Inhibitor and ARBs
- Prevent ventricular remodeling and HF

Anticoagulant (Heparin or Enoxaparin)
- enhance perfusion
- If thrombocytopenia, give direct antithrombotic (e.g., bivalirudin, argatroban)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

MI: Priority Non Pharmacological Care (4)

A
  • place two large bore IVs
  • Door-to-PCI within 120 minutes if need transfer to PCI-capable facility (90 min if PCI-capable hospital)
  • Balance myocardial oxygen supply and demand (use Bed rest w/ bathroom privileges and place upright for venous return, lower preload, decrease workload)
  • Prevent immobility complications (DVT, pneumonia) w/ early mobility and HOB 30 or more
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Fibrinolytics (tPA (ateplase); Reteplase (rPA) or Tenecteplase (TNKase))

Eligibility (2)
Exclusion (4)

A

Eligibility
- Onset of STEMI within 12 hrs
- <30 min after STEMI diagnosis

Exclusion
- Uncontrolled hypertension (need antihypertensives first)
- Ischemic stroke within 3 months
- Recent surgery, facial or head trauma
- Unstable angina or NSTEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

MI complication: Pericarditis

What is it?
S/s (4)
Care (3)

A
  • inflammation of pericardial sac during or after MI or CABG leads to pericardium irritation

S/s
- Cardiac Friction Rub (grating, scraping, leathery scratching at sternal border)- most common initial
- Chest pain (exacerbated by deep breathing/coughing and supine)- most common
- Pericardial effusion
- ST elevation in all EKG leads

Care
- NSAIDS/Aspirin
- Rest
- Pericardiocentesis (removal of fluid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

Fibrinolytics (tPA (ateplase); Reteplase (rPA) or Tenecteplase (TNKase))

Action
Care (5)

A

Action: lysis of acute thrombus to reopen obstructed coronary artery and restore blood flow; short half-life

Care
- Anticoagulants(heparin) for 48 hrs after
- Antiplatelets (clopidogrel) for 14 days to 1 year after
- Continue aspirin indefinitely
- Bleeding precautions (gently handling, avoid venipunctures, apply add’l pressure)
- STOP if IC bleeding or internal bleeding and give volume expanders and coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

MI: Other Drugs Purposes

Stool Softener
Inotropic (dobutamine, dopamine, milrinone)
Diuretic
Amiodarone (antidysrhythmias)

A

Stool softener
- prevent straining which can slow HR via vagal stimulation

Inotropic (dobutamine, dopamine, milrinone)
- Increase CO

Diuretic
- If elevated BNP, pulmonary edema, CHF exacerbation

Amiodarone (antidysrhythmias)
- If v-tach w/ pulse or a-fib w/ RVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

PCI: Nursing Interventions r/t to risk of bleeding (4)

A
  • Watch for S/S of bleeding (hematoma, hypotension, tachycardia; Back pain (retroperitoneal bleeding))
  • Assess insertion site and apply direct pressure if bleeding
  • HOB should be less than 30 degrees
  • Bedrest: Instruct to keep limb straight/minimize movement for 4-6 hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

PCI: Nursing Interventions r/t to risk for ineffective peripheral tissue perfusion (3)

A
  • Monitor neurovascular of affected extremity (distal pulses, cap refill, color, sensation, and temperature in involved extremity)
  • VS q15 for 1h, q30 for 1 hr, q1 for 4 hrs
  • Monitor for graft occlusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

PCI: Nursing Interventions r/t to risk of Angina (4)

A
  • Watch for increased chest pain r/t thrombosis or transient coronary vasospasm
  • Monitor EKG for ST elevation
  • Give IV NTG
  • Monitor labs for hypokalemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

PCI: Nursing Interventions r/t to risk of AKI (3)

A
  • Maintain hydration before and after (NS and/or sodium bicarb)
  • Check Crt, BUN, GFR prior
  • Avoid nephrotoxic drugs (NSAIDS, metformin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

MI: Signs of Reperfusion (4)

A
  • Chest pain stops due to return of blood flow
  • CK and troponin increase rapidly then decrease (a washout)
  • ST elevation returns to baseline (note Failure of fibrinolytic = inability to achieve 50% resolution of ST elevation within 60-90 minutes of med admin)
  • Reperfusion dysrhythmias (ex. PVCs, bradycardia, heart block, VT)- Usually self-limiting –> Care for PVCs: oxygen and correct f/e imbalance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

Components of Hemodynamic Monitoring (4)

A
  • Invasive catheter (Art-line least invasive)
  • 250-300 mm Hg pressure tubing with 0.9% NS flush solution
  • Transducer to convert physiologic signal into electrical energy
  • Bedside monitor to display volume of electrical signal on digital scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

Care for Hemodynamic Monitoring (7)

A
  • separate pressure bags for separate lines
  • place transducer at phlebostatic axis (midaxillary 4th intercostal space) while HOB 0-60 degrees every shift
  • zero transducer once a shift (open to atmospheric pressure and close to patient and flush solution)
  • monitor for bleeding, infection (CLABSI), air embolus, thrombus, dislodgement
  • alarms should always be audible
  • do fast flush square wave test to ensure waveform not over or underdamped
  • daily x-ray for placement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

Art-line

What is it?
Indications (4)

A

Continuous measurement of three BP parameters (Systole, Diastole, Mean arterial blood pressure (MAP))

Indications
- Shock
- Hyper or hypotension
- Post-op for major surgery
- Acute lung failure b-c need frequent ABGs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Art-line: Care (3)

A
  • perform Allen test to assess collateral circulation
  • assess wave form (Systole: highest point; Dicrotic notch: closure of aortic valve and start of blood flow into arterial vasculature; Diastolic: lowest point)
  • never put meds in ART
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

Mean Arterial Pressure

Range
Preferred values (2)
Equation

A

Range: 70-100 mm Hg

Preferred
- > 60 to perfuse coronary arteries
- > 65 to perfuse brain and kidneys

Equation: MAP= [(DBP(2) + SBP)/3)]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

Central venous pressure (CVP)

What is it?
Indication
Placement (3)
Normal Range

A
  • Measures right ventricular end-diastolic pressure( filling pressures of the right side of the heart) and sits in superior vena cava

Indicated for alteration in fluid volume (high = overload; low = dehydration)

Catheter Placement
- Subclavian (SC- better if > 5 days)
- Internal jugular (IJ- has best blood flow and less risk for pneumothorax)
- Femoral (if others inaccessible b-c higher risk for infection)

Range: 2-5 mm Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

Cardiac Output

What is it?
What does Starling Law say?
Equation
Normal range

A

Volume of blood ejected from the left ventricle in 1 minute

Starling Law: force of ventricular blood volume ejection is related to preload (Volume of blood in the ventricle at end-diastole) and Amount of stretch (force) placed on the ventricle

Equation: HR (# of beats per minute) X SV (amount of blood ejected by ventricle w/ each heartbeat) = CO

Normal range: 4-6 L/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

Preload

What is it
Factors on left and right side (2)
When increased (2)
How to reduce (3)

A
  • pressures resulting from volume coming into ventricles (end diastolic pressure)

Factors on left and right side
- Left side (Pulmonary artery diastolic pressure and pulmonary artery occlusion pressure)
- Right (CVP aka right atrial pressure)

  • increased (hypervolemia, regurgitation of valves)

How to reduce
- diuretics
- vasodilators
- fluid restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Afterload

What is it
Factors on left and right side (2)
When increased (2)
Care (2)

A
  • resistance left ventricle must overcome to circulate blood/ overcome systolic ejection

Factors
- Left (SVR– high SVR = decreased CO)
- Right (PVR)

  • increased (HTN, vasoconstriction) = increased cardiac workload

Care
- to reduce, ACEI, ARBS, vasodilators (sodium nitroprusside, NTG)
- to increase, vasopressors and IV fluids (preferably w/ art-line)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Contractility

What is it?
Relation to Afterload, Preload, Ventricle distention (3)
Drugs to improve contractility (3)

A

The heart’s ability to stretch and contract

Relation
- Afterload/SVR increases, contractility decreases
- Preload increases, contractility increases
- If ventricle overdistended, contractility decreases

Drugs:
- Cardiac glycoside (digoxin)
- Inotropic drugs (dobutamine, dopamine, milrinone
- Oxygen (Hypoxia = negative inotrope)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

Hyperglycemia w/ absence of insulin Symptoms (11)

A
  • Polyuria (r/t osmotic diuresis from excess glucose in urine; leads to hypokalemia)
  • Polydipsia
  • Polyphagia (R/t cellular starvation of glucose so need insulin vs food to push glucose into cells)
  • Ketonuria and ketonemia -> metabolic acidosis -> hyperkalemia
  • Kussmaul respirations (to blow off excess CO2 from anion gap) – compensatory respiratory alkalosis
  • Acetone exhaled (fruity odor)
  • Hemoconcentration and Hyperviscosity
  • Hypovolemia (low CVP, high HR, low BP) and hypoperfusion
  • Hypoxia -> lactic acid production
  • Pain (headache, abdominal
  • fatigue, weakness)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

Diabetic Ketoacidosis (DKA): Definition (5)

A
  • Glucose > 250 mg/dL
  • Low bicarbonate level (<18 mEq/L)
  • Acidosis (pH <7.30)
  • Moderate or severe ketonemia and ketonuria
  • Anion gap > 12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

DKA: non-defining labs (6)

A
  • Leukocytosis
  • Urine: High specific gravity and osmolality
  • Glucosuria (Osmotic pull of glucose increases output)
  • BUN, Crt increase b-c risk for kidney impairment r/t decreased organ perfusion
  • K, Na, PO4 excreted in urine (may be low)
  • Serum osmolality (hyperosmolality)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

DKA: Hydration (3)

A
  • NS 1 Liter w/n first hour
  • Then NS 1/2 at 250-500ml/hr
  • When glucose < 200, change to D5W 1/2NS at 150-250ml/hr to prevent hypoglycemia and cerebral edema via replenishing cellular glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

DKA: Correct Electrolytes -5

A
  • replace sodium w/ fluids
  • If hypokalemic, give K immediately before insulin
  • If not hypokalemic, give 20-30 mEq of K+ within 2-3 hrs of treatments
  • If hyperkalemic, insulin and volume expansion will correct
  • Replace phosphate if < 1 mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

DKA: Replace insulin (4)

A
  • 0.1 unit/kg Regular Insulin IV Bolus (onset: 15 min)
    followed by 0.1 unit/kg/hr via continuous IV pump
  • Glucose should drop 50-70 points/hr
  • Switch to SubQ regular insulin 2 hours before discontinuing continuous pump
  • Patient must be stable w/ consistent glucose level, no ketosis, and able to eat prior to switch to subQ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

DKA/HHS: Monitoring response to therapy (5)

A
  • Hourly glucose checks until stable (once stable, q2-4h)
  • Use accuchecks unless CVP or art-line w/ blood conservation system
  • rate of blood glucose change = 50—70 (More important than actual level)
  • Monitor appearance, VS, I & O and Labs: BUN, Crt, K, ABGs
  • NPO until glucose is stable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

DKA: Markers for resolution (4)

A
  • Blood glucose below 200 mg/dL
  • Serum bicarbonate above 18 mEq
  • pH greater than 7.3
  • absence of ketones in urine and blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

DKA/HHS: Complications from management and key care(6)

A

Fluid volume overload r/t HF or kidney disease
- Care: oxygen, reduce infusion, elevate HOB, assess fluid status

Hypokalemia or Hyperkalemia
- Care: ECG monitoring, potassium chloride

Hyponatremia
- Care: NGT intermittent suctioning if NV

Cerebral edema
- Care: hourly neuro assessment esp sudden headache, confusion, pupils

Infection
- Care: oral care, repositioning, sterile technique, check venipuncture sites q4h

Hypoglycemia
- Care: stop IV insulin, give D50 or subQ glucagon q15 until glucose > 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

Hyperglycemic Hyperosmolar State (HHS): Definition (6)

A
  • Blood glucose > 600 mg/dL
  • Arterial pH > 7.3
  • Serum bicarb > 18 mEq/L
  • Serum osmolality > 320 mmol/kg (risk for coma if > 350)
  • Absent or mild ketonuria (No ketogenesis so no fruity breath and Rapid and shallow respirations vs kussmaul)
  • Severe dehydration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

HHS: Management (6)

A
  • NS 1 liter/hr for massive fluid replacement
  • Once hemodynamically stable (look at CVP or PAOP) or serum Na reaches 140mEq/L change to 1/2NS.
  • When plasma glucose reaches 300mg/dL, change to D5W 1/2NS 150-250 ml/hr
  • 0.15 unit/kg Regular Insulin IV Bolus followed by 0.1unit/kg/hr
  • subQ insulin once glucose stable and adequate food intake
  • Correct electrolytes (Potassium is added based on serum level (give if < 3.3))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

Older adults and glucose regulation (6)

A
  • reduced glucose metabolism r/t increased visceral fat and decreased lean muscle mass
  • reduced insulin production r/t decreased pancreatic islet function (unable to regulate and metabolize glucose concentrations)
  • Type 2 DM more common in older adults
  • DM in older adults = increased institutionalization and reduced functional status
  • DM presents as thirst, confusion, infection, poor wound healing in older adults
  • increased DM complications (ESKD, blindness, heart disease, CVA, neuropathy, depression, sexual dysfunction, periodontal disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

Older adults: Reason for increased hypoglycemia risk (3)

A
  • Decreased kidney function so reduced elimination of sulfonylurea and insulin
  • Reduced epinephrine and glucagon release r/t hypoglycemic unawareness
  • Impaired motor skills interfere w/ ability to correct glucose levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

Older adults: Endocrine system (5)

A
  • cold intolerance (hard to distinguish from hypothyroidism) r/t decreased metabolism
  • dilute urine and dehydration risk r/t decreased ADH production
  • reduced thyroid hormone secretion (may not have s/s of hypothyroidism)
  • hypothyroidism is most common thyroid problem in older adults
  • start low and go slow w/ levothyroxine b-c risk of angina, dysrhythmias, HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

DI: Three types

A

Central Diabetes Insipidus AKA neurogenic DI
- Hypofunction of the posterior pituitary gland or hypothalamus leads to ADH (vasopressin) deficiency
- no ADH = kidneys not told to concentrate urine so lose excess H2O

Nephrogenic Diabetes Insipidus
- Inability of kidney tubules to respond to circulating ADH

Dipsogenic Diabetes Insipidus
- Compulsive water drinking (> 5 L/day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

DI: labs (4)

A
  • High Serum Na+ > 145 mEq/L
  • High Serum Osmolality > 295 mOsm//L (Normal: 275-295)
  • Low Urine Osmolality < 300 mOsm/L
  • Low Urine specific gravity < 1.005
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

DI: manifestations (3)

A
  • Dehydration (decreased skin turgor, dry mucous membrane, tachycardia, hypotension/hypovolemia, hemoconcentration, constipation, LOC change)
  • large dilute urine (polyuria and nocturia ; > 3L/24 hr) w/o hyperglycemia, diuretics, or fluid challenge
  • Polydipsia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

DI: Medical Management

General - 3
Central DI - 2
Nephrogenic DI - 1

A

General
- volume resuscitation (oral or IV hypotonic)
- may need lifelong care for chronic DI w/ daily weights (ED if > 2.2 lb overnight)
- monitor for fluid balance (overload or dehydration)- need urinary catheter

Central DI
- Vasopressin (antidiuretic and vasoconstrictor): risk for HTN, angina, vasospasm (MI, CVA) so not preferred
- Desmopressin (DDAVP- strong antidiuretic w/ little effect on BP - preferred

Nephrogenic DI
- Hydrochlorothiazide (HCTZ) - reduces amount of urine via resorption of sodium and water in proximal nephron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

Water deprivation Test

Purpose
Procedure
Results (2)

A

Purpose: measure ADH and determine type of DI

Procedure: give ADH (vasopressin)

Results
- If condition improves, there is central DI
- If condition does not improve, there is nephrogenic DI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

SIADH: Labs (5)

A
  • Hyponatremia (less than 125 mEq/L)
  • Decreased Serum Osmolality – < 275 mOsm/L
  • increased Urine osmolality – >100 mOsm/L
  • Elevated urine sodium
  • Elevated urine specific gravity (> 1.030)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

SIADH: Manifestations (9)

A
  • GI: loss of appetite, NV
  • Dilutional hyponatremia (Lethargy, NV, Headache, hostility, disorientation)
  • Severe Neurological Symptoms (Serum Sodium< 120 mEq/L)- > Decreased LOC, Seizures/ Coma, Apprehension
  • Hypothermia r/t CNS disturbance
  • Full and bounding pulse r/t increased fluid volume
  • Decreased DTR’s
  • Weight gain but no edema b-c water not salt is retained
  • Decreased urine output
  • increased thirst (polydipsia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

SIADH: Nursing Management (6)

A
  • Meds (hypertonic NaCl, Vaptans, Diuretic(if normal Na))
  • Fluid restriction (usually 500 -1000 mL/day)
  • Oral care for comfort and to prevent dry mouth
  • If they need any free water, use saline vs tap water
  • Monitor for complications (I &O, daily weights, fluid status q2h; neuro status hourly if any changes in LOC)
  • Always seizure precautions and reduce stimulation if SIADH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

SIADH: Na replacement (3)

A
  • Hypertonic saline (3%NaCl) when Na level is too low to prevent extra volume
  • do not want rapid sodium increase (want gradual increase 8 mEq/L in 24 hr to prevent osmotic demyelination)
  • Monitor Na+ and K+ q4h during acute phase of sodium replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

Vaptans (Conivaptan (Vaprisol)- IV or Tolvaptan (Samsca) – PO)

Indication
Action
Risks (2)

A

Indication: euvolemic hyponatremia in SIADH

Action: excretes water and conserves sodium (aqua diuresis)

Risks
- For Conivaptan, hypotension (contraindicated in hypovolemia)
- For Tolvaptan, black box warning for rapid hypernatremia (risk for CNS demyelination) AND liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

Myxedema Coma: Manifestations (8)

A
  • Cardiac (anemia, hypotension, bradycardia, peripheral vasoconstriction, cardiomegaly, narrow pulse pressure, prolonged QT/PR)- risk for shock and cardiac tamponade
  • Pulmonary (hypoventilation)
  • GI: constipation, anorexia, abdominal distention)
  • cold intolerance (< 36.1)
  • CNS (blank facial expression, apathy, slow speech, depression, delirium, stupor, coma)
  • Skin (thick tongue w/ husky voice, brittle/thin nails and hair, nonpitting edema (weight gain), poor wound healing
  • Muscle (decreased DTR, paresthesia of hands and feet r/t hyaluronic acid deposits)
  • Renal (decreased GFR, specific gravity, urine osmolality and output) b-c decreased blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q

Myxedema Coma: Labs (6)

A
  • Low T3 and T4
  • Hypoglycemia
  • Increased TSH
  • Hyponatremia (confusion, NV)
  • metabolic acidosis/respiratory acidosis
  • hypercholesterolemia (r/t incomplete metabolism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

Myxedema Coma: Medical Management (8)

A
  • give IV levothyroxine then PO (risk for angina and dysrhythmias) - take on empty stomach
  • give IV NS, glucose, steroids as needed
  • mechanical ventilation for hypoventilation and respiratory acidosis
  • warm blankets for hypothermia
  • emollient and repositioning for skin (rough, edema, risk for breakdown)
  • continuous ECG monitoring b-c risk for dysrhythmias
  • communicate slowly and in written form b-c decreased comprehension
  • fiber and fluids for constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

Older Adults: GI system alterations (6)

A
  • decreased GI blood flow and motility
  • decreased Gastric emptying
  • increased risk of dehydration (decreased thirst sensation)-> constipation
  • More prone to GI bleeds b-c more prone to h. pylori
  • Decreased absorption -> nutrient deficiency and anemias
  • decreased swallowing = risk for aspiration and malnutrition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

GI bleed: General Management

Prevention of Shock (3)

NGT Placement (2)

A

Prevent hypovolemic or hemorrhagic shock
- large bore IV for IV crystalloids, blood products (plasma, platelet, PRBCs)
- if esophageal varices, avoid frequent swallowing or activities that could rupture varices like vomiting or straining
- give Supplemental oxygen to Increase oxygen delivery and tissue perfusion

Nasogastric Tube Placement (NGT)
- Purpose: Gastric lavage to confirm bleeding via irrigation w/ NS; aspiration prevention, decompression (low suction); feeding
- Care: Do Not place if esophageal varices ; Lie on left side; Secure to gown; irrigate q4h w/ NS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

Endoscopy

What is it?
4 types

A

What is it?
- direct visualization and evaluation of GI tract (for lesions, mucosal changes, obstructions, motility dysfunction, bleeding

Types
EGD
- esophagus to duodenum
- evaluate upper GI bleed, chronic gastritis

Colonoscopy: rectum to distal ileum
- screens for colon cancer, evaluate UC

Sigmoidoscopy: sigmoid colon
- screen for Crohn’s disease

Endoscopic retrograde cholangiopancreatography (ERCP)
- visualize the liver, gallbladder, bile ducts, and pancreas
- evaluate pancreatitis, cholecystitis

171
Q

Endoscopy: safety (6)

A
  • If contrast dye involved, ask about shellfish allergies and check kidney function (BUN, Crt, urine output)
  • If sedation or anything down throat, check gag reflex before oral feedings (risk for aspiration, vasovagal stimulation, oversedation)
  • Ensure HCP gets informed consent
  • need Two large IV catheters
  • NPO 6-12 hrs prior
  • Bowel prep if lower GI
172
Q

GI Bleed: Assessment findings (7)

A
  • bleeding labs and VS (low H/H; low BP, high HR, decreased peripheral pulses)
  • Change in LOC (r/t dehydration or anemia)
  • Coffee ground emesis r/t gastric acid converting hemoglobin to brown hematin
  • Bright red emesis r/t profuse bleeding with little contact with gastric secretions
  • Hematochezia (bright red stools) – rectum or sigmoid (lower GI bleed)
  • Melena (black, tarry, or dark red stools) due to digestion of blood in upper GI bleed
  • Gastric perforation (sudden severe abd pain w/ rebound tenderness and rigidity plus fever, leukocytosis, tachycardia)- emergency
173
Q

GI bleed: Diagnostics (5)

A

Endoscopy
- achieve control of GI bleeding via cauterization, vasopressin, or embolic material

Angiography (has contrast dye)
- evaluate status of GI circulation, cirrhosis, portal HTN, intestinal ischemia

Abdominal x-ray
- visualize bowel obstruction and perforation

GI bleeding scan
- evaluate presence and location of of active GI bleed not detected on EGD and assess need for arteriogram

MRI
- identify tumors, abscesses, hemorrhages, and vascular abnormalities

174
Q

Liver Failure/Cirrhosis: Diagnostics

Liver Biopsy (4)
Ultrasound
Hepatobiliary scan (3)
CT

A

Liver Biopsy
- For liver failure, cirrhosis, or hepatitis (or diagnosis GI bleed)
- Pre-op: NPO 6 hrs prior, blood drawn for coagulation
- Post-op: position on right side and bed rest 6-8 hrs
- Complications: damage to other organs, peritonitis (r/t gallbladder leakage of bile), hemothorax, infection

US
- more sensitive than x-ray for liver problems

Hepatobiliary scan (HIDA scan)
- visualize the gallbladder and liver and determine patency of the biliary system w/ dye
- Results: decreased bile flow = obstruction
- Care: NPO 2-4 hr prior; usually no sedation but be still

CT
- evaluate abdominal vascular space

175
Q

GI bleed: Medical Management

Misoprostol -2
Vasopressin - 3
Sandostatin - 3
Epinephrine -1

A

Misoprostol
- Prevention of GI bleed
- contraindicated if pregnant

Vasopressin (Pretessin)
- prevent esophageal varices rupture via decreasing portal HTN
- not preferred unless pt in shock
- Risk for systemic vasoconstriction (chest pain, HTN, HF, dysrhythmias, phlebitis, CVA), bradycardia, fluid retention

Sandostatin (Octreotide)
– preferred to prevent esophageal varices rupture unless pt in shock
- Decrease portal venous pressure when acute bleeding and cirrhosis
- Risk for hyper/hypoglycemia when initiating drip

Epinephrine
- Vasoconstrictor agent

176
Q

Crohn’s Disease: Complications (9)

A
  • acute gastritis (inflammation of gastric mucosa)
  • Perianal ulcerations/ fistulas (usually pyuria and fecaluria) – may need skin barrier if draining b-c intestinal fluid enzymes are caustic
  • hemorrhage/Perforation (lower GI bleed)
  • abscess formation
  • toxic megacolon (dilation leads to ileus then gangrene and peritonitis)
  • intestinal malabsorption (esp folic acid and vitamin B12)-> malnutrition -> weight loss
  • Anemia (r/t slow bleeding and poor nutrition)
  • nonmechanical bowel obstruction (r/t inflammation, edema - > fibrosis and scar tissue)
  • extraintestinal (polyarthritis, erythema, cholelithiasis, oral and skin lesions, iritis, osteoporosis)
177
Q

GI Bleed: main causes

Peptic Ulcer Disease (2)
Stress-related erosive syndrome (SRES) (4)

A

Peptic Ulcer disease
- Gastroduodenal mucosal breakdown results in damaged blood vessels from acid secretions
r/t H. pylori, NSAIDs, steroids
- Diagnostic: anti H.pylori antibodies (IgG or IgM OR C13 urea breath test) - discontinue antacids and PPI a week prior

Stress-related erosive syndrome (SRES)
- Acute erosive gastritis covers mucosal lesions; common in ICU
- Increased stress = increased gastric acid secretion
- decreased mucosal blood flow = ischemia and degeneration of mucosal lining
- Reason for prophylactic PPI or H2 antagonists

178
Q

GI Bleed: Antiulcer agents

Antacids - 3
H2 Antagonists - 2
PPI - 2
Sucralfate - 3

A

Antacids
- mag = diarrhea and avoid if CKD
- calcium or aluminum = constipation
- give 1-2 hrs within other drugs OR after meals

H2 antagonists (Famotidine-Pepcid)
- dose at bedtime
- risks: CNS toxicity (confusion,deliruim) and thrombocytopenia

Proton pump inhibitors (Pantoprazole-Protonix)
- Can give w/ antacids
- risk for VAP and C-diff

Sucralfate (mucosal barrier)
- dissolved in water to form slurry, not crushed
- hold feedings before and after
- No antacids within 30 minutes

179
Q

Crohn’s Disease: Clinical Manifestations (6)

A
  • RLQ Abdominal Pain and/or distention
  • Peritonitis (guarding, masses, rigidity, tenderness)
  • High pitched sound on auscultation r/t narrowed bowel loops
  • Diarrhea (5-6 nonbloody stools a day
  • Steatorrhea (mucusy fatty stools)
  • Fever r/t fistula, abscess, severe inflammation
180
Q

Crohn’s Disease: Basics (4)

A
  • Inflammatory disease causing thickening of walls of small intestine, colon, or both (esp. terminal ileum)
  • Recurrent with remissions and exacerbations.
  • Strictures and deep ulcerations (cobblestone appearance)
  • less severe than Ulcerative Colitis
181
Q

Crohn’s Disease: Labs (4)

A
  • Decreased Hgb/Hct (slow blood loss)
  • Elevated WBC/CRP/ESR (inflammation)
  • Hypokalemia, hypomagnesemia, hyponatremia, hypochloremia (diarrhea)
  • Hypoalbuminemia (malnutrition and lost protein in stool)
182
Q

Barium enema w/ air contrast

Purpose
Safety (3)

A
  • differentiate UC and Crohn’s Disease i.e. complications, mucosal patterns, depth of disease

Safety
- void after to remove contrast
- NPO prior to procedure
- expect light colored stools b-c barium is white

183
Q

Crohn’s Disease: Drug Therapy (6)

A
  • Aminosalicylates (ER Mesalamine)
  • Glucocorticoids (Methylprednisolone) - risk for infection
  • Antidiarrheal drugs (w/ caution b-c risk for toxic megacolon)
  • Immunosuppressive drugs/ Biologics - risk for infection
  • antibiotics if peritonitis
  • pain medication for pain
184
Q

Crohn’s Disease: Nutritional Support (6)

Risks of poor nutrition: inadequate fistula healing, loss of lean muscle mass, decreased immune response, increased morbidity and mortality

A
  • recore accurate I & O for calorie counts
  • proper hydration
  • TPN (if severe and malnutrition present)
  • high calorie, high protein, high vitamin, low fiber diet
  • if fistulas, need up to 3,000/day
  • Avoid caffeine, alcohol, milk, gluten
185
Q

Acute Pancreatitis: Clinical Manifestations (10)

A
  • epigastric to periumbilical abdominal pain (boring i.e going through body)
  • Nausea and Vomiting
  • Shock s/s (tachycardia, hypotension, diaphoresis)
  • Hypoactive bowel sounds
  • Peritonitis (Abdominal tenderness, guarding, distention, tympany, rigidity)
  • Severe jaundice (swelling of pancreas head, blocking bile)
  • Palpable abdominal mass = pseudocyst or abscess
  • Dull to percussion = pancreatic ascites
  • Grey Turner sign (gray-blue discoloration of the flanks) r/t Pancreatic hemorrhage
  • Cullen sign (discoloration of the umbilical region) r/t Pancreatic hemorrhage
186
Q

Acute Pancreatitis: Diagnostics (3)

A
  • Abdominal CT with contrast (gold standard) –diagnosis pancreatitis, r/o pancreatic pseudocyst
  • Abdominal ultrasound –check for liver, gallbladder, biliary system; Gas, ascites, obesity may interfere w/ viewing
  • ERCP
187
Q

Acute Pancreatitis: Management

Pain (3)
Nutrition (5)
Fluids and electrolytes (2)

A

Pain
- w/ hydromorphone (morphine causes sphincter of Oddi spasm)
- relieved by knee-to-chest or fetal position
- ulcer prophylaxis (H2 antagonist and PPI)

Nutrition
- NPO to rest pancreas
- small frequent meals afterwards
- mod to high carb, low fat, high protein
- avoid caffeine (coffee, tea, cola) and alcohol
- NGT if vomiting, obstruction or distention

Fluids and electrolytes
- IV crystalloids (LR)
- correct hypocalcemia, hypomagnesemia, and hyponatremia as needed

188
Q

Acute Liver Failure: Clinical Manifestations (9)

A
  • yellow skin (jaundice) or sclera (icterus)
  • Changes in color of urine (dark) or stool (clay colored)
  • Pruritus (itching) or rash or dry skin
  • Ascites (r/t portal HTN and hypoalbuminemia)- risk for orthopnea or dyspnea; posture problems
  • Asterixis (downward flapping of hands when arm dorsiflexes wrist)
  • Pulmonary (hyperventilation)
  • CNS (Headache; Hepatic encephalopathy r/t breakdown of blood brain barrier) –Increased ICP and cerebral edema
  • Coagulation (Palmar erythema, Spider nevi, Bruises)
  • Peripheral edema
189
Q

Acute Liver Failure/Cirrhosis: Labs (8)

A

↑ ALT, AST, ALP (ALT more liver specific)
- Normal ALT: 10-40 m, 9-32 f
- Normal AST: 8-40 m, 6-34 f
- Normal ALP: 35-150

↑Bilirubin (Normal: < 1) - decreased fecal bilirubin

↑ LDH (Normal: 110-220)

↑ Ammonia (risk for hepatic encephalopathy

Decreased Albumin (b-c reduced synthesis)

Anemia, thrombocytopenia, and leukopenia

Prolonged PT and INR r/t decreased prothrombin production
- Normal PT: 10-13 s
- Normal INR: 0.9-1.3

↑ BUN

190
Q

Acute Liver Failure: Management (7)

A
  • Reduce Ammonia (lactulose or nonabsorbable antibiotics) - force out ammonia
  • stress ulcer prophylaxis (PPI, H2 antagonists)
  • Treat GI bleeding (Vitamin K, PRBCs, platelets, coagulation factor replacement, plasma or Beta blocker)
  • antibiotics to prevent infection
  • definitive treatment = liver transplant
  • paracentesis or diuretics for ascites (pre-op: coagulation labs, void, and give vitamin K if high INR)
  • avoid too many drugs b-c liver cannot metabolize (NSAIDS, acetaminophen, alcohol, smoking)
191
Q

Acute Pancreatitis: Labs (10)

A
  • high amylase (Normal 25-125)
  • high lipase (Normal 20-240) - elevated longer
  • high trypsin and elastase
  • AST >250 units/L (liver involvement)
  • Increased LDH (> 350)
  • hyperbilirubinemia
  • Leukocytosis (>16,000/mm3) and thrombocytopenia
  • Hyperglycemia (>200 mg/dL; no diabetic history) r/t decreased insulin from destroyed islet cells
  • Hypocalcemia and hypomagnesemia
  • Also present ( increased BUN, ALP, ESR, CRP; Hypoalbuminemia; Hypertriglyceridemia)
192
Q

Acute Pancreatitis: Complications

Systemic (2)
Local

A

Systemic
- Hypovolemic or hemorrhagic shock r/t third spacing
- Acute necrotizing pancreatitis -> Multi-organ damage (ARDs, AKI, paralytic ileus, GI hemorrhage , DIC, Type 2 DM)

Local
- Pancreatic pseudocyst (pancreatic fluid enclosed in non epithelialized wall) w/ Risks: peritonitis (if rupture), erode BVs (hemorrhage), bacterial infection (abscess), invade surroundings (obstruction) – may drain on own

193
Q

Acute Liver Failure: Complications (9)

A
  • Impaired bilirubin conjugation (Result: jaundice)
  • Decreased clotting factor production (Result: bleeding)
  • Depressed glucose synthesis (Result: hypoglycemia)
  • Decreased lactate clearance (Result: metabolic acidosis -> respiratory alkalosis)
  • infection
  • altered carb, protein, glucose metabolism
  • Hepatic encephalopathy and Acute Neurologic changes (Care: Give mannitol, elevate HOB 30, treat fever HTN, minimize stimulation; may need restraints)
  • Respiratory failure (ascites -> increased abdominal pressure -> shallow breathing ->atelectasis) - care: intubation
  • Cardiac dysrhythmias due to acidosis, hypoxemia, cerebral edema
194
Q

Cirrhosis: Complications (6)

A
  • Portal hypertension (Risks: Splenomegaly, ascites, Bleeding esophageal varices (distended veins), hemorrhoids)
  • Coagulation defects (result: bleeding)
  • Biliary obstruction (Decreased bile production = decreased absorption of fat soluble vitamins i.e vitamin K and jaundice and itching)
  • Portal-systemic encephalopathy (PSE) with hepatic coma
    S/s: sleep disturbance, mood disturbance, mental status change, speech problems, asterixis (hand flap)
    Late s/s: altered LOC, impaired thinking, neuromuscular problems r/t nonrhythmic extension and flexion of wrists and fingers
  • Hepatorenal syndrome
    S/s: oliguria, elevated BUN, Crt, urine osmolarity
  • Spontaneous bacterial peritonitis r/t ascites or hypoproteinemia
    S/s: abd pain, fever, chills, tenderness; worsened encephalopathy, increased jaundice
    Drug of choice: antibiotics
195
Q

GI bleed: Controlling bleeding (less invasive)

Tagged Red Blood Cell Scanning
EGD (4)

A

Tagged red blood cell scanning
- identify location of bleed and treat if able to view

EGD
- thermal therapy: heat to cauterize the bleeding vessel
- injection of sclerosing therapy (epi or alcohol, hypertonic saline) to induce localized vessel vasoconstriction and sclerosing to form thrombosis
- intraarterial embolization
- Endoscopic variceal ligation: band or clip around bleeding site to obstruct and control bleeding (Risk: mucosal ulcers)

196
Q

GI bleed: Trans-jugular Intrahepatic Portosystemic Shunting (TIPS) (most invasive management)

Indication
Procedure
Risks (3)

A

Indication: ascites or prevent esophageal varice rupture

Procedure: stent placed b/w systemic and portal venous system to redirect portal blood, decrease portal HTN, and decompress varices to control bleeding

Risks: hepatic encephalopathy, elevated pulmonary artery pressure, bleeding

197
Q

GI Bleed: main causes

Esophagogastric Varices (2)
Medications (3)
Conditions (2)

A

Esophagogastric Varices rupture
- r/t portal HTN and liver dysfunction diverting blood from high pressure to low pressure
- Risk w/ increased abdominal pressure (vigorous physical exercise, heavy lifting); hard dry food, chest trauma

Exacerbated by medications (anticoagulants, steroids, NSAIDS)

Conditions (Hepatitis, necrotizing pancreatitis, Acute liver failure))

198
Q

TPN: Indications (8)

A
  • cannot tolerate enteral nutrition (i.e GI bleed)
  • extensive burn injuries
  • poor wound healing
  • specific GI disease (UC, Crohns, GI fistula)
  • hepatic failure
  • pancreatitis
  • malignant diseases
  • malnourished
199
Q

TPN:Care (6)

A
  • need central line and filter b-c hyperosmolar
  • Keep it going! (Dextrose 10 % if bag not ready)
  • Scheduled Accuchecks q6h
  • IV site assessment (phlebitis)
  • Maintain aseptic technique
  • change bags/tubing per protocol (typically q24h)
200
Q

Renal Elimination: Older age risks (5)

A
  • Organs systems decline (atrophy of kidney)
  • Decreased # of functional nephrons -> decreased GFR
  • More prone to development of AKI, CKD, and ESKD
  • higher risk for HTN and DM which cause ESKD
  • Risk for dehydration r/t sodium retention, increased dilution of urine, and decreased thirst perception
201
Q

Renal Elimination: Risky Medications (5)

A
  • Antibiotics (aminoglycosides)
  • Iodine Contrast-dye
  • Immunosuppressives (steroids, transplant meds)
  • NSAIDs
  • ARBs and ACEIs
202
Q

Most common causes of AKI (4)

A
  • Sepsis or overwhelming infection - leading cause of death
  • Hypovolemia
  • Drug or medication-related
  • Cardiogenic shock
203
Q

Multisystem effects of ESKD

  • neurologic
  • hematologic
  • skeletal
  • cardiovascular
  • GI
  • GU
  • Dermatologic
  • Respiratory
A
  • Neurologic (coma, headache, inattentiveness, lethargy, seizures)
  • Hematologic (bleeding, immunosuppression, platelet dysfunction)
  • Skeletal (hyperphosphatemia, hypocalcemia, weak, brittle bones)
  • Cardiovascular (arrhythmias, Edema, heart failure, HTN, pericarditis, pericardial)
  • GI (anorexia, decreased appetite, hypomotility, glucose intolerance, hyperphosphatemia)
  • GU (amenorrhea, hematuria, proteinuria)
  • Dermatologic (dry skin, poor healing, pruritus)
  • Respiratory (Pleural effusions)
204
Q

RIFLE Criteria

A

Risk
- Crt 1.5x normal OR Crt increases ≥ 0.3 mg/dL

Injury
- Crt 2x normal

Failure
- Crt 3x normal OR ≥ 4 mg/dL

Loss
- Persistent AKI = complete loss of kidney function for more than 4 wks.

ESKD
- End-stage kidney disease

205
Q

AKI: Onset Phase (3)

A
  • Begins when the kidney is injured causing ischemia and decreased GFR
  • Ends when oliguria develops (goal to detect prior to this)
  • Duration: lasts from hours to days.
206
Q

AKI: Oliguric/Anuric Phase

Duration
S/s (2)
Labs (4)

A

Duration: a range of 8-14 days depending on nonoliguric vs. oliguric.

s/s
- Urine production is < 400 cc for 24 hrs
- Fluid overload (b-c inability to excrete water)

Labs
- Greatly reduced GFR and urine formation due to renal tubule damage
- increased BUN, Creatinine,
- Electrolyte disturbances (Hyperkalemia, hyperphosphatemia, hypocalcemia)
- Metabolic acidosis

207
Q

AKI: Diuretic Phase

Duration

5 notes

A

Duration: Lasts 7- 14 days

  • Occurs when cause of AKI corrected
  • GFR increases but nephrons still not fully functional
  • Unable to excrete some waste products
  • tubule scarring and damage and edema present
  • Urine > 400 cc in 24 hours (up to 2-5L/24 hr) -> high BUN (observe for dehydration)
208
Q

AKI: Recovery Phase

Duration

3 notes

A

Duration: lasts several months to 1 yr.

  • Normalization of F/E balance or onset of polyuria
  • Return of GFR to 70-80% normal (Normal GFR: 120)
  • Tubular edema resolves and renal function improves
209
Q

Categories of AKI (what is it and priority care)

  • Prerenal (2)
  • Intrarenal (2)
  • Postrenal (2)
A

Prerenal
- Decreased perfusion (renal blood flow, BP, Low cardiac output, MAP < 65) cause kidney ischemia
- Priority: establish hemodynamic stability

Intrarenal
- direct damage to kidneys
- Priority: maintain renal perfusion, discontinue nephrotoxic drugs, treat cause

Postrenal
- obstruction of urine flow from kidneys
- Priority: prevent UTI, remove source of obstruction, ensure catheter patency, maintain renal perfusion

210
Q

Sepsis and AKI

Patho (2)
Labs
Care (3)

A

Patho
- Sepsis causes reduced perfusion to kidney -> hemodynamic instability and ischemia
- Inflammation increases vascular permeability and causes third spacing

Labs: elevated WBC and lactate plus AKI labs

Care
- Need rapid fluid resuscitation then vasopressors in septic shock
- Avoid aminoglycosides
- Prevention: MAP > 65

211
Q

Trauma and AKI: Rhabdomyolysis

What is it?
Risks (3)
S/s (3)
Primary treatment (3)

A

What is it?
- release of myoglobin and creatine from damaged muscle cells after burns, trauma, crush injuries

Risks
- life-threatening hyperkalemia due to cell lysis
- metabolic acidosis
- AKI from myoglobin toxicity (myoglobinuria and hemoglobinuria)

S/s
- compartment syndrome
- elevated CK, crt, K
- dark brown or tea colored urine (myoglobinuria and hematuria)

Primary treatment
- IV crystalloid fluid resuscitation (NS, LR)
- sodium bicarb for acidosis and to alkalize urine for myoglobin excretion
- Mannitol to increase renal blood flow and GFR for myoglobin clearance

212
Q

At-risk disease states and AKI

  • Heart failure (2)
  • Respiratory failure (2)
A

Heart failure and AKI
- Several risk factors overlap
- BP: 130/80 and normal range glucose recommended to prevent CKD and atherosclerotic changes (CAD, PAD)

Respiratory failure and AKI
- Mechanical ventilation (PEEP and positive-pressure) alter kidney via reduced renal blood flow, GFR, UOP
- AKI increases inflammation and risk for ARDS which can lead to ventilation dependence

213
Q

Contrast-induced nephrotoxic (CIN) injury and AKI

Risk factors (4)
Prevention (5)

A

Risk factors: CKD, Crt > 1.5, dehydrated pts, CHF, advanced age (> 75)

Prevention
- Stop metformin day before and resume 48 hrs procedure w/ contrast dye (risk for lactic acidosis)
- Promote hydration and avoid dehydration (IV fluids) before, during, and after
- use lowest dose of dye
- do not repeat dye doses within 48 hrs
- Remove nephrotoxic drugs (NSAIDs, diuretics, ACEI, ARBs)

214
Q

AKI: Labs (7)

A
  • metabolic acidosis (increased anion gap, low bicarb, low pH)
  • elevated BUN (not reliable indicator of AKI)
  • elevated Crt (late indicator)
  • Decreased Creatinine Clearance /GFR (<50) ->most accurate indicator of kidney function
  • BUN: Crt ratio (normal = intrarenal AKI; high = prerenal AKI from high BUN)
  • Electrolytes (hyperkalemia, hypocalcemia, hyperphosphatemia; hypo/hypernatremia)
  • Anemia (decreased H/H due to kidneys not producing erythropoietin)
215
Q

AKI: Physical Assessment (7)

A
  • Chest pain or pressure
  • Fluid overload or loss (oliguria to diuretic)
  • Intravascular overload (CHF, pulmonary congestion, high BP)
  • Edema r/t fluid retention, low albumin, inflammation
  • Grey-turner sign (kidney trauma seen on flank)
  • Bruit = aneurysm or stenosis
  • Azotemia = uremia
216
Q

AKI and Electrolyte Balance: Treatments

  • Hyperkalemia (2)
  • Hypocalcemia
  • Hyperphosphatemia (3)
A

Hyperkalemia (>5)
- IV diuretics if making urine (dialysis if oliguria)
- DICK (Dextrose, Insulin, Calcium gluconate, kayexalate)

Hypocalcemia (< 8.5)
- calcium and vitamin D supplements b-c risk for renal osteodystrophy

Hyperphosphatemia (> 4.5)
- give phosphorus binders w/ every meal
- frequent skin care for pruritus
- Limit phosphorus food (high protein aka meat, fish, dairy, additives, carbonated beverages)

217
Q

AKI: Meds for Treatment

  • IV fluids (3)
  • Sodium bicarb (2)
  • RBC production (2)
  • Acetylcysteine
A

IV Fluids
- Crystalloids (NS, ½NS, LR) – to increase renal perfusion and output
- avoid LR b-c has potassium)
- Colloids (Albumin) – volume expanders to maintain hemodynamic stability

Sodium Bicarbonate
- For Metabolic acidosis
- must be in separate line, no y-site connections

Red blood cell production stimulation/production
- Give iron, PRBCs, erythropoietin (epoetin alfa), vitamin B12, B6, folate
- stress ulcer prophylaxis to prevent GI bleed

Acetylcysteine (Mucomyst)
- Used to reduce contrast-dye induced AKI

218
Q

AKI: Meds for Treatment

Diuretics
- purpose
- Loop (budesonide, furosemide) - 2
- Thiazide (Hydrochlorothiazide) - 2
- Carbonic anhydrase inhibitor (Acetazolamide) - 1
- Potassium-sparing (spironolactone) - 2

A

Purpose: stimulate UOP if fluid overload and functioning kidneys

Loop (budesonide, furosemide)
- Caution if sulfa allergy
- Furosemide is ototoxic

Thiazide (Hydrochlorothiazide)
- Caution if sulfa allergy
- Ineffective if GFR < 10

Carbonic anhydrase inhibitor
- for metabolic alkalosis after aggressive diuresis to increase release of bicarb

Potassium-sparing (spironolactone)
- Weak diuretic
- No potassium supplements

219
Q

Mannitol (Osmotic Diuretic)

Use (3)
Action (2)
Care (3)

A
  • Use: cerebral edema, excretion of toxins, increased ICP

Action
- Increases UOP and GFR via high plasma osmolality and water flow
- increase cerebral blood flow by pulling water out of intracellular space but causes cerebral vasoconstriction as part of autoregulation

Care
- need filter
- risk for hypernatremia, hypokalemia
- need CVP to prevent hypovolemia

220
Q

Indications for Dialysis: AEIOU

A

A = Acidosis (metabolic <7.1) or Azotemia

E = Electrolyte Imbalance (hyperkalemia)

I = Intoxication/Toxins (drug or alcohol)

O = Oliguria or Overload of Fluid

U = Uremia (azotemia with symptoms i.e. metallic taste in mouth, anorexia, muscle cramps, dyspnea, hiccups, uremic frost on skin, change in mentation, pericarditis (pericardial friction rub), neuropathy (paresthesia)) = Elevated BUN

221
Q

Hemodialysis

Basics (2)
Disadvantages (4)

A
  • Separates and removes excess electrolytes, fluids, and toxins from blood
  • Loss of fluid over short period of time (3-4 hrs)

Disadvantages
- Needs Anticoagulation (heparin)
- needs special nurse
- Risks of hypotension, infection, graft-clotting, hemorrhage, and embolism
- Contraindicated in hemodynamically unstable patient

222
Q

CKRT: Care (6)

A
  • Monitor ultrafiltration hourly
  • add replacement fluid if large volume removed
  • Hemofilter change q24-48 hours
  • Anticoagulation (heparin) is required
  • Only in ICU
  • contraindicated if Hct > 45% or terminal illness
223
Q

CKRT: Indications (7)

A
  • hemodynamically unstable pt who requires removal of large volumes of fluid
  • Hypervolemic or edematous pts. unresponsive to diuretic therapy
  • Pts. with MODS (multi-organ dysfunction syndrome)
  • Ease of fluid management in pts requiring large daily fluid volume
  • Replacement for oliguria
  • Admin of TPN
  • Inability to be anticoagulated
224
Q

CKRT: Complications (8)

A
  • decreased ultrafiltration rate (risk for clotting) - place pt supine, lower container
  • filter clotting - reset up system and use anticoagulant
  • hypotension - clamp line
  • f/e imbalance
  • bleeding (hemorrhage)
  • Access dislodgement or infection - sterile dressing changes
  • EKG interference - assess pt
  • Air embolus - prime tube properly
225
Q

SCUF: Slow continuous ultra filtration

Use (3)
Notes (4)

A

Use
- acute HF
- unresponsive to diuretics
- when azotemia or uremia not a concern b-c only fluid loss (no electrolyte loss)

Notes
* No replacement fluid added
* Rate: 100 to 300 ml/ hour (slow)
* Requires both arterial and venous access
* Clots easily

226
Q

CVVH: continuous venovenous
hemofiltration

Use
Notes (3)

A

Use: fluid and moderate solute removal via convection (urea, creatinine, and other small non-protein toxins)

Notes
* Must have MAP of 60 (BP driving force)
* Rate: 5 -20 mL/min or up to 7- 30 L/24 hr
* Replacement fluid is added

227
Q

CVVHD: continuous venovenous
hemodialysis

Use (3)
Notes (5)

A

Use
- fluid and max solute removal via diffusion (dialysate pumped concurrent to blood)
- resistance to diuretics
- severe uremia or critical acid-base problems

Notes
* most like traditional HD
*Must have MAP of 70 (BP is driving force)
*Rate: 500-800 mL/hr (more effective over days)
*Replacement fluid added
* Ideal for hemodynamically unstable in ICU b-c do experience abrupt fluid and solute changes

228
Q

CVVHDF: continuous venovenous
hemodiafiltration

Use (2)
Notes (2)

A

Use
- max fluid and max solute removal via convection and diffusion
- Combines CVVH and CVVHD - most complex

Notes
- Requires a MAP of at least 60 (BP driving force)
- Replacement fluid is added

229
Q

Older Adults: Urinary Incontinence

Contributing Factors (7)

A
  • Drugs (anticholinergics, diuretics, CNS depressants)
  • Diseases (Depression, Arthritis, Parkinson, Dementia)
  • Inadequate Resources (lack of support, lack of assistive devices, high cost of products)
  • Nocturia
  • urinary retention from age or drugs
  • weakened urinary sphincter
  • decreased bladder capacity
230
Q

Intracranial Regulation: Older adults risks

  • CNS (6)
  • Sensory (4)
A

CNS
- Confusion due to infection and delirium often seen
- Neurodegeneration (Reduced brain volume and weight, blood flow)
- Decrease in neurotransmitters (Ach, dopamine, serotonin, glutamate)
- altered sleep-wake cycle (increases risk for delirium and dementia)
- Increased blood brain barrier permeability (increased drug effects)
- slower processing times and memory loss)

Sensory
- Decreased pupil size and reactivity (vision)
- Decreased touch sensation (falls)
- Reduced reflexes r/t neuronal loss (falls)
- decreased taste, hearing, and smell

231
Q

5 components of Neuro Exam

A
  • LOC (earliest indicator of change in neuro status)
  • Motor function
  • pupillary function
  • respiratory function
  • vital signs
232
Q

Levels of Consciousness (7)

A
  • Alert
  • Confused
  • Delirious (disoriented to time, patient, place and may have hallucinations)
  • Lethargic
  • Obtundent (dull indifference to any stimuli)
  • Stuporous (only respond to continuous stimuli)
  • Comatose (no response to any stimulus)
233
Q

LOC: Areas

  • Arousal (3)
  • Alertness (1)
  • Awareness (1)
A

Arousal
- ability to respond to verbal or noxious stimulus. (Verbal (calm then loud), sternal rub, trapezius muscle pinch)
- Central stimulation preferred (trapezius muscle pinch or sternal rub) over Peripheral stimulation (nailbed pinch) for overall body response.
- no need for noxious stimuli if follows commands

Alert (LOC)

Awareness (orientation to person, place, time, situation) if arousable

234
Q

Glasgow Coma Scale: Tips (5)

A
  • Highest = 15 & lowest = 3.
  • < 7 = comatose i.e. “Less than 8, intubate”.
  • Never use GCS in place of complete neurologic assessment
  • does not account for patients with aphasia or mechanically ventilated.
  • Change in 2 or more points is significant
235
Q

GCS

Eye Opening
Verbal Response
Motor response

A

Eye opening (4-1)
- spontaneously
- to speech
- to pain
- none

Verbal Response (5-1)
- oriented
- confused (appropriate language but disoriented)
- inappropriate
- incomprehensible (mumbles, moans, groans)
- none

Motor response (6-1)
- obeys commands
- localizes pain (spontaneous w/ purpose away from noxious stimuli)
- withdraws from pain (does not cross midline but moves away)
- flexion to pain (Decorticate)
- extension to pain (decerebrate) - brainstem dysfunction
- none

236
Q

ICR: Motor Function

Posturing - 1
Reflexes - 4

A

Posturing
- denote decorticate (flexion), decerebrate (extension), or flaccid after peripheral noxious stimuli

Reflexes
- DTRs (achilles, quadriceps, biceps, triceps) should be present
- corneal (CN 5 and CN7) should be present
- pharyngeal/gag (CNIX and CNX) should be present
- Babinski, grasping, rooting if > 2 yrs = brainstem lesion or herniation

237
Q

ICR: Motor Function

Muscle
- size and shape (1)
- tone (2)
- strength (3)

A

Muscle size and shape
- any atrophy

Muscle tone
- via passive movement
- flaccid, hypotonia, hypertonia

Muscle strength
- via active movement
- graded 0 to 5
- pronator drift (arm held out and pronated then drops due to weakness)

238
Q

ICR: Pupillary function

  • Size, shape, symmetry (2)
  • Reaction to light (4)
  • Eye movement (2)
A

Size, shape, symmetry
- pupils should be equal b/w 2-5 mm
- any new discrepancy = significant b-c may be herniation or increased ICP)

Reaction to light
- should be direct and consensual response
- Dilated, nonreactive or oval shape= CN III (oculomotor compression)
- Pinpoint & fixed = brainstem dysfunction/ loss of sympathetic control from opioid
- Asymmetric, loss of reaction, unilateral/bilaterally dilated = brain herniation

Eye movement
- use H test if conscious
- If unconscious, use doll’s eye reflex or ice caloric text

239
Q

ICR: Eye Movement

  • Doll’s eye reflex (oculocephalic reflex) - 3
  • Ice caloric text (oculovestibular reflex) - 3
A

”Doll’s eyes”
- Action: turn head side to side quickly while someone holds eyes open (DO NOT DO IF CERVICAL INJURY)
- positive = eyes move in opposite direction of head movement = intact brainstem.
- Negative = eyes stay fixed and midline or move in same direction as head movement = significant brainstem injury

Cold caloric test”
- Action: place 20-100 ml of ice water in ear while head raised to 30 degrees (HCP ensures tympanic membrane is intact first)- very NOXIOUS
- Positive: eyes turn toward ear with water in it
- Negative: disconjugate/abnormal or absent reflex = degree of brainstem injury

240
Q

ICR: Vital signs

Initial (4)
Late (3)

A

Initial
- increased BP
- Increased HR and CO
- Decreased RR (hypoventilation i.e. hypoxemia and hypercapnia lead to cerebral vasodilation = increased ICP
- Temp (hypo or hyperthermia b-c unable to regulate)

Late (Cushing’s Triad- opposite of shock)
- Increased SBP (widened pulse pressure
- Abnormal respirations/Airway status (Cheyne stokes, cluster breathing, apnea)
- Bradycardia

241
Q

ICR: CT

Use
Care (4)

A

Use: gold standard rapid noninvasive test for TBI, vascularity, mass lesions

Care
- Serial CT to detect changes (increased ICP or midline shifts)
- May be w/ or w/o contrast dye (need contrast dye care i.e. hydration, allergy check, kidney check, previous reactions (antihistamine or corticosteroids if mild reactions previously))
- Stay w/ patient during procedure to monitor neuro, VS, and ICP
- keep patient flat

242
Q

ICR: Cerebral angiography

Use
Contraindications (3)
Care (5)

A

Use: Allows visualization of lumen of vessels to provide info on patency, size (narrowing or dilation), irregularities, occlusion (thrombosis) i.e. aneurysm, vasospasm, AV malformation, carotid artery disease, vascular tumor, stroke

Contraindications: renal insufficiency, bleeding, cardiac instability

Care
- NPO for 4 hrs prior b-c sedated
- Uses contrast dye (check for allergies and check kidney function; enhance hydration)
- Bedrest for 8-12 hrs after
- Care similar to cardiac cath (Keep patient flat and leg straight for 2-6 hrs, monitor puncture site and pulses after procedure)
- Monitor: VS, Neuro and neurovascular q15 for 1 h

243
Q

ICR: Diagnostics

  • MRI (3)
  • EEG (1)
  • X-ray (2)
A

MRI
- more detail than CT to show subtle details (small tumors, cerebral infarct, CNS infections and inflammation, malignancy, metastatic lesions, spinal cord injury
- Requires patient to be motionless in tight space for long time (blindfold, music, or light sedation may be needed)
- Remove all metal from pt body and clothing (do not use if ICP monitoring)

EEG
- Looks at electrical impulses to view seizure activity, cerebral infarct, metabolic encephalopathies, alt LOC, infectious disease, head injury, confirm brain death

X-ray
- Identify fractures (except basilar), anomalies, or possible tumors
- may be unnecessary if CT

244
Q

ICR: Lumbar Puncture

Use
Contraindications (2)
Care (3)

A

Use: visualize CSF and analyze to diagnose meningitis

Contraindications
- increased ICP associated with space-occupying lesion, mass or trauma b-c risk of brain herniation
- increased bleeding risk (anticoagulants, thrombocytopenia, coagulopathies)

Care
- Monitor for changes in neuro or breathing pattern
- properly align patient (flexed lateral)
- Do CT first to rule out mass, lesion, or trauma prior to LP if increased ICP suspected

245
Q

Increased ICP

Pharmacological Management (8)

A
  • AEDs to prevent seizures
  • Antipyretics and cooling blankets to decrease metabolic demand.
  • sedation and antihypertensives to reduce CPP
  • hypertonic saline (keep Na on high side of normal and reduce cerebral edema)
  • Steroids (decrease cerebral edema and inflammation)
  • Diuretics (mannitol or furosemide)
  • Opioids (fentanyl, morphine) and sedatives (propofol)- smallest amount b-c interferes w/ neuro exam
  • Neuromuscular blocking agents – must use ICP monitor b-c not able to get neuro exam w/ these
246
Q

Increased ICP: Key features

Early (4)
Late (7)

A

Early
- Decreased LOC (earliest)
- behavior changes (restlessness, irritability, confusion)
- speech changes (aphasia
- sensorimotor changes (CN dysfunction, ataxia, motor dysfunction, change in muscle tone)

Late
- Severe headache
- Nausea and vomiting (may be projectile)
- Seizures (usually within first 24 hours after stroke)
- Cushing triad (very late sign):
- Abnormal posturing (very late sign): Decerebrate or Decorticate
- Pupillary changes: fixed, constricted, dilated
- Papilledema (edema and hyperemia due to increased blood flow to eye)

247
Q

Cerebral Perfusion Pressure (CPP)

What is it? (2)
Normal range
Note (2)

A
  • pressure needed to ensure blood flow to brain
  • MAP - ICP = CPP

Normal range: 50-70 ( CPP < 30 = neuronal hypoxia and cellular death)

Notes
- Increased ICP -> decreased CPP and causes cytotoxic edema
- maintain SBP > 90

248
Q

ICP Monitoring

Use
Normal range
Care (6)

A

Use: monitoring or treatment via draining CSF in EVD (external ventricular drain) for TBI, ICH, stroke, meningitis, hepatic encephalopathy,

Normal range ICP: 5-15 mmHG (Persistent elevation > 20 remains most significant factor associated with fatal outcomes

Care for device
- Need waveform (3 notches) along w. numeric value
- Zero device once per shift
- Check for catheter dislodgement or kinks in tubing
- Transducer must be leveled w/ ear (external auditory meatus) once a shift
- Do not move HOB b-c misaligns transducer and changes drainage
- reinforce but do not change cranial dressings

249
Q

ICP Monitoring

Contraindication
Complications (4)

A

Contraindication: coagulopathy

Complications:
- Ventriculitis (decrease risk w/ antibiotic impregnated catheter)
- Meningitis
- Post-op hemorrhage,
- Decreased drainage (increases ICP)

250
Q

TBI: Basilar Skull Fracture

s/s (4)
Care (2)

A

S/s
- CSF leak (otorrhea, rhinorrhea)
- Battles sign (ecchymosis behind the ear over mastoid process)
- Raccoon eyes (purplish discoloration around eyes)
- Palsy of CN VII

Care
- detect w/ CT
- NO NGT for this client! (rule out basilar fracture b-c can accidentally insert into brain)

251
Q

TBI: Concussion

What is it?
Diagnostic
S/s (6)

A

Mild brain injury (GCS 13-15 and d/c home) w/ brief loss of neurologic function, particularly loss of consciousness.

Diagnostic: based on hx

S/s
- Loss of consciousness (few minutes to hour) -> anterograde or retrograde amnesia
- confusion/disorientation/dizziness
- irritability/headache
- NV
- ringing in ear
- may have long term secondary effects (CTE or post concussion syndrome)

252
Q

TBI: Contusion

What is it? (2)
Diagnostic
S/s (5)

A
  • bruising of brain (blood collects) due to acceleration-deceleration injuries
  • coup (at point of impact) or contrecoup (secondary opposite point of impact)

Diagnostic: CT

S/s
- inability to concentrate
- numbness and tingling
- issues speaking
- risk for intracerebral hematoma or hemorrhage
- risk for cerebral edema - may need surgery

253
Q

TBI: Epidural Hematoma

What is it?
S/s (3)
Care

A
  • Arterial Bleeding (FAST) into the space between the skull and outermost layer of the dura mater

S/s
- Severe, localized headache (sleepy)
- Dilated and fixed pupil on impact side
- Brief loss of consciousness followed by a period of lucidity then rapid deterioration of LOC (Walk – Talk – Die phenomenon)

Care: Requires EMERGENCY surgical evacuation to remove blood and cauterize vessels

254
Q

TBI: Subdural Hematoma

What is it? (2)
Risk Factors (2)
Care

A
  • Venous bleeding (SLOW) into the space between the dura and above the arachnoid space.
  • Most frequently seen intracranial hemorrhage

Risk factors:
- Coordination or balance disturbance
- Anticoagulants

Care: craniectomy or craniotomy

255
Q

TBI: General Care (8)

A
  • ABCs = priority (b-c risk for Hypoxia, hypercapnia; Hypertension/Hypotension, fever) - need controlled hyperventilation and hypothermia
  • Continuous and Frequent Neurologic Assessment and GCS q1h for early detection and treatment
  • Assess electrolytes q6h if diuretics used
  • Spine precautions (cervical collar, supine, neutral, log roll) until cervical injury ruled out)
  • Seizure precautions
  • Use Foley and PEG/ NG for strict I & O measurement
  • Avoid noxious stimuli (excess suctioning, coughing, irritation, clustering care)
  • Early consults: OT/PT/SLP/social work/organ donation
256
Q

Increased ICP: Things to Avoid (7)

A
  • head, hip or neck flexion
  • clustering of nursing procedures
  • unnecessary suctioning
  • PEEP > 20 cm H2)
  • vomiting (antiemetics)
  • Constipation and straining (stool softeners)
  • Coughing (lidocaine)
257
Q

Mobility: Older Adult risks (6)

A
  • Decrease in lean body mass
  • Increase in body fat
  • Decline in muscle strength (osteoporosis, fractures, immobility)
  • Decreased sensation
  • polypharmacy (fall risk w/ benzos, SSRIs, TCA, neuroleptics, and AEDs = highest risk of falls)
  • frailty (decreased muscle mass, poor nutrition, diminished cognition)
258
Q

Guillain-Barre Syndrome (GBS): Basics (3)

A
  • autoimmune disease
  • demyelination of peripheral nerves causes inflammatory peripheral neuropathy
  • TEMPORARY
259
Q

GBS: Care (7)

A
  • sensory and neuro assessment q1h
  • no cure but hasten recovery w/ Plasmapheresis, IVIG, and steroids for inflammation
  • Respiratory care (may need ventilatory support)- admitted to ICU if requires respiratory support
  • Pain management (opioids)
  • Nutritional management (NG or OG tube if swallowing difficulties)
  • Communication boards or writing if on ventilator and has strength
  • Initiating OT and PT rehabilitation
260
Q

Multiple Sclerosis (MS): Basics (4)

A
  • Chronic autoimmune disease
  • Destruction of myelin (fatty and protein materials) sheath that cover certain fibers in the brain and spinal cord
  • Slows or stops impulse transmission via neuronal injury and muscle atrophy
  • Periods of remission and exacerbation
261
Q

MS: S/s

Mobility (3)
Visual (4)
Audio (3)

A

Musculoskeletal/mobility
- Muscle weakness and spasticity (paresthesia, flexor spasms) -> paralysis
- Intention tremors (when doing activities) i.e. dysmetria
- Ataxia

Visual
- Nystagmus
- Diplopia
- Decreased acuity (blurry)
- Scotoma (change in peripheral vision)

Audio
- Decreased hearing acuity
- Tinnitus
- Vertigo (dizziness)

262
Q

Myasthenia Gravis (MG): Basics (3)

A
  • Autoantibody attack on the acetylcholine receptor sites (AChRs) in the muscle end plate membranes
  • Inadequate ACh = result which prevents muscle contraction
  • exacerbations and remissions
263
Q

MG: s/s (6)

A
  • Fatigue/extremity weakness -> Respiratory muscle compromise
  • Poor posture
  • Ptosis/ diplopia
  • Dysarthria (difficulty speaking)
  • Dysphagia (difficulty swallowing) –Risk for aspiration
  • Loss of bowel and bladder control
264
Q

GBS

S/s (5)
Complications (2)

A

-Initial muscle weakness and pain
- bilateral paresthesia, ataxia -> paralysis
- Ascending paralysis (flaccidity to respiratory paralysis) over 2-3 weeks then plateaus
- No effect on LOC or cerebral function (may have CN dysfunction)
- Decreased DTR

Complications
- Pulmonary (atelectasis, pneumonia, pneumothorax)
- Autonomic dysfunction (HTN, Tachycardia -> beta blocker needed)

265
Q

GBS: Diagnostics (3)

A
  • autoimmune antibodies
  • CSF analysis (Elevated CSF protein with normal cell count)
  • Nerve conduction studies (Reduced conduction in GBS)
266
Q

Plasmapheresis

Use
Action
Pre-op care (2)
Contraindications (2)

A

Use: GBS, MG

Action: Removes circulating antibodies assumed to cause disease from blood then reinfuse blood (similar to dialysis)

Pre-procedure
- place vascular Cath
- need informed consent

Contraindications: sepsis, hemodynamic and venous access complications

267
Q

Intravenous immune globulin (IVIG)

Use
Minor discomforts (3)
Major complications (3)
Contraindications (3)

A

Use: GBS

Minor discomforts ( mild fever/chills, myalgia, and headache)

Major complications (anaphylaxis, retinal necrosis, AKI)

Contraindications: hypercoagulable states, renal failure, hypersensitivity

268
Q

MG: Tensilon Test

Procedure
Results (2)
Risks (2)
Care (3)

A

Procedure: patient in controlled environment and given acetylcholine or edrophonium (acetylcholinerase inhibitor)

Result (observe or take before and after pics of ptosis)
Symptoms improve = MG crisis
Symptoms worsen = cholinergic crisis

Risks
- cardiac dysrhythmias and cardiac arrest (bradycardia, hypotension, bronchospasm, syncope)
- Ach Toxicity: lacrimation, salivation, hyperhidrosis, abdominal cramping, diarrhea

Care
- Antidote = atropine
- Have continuous BP, O2, and cardiac monitoring
- contraindicated w/ asthma or cardiac diseases

269
Q

Crises

  • Myasthenic (3)
  • Cholinergic (2)
A

Myasthenic crisis
- Acute exacerbation of MG from enough anticholinesterase drugs (too little Ach)
- s/s: dysphagia, nasal regurgitation, nasal speech, jaw or tongue weakness, decreased facial sensation, dyspnea, acute respiratory failure
- Treat: Mestinon (pyridostigmine);IVIG or plasmapheresis; respiratory support w/ artificial airway

Cholinergic crisis
- Acute exacerbation of muscle weakness caused by too much anticholinesterase drugs (too much Ach)
- Treat: atropine

270
Q

MG: Care

Nonsurgical (3)
Surgical (1)

A

Non-surgical Management
- Ventilator support (ETT or noninvasive)
- Pulmonary support (CPT, vibration, airway clearance; adequate nutrition, f/e balance)
- Promote mobility to prevent DVT and other immobility complications

Surgical Management
- Thymectomy (take thymus out)-

271
Q

MG: Diagnostics (6)

A
  • Ice pack test (Procedure: place ice pack for 2 min and see if ptosis improves)
  • Thyroid function
  • CT: show thymus gland abnormalities or confirm presence of thymoma (tumor outside thymus)
  • Antibodies to acetylcholine receptor antibody (AChRs)
  • Repetitive nerve stimulation (RNS) or Electromyography (EMG): show impaired neuromuscular transmission
  • Tensilon test

Note: MRI not used b-c contrast can worsen weakness

272
Q

MG: Pharmacological Care

  • Cholinesterase (ChE) inhibitor drug (Mestinon (pyridostigmine)) – (2)
  • Immunosuppressants (steroids, cyclosporin, methotrexate) – (2)
  • IVIG or Plasmapheresis – (1)
A

Mestinon (pyridostigmine) (Cholinesterase (ChE) inhibitor drug)
- Gold standard for MG (no impact on autoimmune response)
- enhances functional AChRs by increasing ACh release

Immunosuppressants (steroids, cyclosporin, methotrexate)
- reduce autoimmune process and progression
- avoid crowds and report s/s of infection; don’t stop steroids abruptly b-c adrenal insufficiency

IVIG or Plasmapheresis
- If severe w/ bulbar dysfunction or respiratory insufficiency

273
Q

MS: Diagnostics (4)

A
  • CSF: elevated proteins and increased WBC count
  • CSF electrophoresis: increased myelin basic protein and presence of increased IgG
  • MRI (shows at least two areas of diffuse random or patchy areas of plaque in white matter of CNS ) = definitive finding
  • Evoked potential testing (Visual evoked response (VER)): identify impaired transmission along optic nerve pathway
274
Q

MS: S/s

Speech (2)
Cognitive (3)
Elimination/Repro (3)

A

Speech
- Dysarthria (difficulty speaking)
- Dysphagia (difficulty swallowing)

Cognitive changes
- memory loss, impaired judgment, inattention
- Mood swings (euphoria; depression)
- Pain -> hypoalgesia (decreased pain sensation)

Elimination/repro
- Urinary retention (Spastic bladder)
- Constipation
- Decreased sexual function (sensation, interest, erection)

275
Q

MS: Drug Therapy (5)

A
  • Immunosuppressive therapy (Cyclophosphamide (Cytoxan);
    methylprednisolone (Solu-Medrol))
  • Anticholinergic agents for overactive bladder
  • Antispasmodics (baclofen or tizanidine) for muscle spasticity which cause pain
  • Antiepileptics (carbamazepine) and TCA for paresthesia
  • Analgesics– pain
276
Q

Neurogenic Shock

Basics (4)

A
  • secondary mechanism of spinal cord injury
  • medical emergency
  • Loss of vasomotor tone -> systemic vasodilation -> hypotension and hypoperfusion (give fluids)
  • Bradycardia (give atropine and norepinephrine)
277
Q

Spinal shock

Basics (4)

A
  • Temporary (Happens immediately and usually lasts 48h but can Last up to 4-12 weeks)
  • complete paralysis/weakness below injury (may lack reflexes and have priapism)
  • Decreased bowel sounds and gastric distention -> hypotonic bowel
  • must resolve before level of injury can be determined
278
Q

SCI: Care

Assessments (3)
Nonsurgical (6)

A
  • assess neurological status ( GCS <8 = intubate) q1h for 4-6h
  • Assess for hemorrhage (internal bleeding; may need blood)
  • Determine level of injury based on ROM, paralysis, DTRs, weakness

Nonsurgical management
- ABCs (evaluation respirations and perfusion) q2-4h
- spinal precautions (collar, bed rest, log roll, jaw thrust)
- ventilation ( no nerve blocking agents; often difficulty weaning)
- pulmonary support (suctioning, chest percussion, incentive spirometer)
- Traction (skeletal, halo fixation)- assess for infection and bleeding; do not adjust
- Prevent complications (musculoskeletal, integumentary, elimination)

279
Q

SCI: Complications (7)

A
  • Shock (hypovolemic, spinal, neurogenic)
  • Cardiac (Dysrhythmias esp. if C3-C5 level, symptomatic bradyarrhythmias, treated w/ atropine or inotropic meds then pacemaker; DVT; orthostatic hypotension)
  • Pulmonary complications (O2 < 92%, atelectasis, pneumonia, respiratory paralysis)
  • Musculoskeletal complications ( contractures, osteopenia, osteoporosis, heterotopic ossification (bony overgrowth onto muscle) —Care: PT/OT for ROM exercises, foot drop splints, hand splints, celecoxib to prevent heterotopic ossification
  • Integumentary complications (Risk for pressure ulcers, temp dysregulation, VTE) – use cooling blanket prior to antipyretics
  • Elimination complications (Risk for abdominal distention, constipation, fecal impaction; Spastic bladder if upper SCI; flaccid bladder if lower SCI) – care: Foley and stool softeners; bowel program (Fluids, fiber, proper position, physical activity, reflex stimulation)
  • Autonomic dysreflexia (EMERGENCY)
280
Q

SCI: Pharmacologic care (6)

A
  • Methylprednisolone (Medrol) for edema and inflammation
  • Baclofen for spasms (risk for CNS depression, hypotension; OR Hallucination and seizures if sudden withdrawal)
  • Stress ulcer prophylaxis (PPI)
  • IV fluids and vasopressor support to keep SBP > 90 and MAP > 85-90 to prevent hypotension
  • Dextran (plasma expander) to increase capillary blood flow in spinal cord and prevent/treat hypotension
  • Atropine sulfate to treat bradycardia if pulse < 50-60 beats/min
281
Q

Autonomic Dysreflexia: Risk factors (7)

A
  • Restrictive clothing
  • Pressure area (Epididymitis or scrotal compression; Sheet wrinkles or hard objects)
  • UTI
  • Irritation of hemorrhoids
  • Pain
  • Distended bladder (Areflexic (neurogenic) bladder)
  • Constipation (fecal impaction)
282
Q

Autonomic Dysreflexia

  • S/s (3)
  • risks (3)
A

S/s
- Vasodilation above level of injury
(Severe HTN, severe headache, nasal stuffiness, blurred vision, spots in visual field, Flushing, Diaphoresis, goosebumps, JVD, apprehension)

  • Bradycardia
  • Vasoconstriction below level of injury (Pale, Cool, No sweating)

Risks
- cerebral hemorrhage
- seizures
- stroke

283
Q

Autonomic Dysreflexia

Basics
Care (5)

A

Basics
- Exaggerated sympathetic response to stimuli in people w/ high level SCI (T6 or higher)

Care
- Raise HOB to reduce BP
- Treat the cause i.e. remove impact, check catheter, loosen clothes, identify UTI, examine for pressure ulcer
- Notify MRT
- Monitor BP q10-15 min
- Give nifedipine or nitrate to lower BP

284
Q

Older adults: Common skin problems (5)

A
  • Xerosis (dry, cracked, itchy skin) –Worsened by inadequate water intake or environmental conditions; interventions: moisturizers, natural oils
  • Seborrheic keratosis (Noncancerous growths)
  • Cancer (skin cancer)– avoid hot day, protective clothes, sunscreen, check sin
  • Skin tears (wound from shear, friction, and or blunt force which separates skin layers)
  • Pressure ulcers –assess w/ Braden Scale
285
Q

Older adults: Skin Changes (5)

A
  • Less elastic r/t collagen depletion
  • Drier ((less moisture) so prone to dermal-epidermal separation, reduced subQ blood flow, decreased dermal lymphatic drainage
  • More fragile b-c epidermis thins, BVs break easy
  • Decreased wound healing r/t decreased cytokine and growth factor production; diminished inflammatory response and reduced cell proliferation
  • increased breakdown r/t incontinence, immobility, diarrhea
286
Q

Patients Best Treated in Burn Center (6)

A
  • partial thickness of 10% TBSA
  • Any full thickness/ 3rd degree
  • Burn to face, genitals, major joints, perineum, hands, feet
  • special Injuries (electrical, inhalation, chemical, frostbite)
  • Burn w/ preexisting conditions (DM, pulmonary, cardiac, kidney, or CNS disorders) that increase risk of mortality
  • Burn injury + former trauma (fracture)
287
Q

Size of Burn: Rule of Nines

Components (6)

A

Components
- chest (18%)
- back (18%)
- genitals (1%)
- Each leg (18%- one side = 9%)
- Each arm (9%- one side = 4.5%)
- Head (9%- face = 4.5%)

Tidbits
- Circumferential from shoulder to elbow = 4.5%
- Palmar surface of hand = 1%

288
Q

Size of Burns: Rule of Nines

Tips (3)

A
  • Must be accurate for burn shock interventions, calculation of TBSA, and caloric needs
  • Quickest way to calculate size of burn injury in adults
  • Do not include first degree burns in rule of nines
289
Q

Depth of Burns: Superficial (1st)

What is it?
S/s (3)
Care (4)

A

Epidermal burn (not included in rule of nines)

s/s
- Red, erythema
- Painful, Tender which resolves in 48-72 hrs
- Possible swelling

Care
- Heals in 2-7 days
- Pain relief
- Anti-Pruritics
- Oral fluids

290
Q

Depth of Burns: Superficial partial (2nd)

What is it?
S/s (5)
Care (2)

A
  • involves all of epidermis and part of underlying dermis

S/s
- Light to bright red or mottled appearance
- Blanch w/ pressure due to inadequate perfusion
- Bullae OR wet and weeping blisters due to microvessel injury increasing permeability and causing leakage of plasma into interstitium
- Extremely painful
- sensitive to air currents

Care
- Uncomplicated heals in 7-21 days w/ minimal scarring
- IV fluids

291
Q

Depth of Burns: deep partial (2nd)

What is it?
S/s (3)
Care (4)

A

Burn involving entire epidermal layer and deeper layers of the dermis w/ Severe blood supply impairment

S/s
- Red with patchy white areas that blanch with pressure
- Turns from white to yellow due to dermal necrosis and surface coagulated protein
- NO blister formation

Care
- Extensive healing time (up to 6 weeks) – full-thickness if infected, inadequate perfusion, or more trauma
- Spontaneous healing (hypertrophic scarring and contractures due to unstable epithelium)
- Surgical excision
- Skin grafting

292
Q

Depth of Burns: Full-Thickness (3rd)

What is it?
S/s (5)
Care (2)

A
  • All 3 layers of skin involved so skin does not grow back on its own

S/s
- Pale white or charred, red or brown
- Leathery and dry - bleed from vessel damage
- Painless (May have background or procedural pain)
- Insensitive to palpitation
- systemic effects on f/e balance, infection, metabolism, thermoregulation

Treatment
- Does not heal by epithelialization or on its own
- Skin grafting

293
Q

Thermal Burn (3)

A
  • Most common type of burn
  • Most at risk: <2 yrs. (scalds) AND > 60 yrs.
  • Temperature and duration of contact determine extent and depth of injury
294
Q

Electrical Burn

Notes (2)
Amount of damage determined by (4)

A

Notes
- Highest incidence in children
- risk for tissue destruction, contracture formation, acid-base balance. Rhabdomyolysis

Amount of damage determined by
- Type and voltage of circuit
- Resistance (insulation)
- Pathway of transmission through body (More serious than outside appearance due to current traveling inside the body and damaging inner tissues)
- Duration of contact

295
Q

Radiation Burn (3)

A
  • Usually localized from high dose radiation (accelerators, cyclotrons, medical treatment) or prolonged sun
  • Appearance similar to thermal injury (Differentiate based on timing of injury and clinical manifestations)
  • Care: not extensive (may need fluids and anti-pruritic)
296
Q

Chemical Burn

Amount of injury determined by: (4)
Care (4)

A

Amount of injury determined by
- Concentration of chemical
- duration of contact
- chemical action (alkaline more severe than acid)
- amount of tissue

Care
- Remove contacts prior to flushing eye
- Remove contaminated clothing and shoes
- Flush area w/ large amounts of water for hours after injury
- Neutralization can worsen injury

297
Q

Stages of Burn Care

Resuscitation/Emergent (3)
Acute (3)
Rehabilitative (2)

A

Resuscitation/Emergent
- Begins at the time of injury and continues for about 48 hrs
- ends when capillary integrity restored and plasma volume repleted
- 1st hour after injury is crucial

Acute
- begins after resuscitation (36-48 hr) w/ diuresis (end of edema)
- lasts until complete wound closure is achieved
- Early eschar excision and grafting = early resolution of inflammation and better healing

Rehabilitative
- Begins with major wound closure to return to optimum level of health (independence and maximum function)
- Usually about 6 months to 2 yrs but may take a lifetime b-c ends when highest level of functioning reached.

298
Q

Burns: Acute Care

Goals (3)

A
  • Save patient’s life (maintain vital organ function and perfusion)
  • Minimize complications and disability (wound healing and prevention of infection)
  • Prepare for rehabilitation and definitive care
299
Q

Burns: History (7)

A
  • Age (higher risk if <2 or > 60)
  • How did it happen? (mechanism of injury) - rule out trauma, fractures, abuse
  • Assess source and cause
  • Where did it happen? (time and place; think CO poisoning if in confined space)
  • Assess for known allergies
  • Assess status of tetanus immunizations
  • significant medical history (preexisting conditions, current meds)
300
Q

Burns: Resuscitation/Emergent Phase

Priorities (6)

A
  • Maintain adequate oxygenation (airway)
  • Maintain adequate fluid balance (circulation to prevent hypovolemic shock from fluid shift)
  • Promote adequate tissue perfusion (may need w/ art line or CVP; remove watches/jewelry which can have tourniquet effect)
  • Maintain body temperature (risk for hypothermia via evaporation and radiation)
  • Prevent infection
  • Keep patient comfortable w/ analgesics and emotional support
301
Q

Burns: Airway Management

Goal

S/s of airway damage (4)

Care

A

Goal: avoid ARDS, pneumonia, pulmonary edema

s/s of airway damage
- Assess ( singed nasal hairs or eyebrows, hoarseness, facial burn carbonaceous sputum, drooling)
- Sudden stop of stridor or wheezing = unable to breath (EMERGENCY)
- Facial edema = intubate prior to airway closing
- Hypoxemia (tachypnea, agitation, anxiety, upper airway obstruction)

Care: 100% oxygen

302
Q

Burns: Airway Management

Care (7)

A
  • Ventilator support (100% oxygen, (low tidal volume, high PEEP, permissive hypercarbia)
  • HOB elevated
  • Early intubation
  • Mobilize and remove secretions (cough, deep breathing, suctioning, bronchodilators, early mobility, elevate HOB)
  • Careful fluid resuscitation to prevent pulmonary edema
  • Cervical precautions if possibility of instability
  • Nebulized heparin (increase airway clearance of debris)
303
Q

Burn: Respiratory Management

Concern
Care (4)

A

Concerns
- chest restriction (reduced expansion and compliance) w/ circumferential full thickness chest burns

Care
- Escharotomy to chest wall ASAP
- Monitor ABGs and O2 sat (Respiratory acidosis -> respiratory alkalosis)
- Monitor respiratory rate and effort
- Monitor for cyanosis (late sign)

304
Q

Burn: Circulatory Managment

Goal
Concerns (2)
Care (4)

A

Goal: maintain end organ perfusion and avoid fluid overload

Concerns
- Under resuscitation = inadequate cardiac output = inadequate perfusion and wound conversion (AKI, cardiovascular collapse, death from shock)
- Over resuscitation = excess wound edema -> moderate to severe pulmonary edema -> decreased perfusion of unburned tissue

Care
- Requires accurate fluid resuscitation
- No diuretics
- Assess HR, BP, pulses, cap. Refill, I & Os, LOC (perfusion to brain)
- Continuous EKG (May need nontraditional placement of leads due to burn locations)- initial if electrical wound or preexisting hear condition

305
Q

Burn Shock

What is it? (3)

Effects (4)

A
  • common cause of death in the emergent phase (Higher TBSA (>20%) = higher chance of shock)
  • Loss of fluid from vascular compartment to area of injury
  • Leads to blisters and edema from damaged blood vessels increasing permeability to protein and water

Effects
- hypovolemic shock
- tissue trauma
- increased PVR (leads to pulmonary edema)
- decreased myocardial contractility and cardiac output b-c increased SVR

306
Q

Burn: Fluid Resuscitation

Parkland Formula (3)
Tips (3)

A

Parkland Formula
- 4cc LR * body weight in Kg* % TBSA burned
- ½ given over first 8 hours post-injury
- ½ given over the following 16 hours post-injury

Tips
- LR via large bore (18 G or 20 G) IV
- LR > NS b-c matches ECF
- Plasma replacement and isotonic fluids used after 24 hours to increase circulating volume

307
Q

Burn: Renal Management

S/s of impairment (AKI) - 4

Care - 5

A
  • urine (hemoglobinuria, myoglobinuria)
  • inadequate fluid replacement (hypoperfusion, hypovolemia)
  • inadequate UOP (edema, elevated BP)
  • Change in LOC (lethargy, confusion)

Care
- Monitor labs (BUN, Crt, GFR, K/Na), PO4
- Assess urine (color, bloody, myoglobin, odor, particles, foamy)
- Monitor UOP and specific gravity
- May need dialysis (hemodialysis or CRT)
- Place foley (if TBSA > 20% or perineum burn)

308
Q

Burn: GI system Management

Risks due to stress response (3)

Care (5)

A

Effects of stress response
- Paralytic Ileus and gastric dilation (also due to burn shock, hypokalemia, SNS response to trauma)
- stress ulcer (Curling’s ulcer)
- Decreased GI activity (also due to hypovolemia and neurologic injury)

Care
- Initial NPO
- Abdominal exam q2h then q4h (incl. eval for abdominal compartment syndrome)
- Place NGT or OGT to low intermittent suction (Prevention of aspiration, distention, emesis)
- Administer GI prophylaxis (PPI, H2A, sucralfate, antacids)
- Enteral nutrition (Purpose: increase intestinal flow, intestinal blood flow, and GI motility)

309
Q

Burn: Extremity Management

Clinical manifestations (3)
Care (5)

A

Clinical manifestations
- arterial insufficiency due to wound edema, circumferential burns (leads to ischemia and necrosis)
- Diminished to absent peripheral pulses
- Loss of muscle function

Care
- Assess neurovascular integrity q6h ( Pulselessness, pallor, pain, paresthesia, paralysis, poikilothermy)
- Doppler flow probe (evaluate arterial pulses)
- escharotomy if circumferential burn to restore circulation and allow swelling
- Extend and elevate extremities to decrease peripheral edema and enhance venous return
- Avoid crossed legs, dependent positions, pillows behind knees

310
Q

Burn: Immune Management

Effects due to stress response

Care (5)

A

Effects due to stress response
- Overwhelming stress leads to bone marrow suppression, anemia, and infection

Care
- IV antibiotics
- Meticulous wound care (hand hygiene)
- Wound monitoring ( for exudate, odor, warmth, fever, and color)
- Supportive care (isolation techniques w/ dedicated equipment)
- Blood transfusions b-c prone to anemia

311
Q

Burn: Pain Management

Types (3)
When to manage pain (3)

A

Types
- background (physiological including damage and exposure of nerve endings) r/t ROM, routine activities
- Breakthrough which is not relieved by routine pain meds
- Procedural (PT, OT, dressing changes, splints)

When to manage pain
- Only after IV fluid resuscitation is underway
- Not initial priority b-c pain sensation diminished if well oxygenated and wound covered
- Premedicated prior to procedural care

312
Q

Burn: Contractures

What is it?
Prevention (4)

A

Contracture: shortening of scar over joint and causes functional deficit

Prevention
- Physical and occupational therapy
- Passive and active ROM to prevent complications
- Splint (Keep joints fully extended in anatomical position on pillows)
- no pillow behind head if face burn to prevent flexion of neck

313
Q

Burn: Wound Care

General (6)

A
  • Daily observation and assessment
  • Multiple dressing changes (application and reapplication of clean, dry dressing.
  • skin graft must be placed on clean, viable, tissue
  • Analgesics and sedatives (morphine, midazolam (versed), hydromorphone) to prevent procedural pain
  • Topical antibiotics (silver sulfadiazine, mafenide acetate cream, bacitracin, silver) to control/decrease bacterial colonization
  • Refer to Burn Center (delivers all therapy incl. rehabilitation and can perform personnel training and burn research)
314
Q

Burn: Labs (7)

A
  • Hgb, Hct, & BUN HIGH (Due to fluid volume loss)
  • Glucose HIGH (Due to stess response
  • Na+ LOW (Due to trapped in wound edema, fluid loss, vomiting, NGT drainage, diarrhea)
  • K+ HIGH or LOW (High due to release from damaged cells, metabolic acidosis, impaired kidney function (hemoglobinuria, myoglobinuria, decreased renal perfusion) –> Care: correct acidosis (no DICK) OR Low due to massive fluid loss or hemodilution)
  • pH LOW (Due to metabolic acidosis
  • Total protein & albumin LOW (Due to loss via burn wound)
  • WBC initial rise then drop as immune system unable to sustain its defenses. (may be sepsis)
315
Q

Burn: Pain Management

Care (4)

A
  • Reduce BMR via preventing catecholamine release i.e. from pain, fear, anxiety, cold
  • use IV in resuscitation phase (no subQ or IM b-c unpredictable absorption
  • use nonpharmacological (imagery, hypnosis, virtual reality, distraction)
  • use opioids (NSAIDs and acetaminophen only if no risk for bleeding)
316
Q

Burn: Nutrition Therapy (4)

A
  • Early continuous enteral feeds
  • Caloric needs are about 5000 kcal/day due to high BMR
  • High-protein, high-carbohydrate foods
  • May need supplmental albumin, iron, zinc, calcium, phosphate, potassium
317
Q

Burn: Debridement

Goal
Types (3)

A

Goal: remove devitalized (nonviable) tissue down to bleeding stable tissue to control inflammation and remove contaminated tissue to prepare for grafting

Types
- Mechanical (via scissors or forceps)
- Enzymatic (via topical substance to loosen and dissolve eschar)
- Surgical (gold standard in OR once hemodynamically stable)

318
Q

Burn: Cleansing

Goal

Notes (2)

A

Goal: maintain moist environment while limiting exposure to prevent hypothermia and bacteria exposure

Notes
- Done in a hydrotherapy tub, cart shower, shower, or bedside
- Hydrotherapy limited to 30 min to prevent hypokalemia

319
Q

Burn: Rehabilitative Phase

Skin care (4)
Mobility (2)
Emotional (2)

A

Skin care
- Discoloration of scar fades with time but not invisible and may not fully go away
- Newly healed areas can be hypersensitive or hyposensitive to cold, heat, and touch
- Healed areas must be protected from direct sunlight for 1 year
- use lotion for itching

Mobility
- Engage in PT, OT
- exercise important

Emotional
- praise minor and major accomplishment
- use group therapy

320
Q

Burn: Scarring

Prevention (6)

A
  • pressure garments which reduce scar blood flow, help organize collagen, prevent venous stasis and edema
  • Scar massage via providing moisture, stretching scar, and preventing contracture
  • High SPF sun protection via preventing long term pigment change
  • Silicone gel sheeting via maintaining scar hydration and reduce tension
  • Laser therapy
  • Steroids for hypertrophic scars via inhibiting fibroblast growth
321
Q

Cold-related injuries

  • Frost-nip
  • Frostbite
A

Frostnip
- superficial cold injury w/ no tissue damage
- causes pain, numbness, pallor or waxy appearance
- Care: resolves w/ body heat or warmth

Frostbite
- freezes and causes tissue damage
- use arteriography once rewarmed to exam perfusion

322
Q

Cold-related injuries: Degrees of frostbite

  • 1st degree/grade 1 (2)
  • 2nd degree/grade 2 (2)
A

1st degree or Grade 1 frostbite (Least severe)
- increased blood flow to area (hyperemia)
- Edema formation

2nd degree or Grade 2 frostbite
- Partial thickness skin necrosis
- Large, clear to milky fluid filled blisters

323
Q

Cold-related injuries: Degrees of frostbite

  • 3rd degree/ Grade 3 (3)
  • 4th degree/ Grade 4 (4)
A

3rd degree or Grade 3 frostbite
- Small blisters w/ dark fluid
- Body part = COOL, blue, numb, no blanching w/ pressure
- Requires debridement b-c full thickness and subQ necrosis

4th degree or Grade 4 frostbite (Most severe)
- Blisters over carpal or tarsal
- Body part = numb, COLD, bloodless
- Extends into muscle and bone
- Amputation if gangrene or compartment syndrome develops

324
Q

Cold-related injuries: Management

  • Rewarming (4)
  • Positioning (3)
  • Care (4)
A

Rewarming
- Rapid rewarming w/ Body heat (hands on face or under arms) - for frost nip or superficial OR w/ Water bath (hydrotherapy)- 37-39 C (99-102 F) for 2nd degree or higher (trunk first to prevent aftershock)
- Never apply dry heat b-c increases tissue damage
- Prevent refreezing once thawed
- warm IV fluids (May need to hold (except vasopressors) if core body temp < 86 F (30 C))

Positioning
- Supine to prevent OH
- Gentle handling to prevent v-fib
- Elevate above heart to decrease tissue edema

Care
- Analgesics w/ IV opiates and ibuprofen to decrease inflammation and secondary injury
- Other Drugs: Antibiotics (topical and systemic), tetanus immunization, no caffeine or alcohol
- Assess for compartment syndrome (6 Ps)
compare affected to unaffected
- Never massage area or compress

325
Q

Medications that can impair sexuality
(cause ED, decreased arousal, orgasm, libidio; vaginal dryness)

10 total

A
  • Antihypertensives
  • Antihistamines
  • Antidepressants
  • sedatives
  • Dopamine agonists
  • Appetite suppressants
  • Anti-ulcer drugs
  • Antineoplastics
  • Corticosteroids
  • Prolonged hormones (estrogen, testosterone)
326
Q

Risk factors for impaired sexuality (6)

A
  • Disabilities: Cognitive, Developmental, and Physical
  • Newly unpartnered (separated, widows, divorced) have new sexual paradigm
  • Sexual Orientation: LGBTQIA+ (engage in more high risk behaviors;
    Higher risk for mental distress, cardiovascular disease, obesity, disability)
  • Medical Treatments (radiation, chemo, certain meds)
  • High-Risk behaviors (multiple partners, casual partners, refrain from safe sex)
  • Underlying Medical Conditions (mental health, CAD, mobility, HIV/AIDS, respiratory, infectious disorders, DM, cancer)
327
Q

Older Adults and Sexuality: Screenings (6)

A
  • Screening for STIs (chlamydia, gonorrhea, HIV) - level of risk based on sexual behaviors, multiple partners, adolescent onset intercourse, hx of STIs, unsafe sexual behavior, sharing IV, unprotected sex
  • Screening for IPV
  • Pap tests q3 years b/w 21-65; after 65 no need unless high risk or cancer in past 20 yrs; No need if hysterectomy unless hysterectomy done for cervical or precervical cancer
  • Mammogram – annual for women > 45 yrs (q2y if > 55 if life expectancy > 10 yrs)
  • PSA – men > 50 yrs
  • self screenings (breast exam, testicular self exam)
328
Q

Older adults and Sexuality: Collaborative interventions (4)

A
  • Medications (Antibiotics for STIs, Hormone replacement therapy (HRT) and lubricants for postmenopausal, PDE-5, prostaglandins, testosterone for ED)
  • Surgical procedures (hysterectomy, penile implant, vasectomy, mastectomy, prostatectomy) – can impair sexual interest, feelings of attractiveness, cause ED
  • Cognitive-Behavioral therapy– counseling
  • kegels to strengthen pelvic muscles
329
Q

Sexuality and Aging

  • Myths (3)
  • Reality (3)
A

Myths
- sexual desires diminish with age and cognitive impairment
- Sexual intercourse is only for young, healthy people for procreation
- All older adults are heterosexual ( The presence of older adults as being LGBTQ is not often considered a possibility)

Reality
- Sexual thoughts, desires and actions continue throughout all decades of life
- Sexuality is Vital part of ones holistic being from birth to death
- Older adults have various sexual orientations

330
Q

Positive Impacts of Sexuality (4)

A
  • Cultural aspect of wellbeing
  • Provides for expressions of affection and passion
  • Enhances arousal of life
  • Enriches communication
331
Q

Older adults and sexuality: Barriers (7)

A
  • Lack knowledge and comfort with sexual health issues i.e. safe sex practices, positions to accommodate health needs
  • normal aging changes (menopause; decreased estrogen and testosterone)
  • pathological aging changes (cognitive impairment, language barrier, meds)
  • body image (worry or discomfort w/ wrinkly and saggy skin; believe not attractive)
  • Fear of discussing sexuality (esp. if LGBT)
  • Cultural and religious beliefs toward sexuality
  • Environmental barriers (Privacy and Consent in nursing home, assisted living facility, or family home)
332
Q

Older adults and Sexuality: Opening the door

  • Environment (3)
  • Components of Assessment (7)
A

Environment
- Quiet and private area (w/ or w/o partner presence)
- Respectful manner (respect diversity, autonomy, responsive, guidance)
- AVOID rigid standards of identify (gender identity is a spectrum)

Components of assessment
- Health history & review of systems
- 5 “P”s: partners, practices, protection from STDs, past history of STDs and prevention of pregnancy- omit pregnancy
- Drug review (bipolar, cholesterol, DM)
- Physical assessment (s/s of abuse)
- cognitive assessment ( ability to give consent)
- Diagnostics (mammogram, CT, MRI, US, HST)
- self-assessment (nurse must be comfortable discussing sexuality)

333
Q

Older adults and Sexuality:

Sex history/interview questions (9)

A
  • Have you disclosed your gender identity and sexual orientation to your primary health care provider? If you have not, may I have your permission to provide that information to members of the health care team who are involved in your care?
  • General: How do you express your sexuality? What concerns do you have about fulfilling your continuous sexual desires?
  • Aging changes: In what ways has your relationship with your partner changed as you have aged?
  • Inquiry: What info or interventions can I provide to help you to fulfill your sexuality? What questions do you have about your continuous sexual needs and function?
  • Abuse: Inquire about sexual assault or abuse (Notice nonverbal indicators: Bruises? Scared when communicating with you?)
  • Living arrangement: Does anyone live with you in your household? Are you in a relationship with someone who does not live with you?
  • Testing: If you have a sexual partner, have you or your partner been evaluated about the possibility of transmitting infections to each other?
  • Protection: If you have more than one sexual partner, how are you protecting both of you from infections such as hepatitis B, hepatitis C, or HIV?
  • Social support: Whom do you consider to be your closest family members?
334
Q

Older adults and sexuality: PLISSIT Model

A

P: obtaining PERMISSION from the client to initiate sexual discussion

LI: Providing the LIMITED INFORMATION needed to function sexually

SS: giving SPECIFIC SUGGESTIONS for the individual to proceed with sexual relations

IT: providing INTENSIVE THERAPY surrounding the issues of sexuality for that client

335
Q

Older adults: Female Sexual Changes

  • Vaginal (6)
  • Breasts (3)
A
  • Menopausal s/s: hot flashes, difficulty sleeping, mood changes

Vaginal
- Thinning, stiffening, drying, smoothing, shortening of the vaginal wall and canal
- Decreased or delayed vaginal lubrication (lead to dyspareunia)
- Labia, clitoris endometrium atrophy
- Graying and thinning of vaginal hair
- Loss of tone and elasticity of pelvic muscle
- Loss of fat pad over pubic symphysis -> pain from direct pressure over bone.

Breasts
- Increased flabbiness and fibrosis of breasts
- Granular and lobular feeling
- Decreased erection of nipples

336
Q

Older adults: Male Sexual Changes (5)

A
  • Graying and thinning of pubic hair
  • Increased drooping of scrotum and loss of rugae
  • Prostate enlargement (Risk for urethral obstruction)
  • Impotence (erectile dysfunction-ED) -> More direct stimulation required to experience a weaker erection.
  • longer refractory time (Loss of erection quicker after orgasm and takes more time to regain erection)
337
Q

Disease processes and Sexuality

  • Heart disease (3)
  • Diabetes (2)
A

Heart disease
- Narrowing and hardening of arteries changes blood vessels so blood does not flow freely
- Results: inability to relax during sex (post-MI), aphasia (post-stroke), clogged blood vessels -> ED
- Medications effects: Antihypertensives (BB, CCB, clonidine, thiazides) -> impotence, ejaculatory disturbances; Cholesterol lowering medications (statins) -> impact sexual health.

Diabetes
- Result: impaired sexual function, ED in men, vaginal infections and dryness in women
-Care: glucose control; hypoglycemics may affect sexuality

338
Q

Disease processes and Sexuality

  • Depression (2)
  • Cancer (3)
A

Depression
- Result: decreased desire, intimacy, sexual activity
- Med effects from TCAs, SSRIs, MAOIs: decreased libido, ED

Cancer
- advanced age most important risk factor
- Women: breast cancer and mastectomy -> loss of sexual interest and femininity
- Men: Prostate cancer, BPH, prostatectomy -> urinary incontinence and ED

339
Q

Disease Processes and Sexuality: HIV/ AIDS

Age-related difficulties (5)
Note: 50% of peeps w/ AIDS > 50 yrs

A
  • immunity decline -> increased risk for infection after HIV exposure
  • late diagnosis b-c aches and pains of HIV/AIDS resemble normal aging or Afraid or ashamed of being testing
  • Increased risk for cardiovascular disease, dementia, DM, osteoporosis, frailty, cancer, mental illness (depression, addiction)
  • Lack knowledge about HIV/AIDS transmission and prevention
  • no cure but antiretrovirals can slow progression and maintain immune function ( use in older adults = complicated b-c of comorbidities)
340
Q

Disease Processes and Sexuality: HIV/ AIDS

Testing frequency (4)

A
  • If diagnosed or treated for hepatitis or TB
  • If you or partner had blood transfusion between 1978 and 1985
  • if you or partner ever had blood transfusion or operation in a developing country
  • if b/w 13 and 64 years old at least once (If over 65, ask doctor about frequency of testing)
341
Q

Disease Processes and Sexuality: Dementia

  • Manifestations (2)
  • Treatment (6)
A

Manifestations
- hyposexual (complete loss of sexual desire)
- hypersexual (may be inappropriate i.e. sexual remarks, propositions, groping, grabbing, obscenities, public masturbation, aggression and irritability)

Treatment
- benzos for hypersexuality
- give privacy, respect, calm response if masturbating
- recognize sexual needs and determine if capacity to consent if others involved (if unable to consent, HCP needs to step in and prevent unwanted sexual advances)
- boundary setting
- support and education for caregivers
- same gender caregivers

342
Q

Older adults and Sexuality: Education (5)

A

Education
- normal and pathological sexual changes with aging.

  • Safe sex practices (condom, dental dam)
  • Alternative sexual positions if uncomfortable or not possible
  • Discuss changes openly w/ partner
  • promote healthy lifestyle (limit alcohol, smoking cessation, healthy diet, exercise, stress management, adequate sleep) b-c impaired health = impaired sexuality
343
Q

Phosphodiesterase-5 Inhibitors (sildenafil, vardenafil, tadalafil)

Use
Care (4)

A

Use: ED

Care
- Risk for hypotension (DO NOT TAKE WITH NITRATES)
- For Viagra (sildenafil citrate) and Levitra (vardenafil), need sexual stimulation w/n 30 min to an hour to promote erection (Take 1 hr prior to sexual intercourse)
- For Cilalis (tadalafil), erection can be stimulated over longer period (36 hrs)–Take 2 hr prior to intercourse
- NO GRAPEFRUIT JUICE

344
Q

Systemic Lupus Erythematosus (SLE): Basics (4 )

A
  • Remissions and exacerbations (mainly women from stress or light)
  • autoimmune complexes deposit in body systems causing excessive inflammation, overactive immunity, and loss of tissue integrity leading to organ failure and death
  • Death from vasculitis, lupus nephritis, cardiac problems (pericarditis)
  • type III hypersensitivity w/ antibody complexes that deposit in tissues
345
Q

SLE: Assessment

  • Integumentary (6)
  • Neurologic (2)
A

Integumentary
- Butterfly rash (red, macular, scaly, dry facial rash over the cheeks and nose in the shape of a butterfly) (nonscarring)
- Coin-shaped lesions (discoid rash) on the face, scalp, and sun-exposed areas (causes scarring)
- Sensitivity to sunlight (photosensitivity)
- Chronic lesions on the mucous membranes of the mouth and throat (ulcers in mouth and throat)
- Lupus profundus: skin of face darkens and cheek volume decreases as vasculitis destroys fatty tissue beneath skin
- Alopecia

Neurologic
- seizures w/o previous hx
- psychosis without previous history

346
Q

SLE: Assessment

  • Hematologic/immunity (6)
  • GI (1)
A

Hematologic/immunity problems
- hemolytic anemia (most common)
- decreased white blood cells (leukopenia) and decreased lymphocytes (lymphopenia)
- decreased platelets (thrombocytopenia)
- Presence of antinuclear antibodies (ANA)
- may have false positive syphilis test
- intermittent fever (unexplainable

GI
- anorexia

347
Q

SLE: Assessment

  • Musculoskeletal (3)
  • Cardiac (3)
  • Kidney (3)
A

Musculoskeletal
- Chronic fatigue
- Polyarthritis–Nonerosive arthritis of two or more bilateral peripheral joints (painful and swollen)
- Muscle inflammation (myositis) due to synovial inflammation but no erosion of bone and cartilage

Cardiac
- Pericarditis (inflammation; s/s: chest pain, tachycardia, myocardial ischemia
- Value thickening
- Murmurs

Kidney
- Persistent casts and protein in the urine due to glomerular damage (proteinuria = foamy) = lupus nephritis
- Hematuria
- Fluid retention (change in UOP)

348
Q

SLE: Management

Goals
General care (3)
Prevention of exacerbation (3)

A

Goal: Aim is to treat the disease aggressively until remission.

General care
- Meds for inflammation (topical steroids, immunosuppressives, anti-malarial, NSAIDs, belimumab)
- tylenol and moist heat can reduce joint pain (cold only is strained or sprained)
- skin care (mild soap, dry and lotion; avoid harsh substances)

Prevention of exacerbation
- Avoid high-impact exercises but continue low impact and strength building exercise to increase endurance
- Avoid UV light (sunlight, fluorescents) b-c exacerbates entire disorder ( SPF 30, no midday sun, umbrella, long sleeves, large hat outdoors)
- Avoid smoking and nicotine

349
Q

SLE: Anti-malarial meds (Hydroxychloroquine (Plaquenil))

Actions (3)
Care (1)

A

Action/Purpose
- decreases inflammation
- anti clotting effects for vasculitis to prevent VTE
- Reduces risk for skin lesions via reducing UV light absorption

Care
- Teach pts to have frequent eye exam b-c risk for retinitis (irreversible loss of central vision)

350
Q

SLE: Immunosuppresives (methotrexate (Rheumatrex), azathiprine (Imuran))

Purpose
Care (2)

A

Purpose: control inflammation and suppress overactive immune system if steroids ineffective or intolerable in CNS or renal lupus

Care
- risk for infections or exacerbation of dormant infections so avoid crowds and ill people
- Report any early sign of infection to HCP

351
Q

SLE: Steroids

Use (2)
Risks (2)
Care (2)

A

Use
- topical for inflammation and skin changes
- systemic used for intense SLE pain, inflammation, immunosuppression

Risks
- Early: acne, sodium and fluid retention, HTN, insomnia, mood instability (easy crying, euphoria, nervousness))
- Chronic: Cushing’s syndrome i.e. fat redistribution (moon face, buffalo hump); PUD; fragile skin (easy bruising, stretch marks, delayed wound healing), Osteoporosis; osteonecrosis; Thinning scalp hair; hirsutism, susceptibility to infections

Care
- Increase dosage in exacerbation and then taper in remission
- Do not stop abruptly to prevent adrenal crisis

352
Q

Organ Transplantation

  • Indications (2)
  • Recipient Assessment (6)
A

Indications
- Preferred and only treatment for irreversible, progressive, end-stage organ disease to improve quality of life and extend survival
- quantified reduced life expectancy

Recipient assessment
- comprehensive health eval w/ multiple labs, tests, procedures
- Physical and mental health eval w/ psychiatric and social screening
- Evaluation of social support
- Evaluation for chemical dependence
- Evaluation of commitment to adhere to strict lifetime medical regimen
- Receive all vaccinations prior to transplant b-c more effective if not immunosuppresed

353
Q

Organ Transplantation: Donation after brain death

  • Criteria
  • must rule out (5)
  • Diagnostics (4)
A
  • Criteria: irreversible coma and family decides to withdraw care, GCS < 5, ICU,

Must rule out
- hypothermia (<32 C),
- Hypotension (SBP < 90)
- drug toxicity – do drug screen, hx, and calculation of clearance
- neuromuscular blocking agent (Can interfere w/ cerebral motor response)
- electrolyte, acid-base, or endocrine dysfunctions

Diagnostics
- EEG – no brain activity
- Cerebral angiography – no cerebral perfusion
- Transcranial Doppler
- Cerebral scintigraphy

354
Q

Organ Transplantation: Donation after brain death

Bedside tests
- motor response (2)
- brainstem reflexes (5)
- absence of respiratory drive (2)

A

Cerebral motor responses
- No cerebral response to pain (nail bed or supraorbital ridge pressure)
- GCS < 5

Brainstem reflexes
- Pupillary reflexes (absence of light reflex; usually round, oval or irregular shaped)
- Oculocephalic reflex – absent Doll’s eyes (no doll’s eyes if cervical injury or TBI)
- Oculovestibular reflex – absent ice caloric (Observe 1 min and allow 5 min b/w each ear)
- Corneal reflexes – absent CN5 and CN7
- Gag and cough reflexes – absent pharyngeal (CN IX and CNX)

Absence of respiratory drive
- Apnea testing b-c loss of brainstem function = loss of central controlled breathing leading to apnea
- Mechanical ventilation

355
Q

Organ Transplantation: Collaboration and roles

  • Organ procurement organization (OPO) (4)
  • Nurse (4)
A

Organ procurement organization (OPO)
- part of health team but separated from decision to withdraw care
- manages donor assessment, obtains authorization, and facilitates recovery after criteria met
- Guides information giving process to the family (Successful donation r/t deep, close and open OPO relationship)
- Goal: get organs suitable for transplant

Nurse
- Links hospital to OPO (Call OPO w/ demographic info, admitting diagnosis, and current neurologic status)
- Do initial work-up (VS, I & O, assessments, labs, ensure diagnostics done)
- Self-assessment around organ donation
- Refer anyone w/ imminent cardiac or brain death to OPO (CMS requirement) w/n 1 hour

356
Q

Organ transplantation: OPO Assessment (6)

A
  • Patient demographics (age, sex, race)
  • Person’s history (conditions, medical and surgical procedures, social history)
  • Hospital’s plan of care for patient
  • History of current illness
  • Current medications
  • determine organ suitability
  • Initial labs: blood type, disease testing (HIV, CMV, Hepatitis, syphilis, EBV)
  • initial diagnostics: x-ray, 12-lead EKG
357
Q

Organ Transplantation: Types of Referrals

Donation after cardiac death (DCD)
- Criteria (3)
- Categories (2)

A

Criteria
- not brain dead but sufficient, irreversible, unsurvivable condition
- cessation of circulatory or respiratory function
- irreversible and unsurvivable condition

Categories
- controlled (family makes decision to withdraw care)
- uncontrolled (unexpected code)

358
Q

Organ transplantation: Donor management

Goal
Duration (4)

A

Goal: preservation of organ function via oxygenation, thermoregulation, perfusion

Duration
- brain death until organ procured
- immediate transport for heart and lungs
- transport within 6-20 hrs for pancreas and liver
- transport within 24 hrs for kidney and tissues

359
Q

Organ transplantation: Donor management

When to call OPO staff (6)

A
  • MAP < 70
  • SBP > 170
  • HR < 60 or > 130
  • Temp < 36.5 C or > 37.8 C
  • UOP < 75 or > 250
  • Glucose < 90 or > 180
360
Q

Organ Transplantation: Donor care protocols

General (5)
GI (2)
Other meds (3)

A

General
- Transfer care to OPO
- Discontinue all prior orders.
- Assess BP, HR, temp, CVP, PAOP q1h
- accuchecks q2h
- Labs q4h (CMP, CBC, ABGs, coags)

GI
- Pantoprazole 40 mg IV every 24 h, first dose now
- NGT to low intermittent suction (if present).

Medications:
- Artificial tears q1h to prevent corneal drying
- antibiotics as previously ordered
- Most anticonvulsants, pain medications, Laxatives, GI, motility agents, eve drops, anti-hypertensives, antinausea agents, subQ heparin, osmotic agents (mannitol), and diuretics are unnecessary during donor care and will be discontinued automatically

361
Q

Organ Transplantation: Donor care protocols

  • Pulmonary (4)
  • Hemodynamic (5)
A

Pulmonary
- mechanical ventilator parameters as previously set.
- Continue routine pulmonary suctioning and side-to-side body positioning.
- Continue chest tube suction or water seal as previously ordered (if present)
- Albuterol and Atrovent (ipratropium unit dose per aerosol every 4 h

Hemodynamic
- Maintain head of bed at 30 to 40 degrees elevation.
- Warming blanket to maintain body temperature above 36.5° c.
- Maintain SCDs.
- IV: D5% in 0.45% NS plus 20 KCL per liter at 75 ml/h.
- Vasoactive medication infusions (dopamine, norepinephrine) at previously ordered concentrations and infusion rates

362
Q

Organ Transplantation

Contraindications (11)

A
  • Advance age (> 75)
  • Co-existing malignancy (except liver cancer for liver transplant)
  • Severe multi-organ dysfunction
  • Severe chronic disabling illness (CT disease, neurologic disease)
  • Severe deconditioning i.e. unlikely to survive major surgery
  • Psychiatric illness i.e. MDD, suicidal, dementia, poorly controlled
  • Active drug or alcohol abuse
  • Active infection (treat first)
  • Excessive obesity
  • Noncompliance w/ current pharm (incl. uncontrolled HIV)
  • unwillingness to receive blood products
363
Q

Organ transplantation: Types of rejection

  • Hyperacute (4)
  • Acute (3)
  • Chronic (3)
A

Hyperacute
- Immediate (w/n 1 hr) graft failure (w/ complement activation, endothelial damage, inflammation, thrombosis) due to humoral immunity
- Seen w/ ABO incompatibility
- Prevent w/ induction therapy and preformed antibody testing
- Care: Remove organ ASAP

Acute
- Weeks to months after transplant placement
- Cell-mediated and causes cell damage and inflammation
- Care: methylprednisolone, antithymocyte globulin, IVIG, monoclonal antibodies

Chronic
- Occurs at various times and progresses for years
- Due to humoral and cellular mediated immunity
- organ deteriorates due to chronic inflammation, initial smooth muscle proliferation, diffuse scarring, and occlusion of organ vasculature -> tissue ischemia and necrosis

364
Q

Organ Transplantation: Rejection Surveillance

  • Heart (2)
  • Lungs (2)
  • Liver (3)
A

Heart
- Endomyocardial biopsies via right IJ to evaluate for perivascular infiltration (risk for perforation (cardiac tamponade, pneumothorax)
- AlloMap (measures genes expressed by activated T cells to mark rejection)- biopsy confirms

Lungs
- PFTs
- Transbronchial biopsy

Liver
- LFT’s (AST, ALT, ALP, serum bilirubin, PT, gamma-glutamyltransferase)
- ERCP, hepatoiminodiacetic acid scanning, transhepatic cholangiography
- Liver biopsy

365
Q

Organ Transplantation: Rejection Surveillance

  • Pancreas (5)
  • Kidney (2)
A

Pancreas
- Serum amylase and glucose not reliable
- Glucose elevation = late finding of rejection
- Kidney biopsy or increased crt b-c usually both transplanted
- Pancreas too fragile for biopsy
- Decreased urine amylase if bladder exocrine drainage

Kidney
- Assessment of renal function (increased creatinine)
- Renal biopsy

366
Q

Organ Transplantation:
Immunosuppressive Therapy

Goal
Three types

A

Goal: prevent allograft rejection to suppress activation of immune response while minimizing med toxicities

Types
- Induction: provide intense post-op immunosuppression when risk of rejection is high and produce tolerance of graft (ex. Cytolytic (depleting)- destroy T-cells (ex. Antithymocyte globulin, alemtuzumab) OR Nondepleting- prevent T cell proliferation (ex. Basiliximab))

  • Maintenance: provide immunosuppression throughout patient’s life to prevent rejection
    (ex. Triple drug regimens: Corticosteroid (Methylprednisolone (solumedrol)); Antimetabolite (Azathioprine (Imuran)); Calcineurin inhibitor (Cyclosporine (Neoral) or tacrolimus (Prograf)))
  • Rejection: reverse acute cellular or antibody-mediated rejection (ex. methylprednisolone, antithymocyte globulin, IVIG, monoclonal antibodies)
367
Q

Heart Transplantation:

Indications (3)
Specific Contraindications (2)

A

Indications
- Severe HF (may be r/t chemo, radiation, tumor, congenital defect)
unable to be medically or surgically managed
- Nonischemic cardiomyopathy (idiopathic, viral, valvular)
- Coronary artery disease

Specific contraindications
- Severe liver and kidney dysfunction
- Diabetes Mellitus (only if s/s of end organ damage i.e. nephropathy, neuropathy, retinopathy

368
Q

Heart Transplantation: Post-op care

  • Assessments (3)
  • Meds (2)
  • Care (2)
A

Assessment
- typical: low CO, dysrhythmias, second p wave on EKG, cardiac tamponade, hypotension
- s/s of hyperacute rejection: hemodynamic collapse, Cyanosis of donor heart (REMOVE ASAP)
- s/s of infection i.e. CMV is common ( fever > 100.4, cough

Meds
- isoproterenol (beta agonist) for chronotropic/HR support (increase HR, CO, decrease PVR) – may need temp pacing
- Dopamine and epinephrine for inotropic support (stop after 24-48 jrs)

Care
- aseptic technique in all procedures (lines and dressing changes
- Prevent CMV w/ antiviral (valganciclovir) or CMV immunoglobulin prophylaxis

369
Q

Heart Transplantation: Rejection

General - REJECTIONEPISODE
Chronic - 1

A

General rejection
- Rub (pericardial friction)
- Electrocardiogram voltage decreased
- JVD
- Edema (peripheral, sudden onset)
- Cardiac dysrhythmias (atrial, bradycardia)
- Tiredness
- Intolerance of exercise
- Onset of low-grade fever (report)
- New S3 or S4 heart sound
- Enlarged cardiac silhouette
- Pulmonary crackles, wheezes
- Increased weight
- Shortness of breath
- Onset of hypotension
- Disturbance in mood
- Echocardiogram findings (systolic function, left ventricular mass thickness)

Chronic
- Coronary artery disease i.e. cardiac graft vasculopathy which causes ischemic injury, HF, sudden death (seen in chronic rejection)

370
Q

Organ transplantation:

  • Heart-lung Indications (2)
  • Single lung indications (1)
A

Heart-lung
- end-stage cardiopulmonary (Congenital anomalies w/ pulmonary HTN, pulmonary HTN w/ irreversible right-sided HF, parenchymal lung disease w/ right HF)
- pulmonary disease who has exhausted medical manage w/ capacity for full rehabilitation (cystic fibrosis)

Single-lung
- End-stage pulmonary disease w/o end-stage cardiac disease (Ex. Severe COPD, interstitial lung disease, cystic fibrosis, alpha-antitrypsin deficiency, Pulmonary fibrosis)

371
Q

Heart-lung transplantation: post-op

Fluid balance (5)

A
  • give fluids for hemodynamic support
  • give Diuretics if overloaded
  • low dose dopamine for 34-48 hrs (inotropic support and kidney vasodilation)
  • Prostaglandin and nitroprusside for systemic and pulmonary vasodilation
  • Pleural drainage from chest tube drain (Tube removal when drainage < 200 ml/24 hrs w/o air leak)
372
Q

Heart-lung or lung Transplantation: post-op care

Assessment (4)
Pulmonary (4)

A

Assessment
- S/s of hyperacute rejection: bleeding (> 100 ml/hr in chest tube), infection, DVT, PE, MODS
- Ischemic-reperfusion injury- disrupts pulmonary lymphatics and increases vascular permeability -> edema
- Monitor CVP, PAOP, daily weights, BP b-c lungs very sensitive to fluid imbalance (pulmonary edema from overload or prerenal azotemia from hypovolemia)
- Bronchoscopy to assess for complications i.e. stenosis, dehiscence, INFECTION, rejection

Pulmonary
- mechanical ventilation w/ extubation within 24-48 hrs
- Suction PRN for airway clearance
- Early mobilization to minimize complications (Risk for pulmonary embolus, atelectasis, phrenic nerve injury, gas trapping, reintubation, pulmonary infections, VAP)
- Nitric oxide to decrease PAOP and improve oxygenation

373
Q

Lung Transplantation: Rejection Surveillance

Chronic
Acute

A

Chronic
- Chronic allograft dysfunction (CLAD) – obstructive or restrictive (restrictive if fibrotic changes in upper lobes and restrictive PFTs)

Acute
- Bronchiolitis obliterans syndrome (BOS) — IRREVERSIBLE decline in forced expiratory volume w/ measurements 3 weeks apart (FEV in PFT) due to dense fibrotic scar tissue affecting small airways

374
Q

Lung Transplantation: types

  • Single (2)
  • Double (2)
  • Lung volume reduction surgery (LVRS) (2)
  • Living donor lobar lung transplantation (2)
A

Single lung
– Pros: shorter intubation, shorter stay, less need for cardiopulmonary bypass
- Risks: lung hyperinflation leading to graft compression (mediastinal shift and respiratory failure)

Double lung
– Pro: higher success rate and quality of life; preferred in cystic fibrosis or bronchiectasis
- Risk: If pulmonary HTN, placed on cardiopulmonary bypass doing procedure to avoid right HF

Lung volume reduction surgery (LVRS)
- Done if end stage lung disease w/ comorbidities that make them ineligible for single or double lung transplant
- Procedure: reduce lung volume via wedge resection of emphysematous tissue which reduces hyperinflation, increases elastic recoil and expiratory flow

Living donor lobar lung transplantation (bilateral lower lobe transplant from two donors)
- Done if patient too ill to wait for cadaver lung
- Disadvantage: higher risk for complications b-c two donors

375
Q

Liver Transplantation or living donor liver transplantation

  • Indication
  • priority
  • donor suitability (3)
A

Indication: irreversible acute or chronic liver disease that is progressive and no effective therapy (Ex. HCV, Cholestatic disease, biliary atresia, metabolic disorders in pediatric patients)

Priority is sickest patient

Donor suitability
- ABO compatibility and similar body size
- Extended donor criteria allows older age, older liver, HCV livers
- potential for ischemic cholangiopathy if DCD vs DBD

376
Q

Liver Transplantation

Pre-transplantation care (5)

A
  • For hepatic encephalopathy, frequent neuro checks, lactulose, antibiotics
  • For portal HTN, elevate HOB, esophageal bleeding procedures, TIPS, Propanolol
  • Provide nutritional support –Fat soluble vitamins (E, D, K, A) and protein supplements
  • For Ascites, do Paracentesis w/ aseptic technique to prevent spontaneous bacterial peritonitis (SBP), diuretics, colloids
  • Sodium restriction
377
Q

Liver transplantation: Rejection Surveillance

  • Signs of Liver graft non function (5)
  • Acute rejection (2)
  • Chronic rejection (1)
A

Signs of Liver graft non function
- hemodynamic instability
- Progressive deterioration of kidney function
- Coagulopathies and abnormal LFTs (LFTs should peak on 3rd to 4th day them decrease)
- Hypoglycemia w/o insulin admin
- ventilatory dependence

Acute rejection
- Early s/s: LFT elevation, fever, change in bile (decrease in bile output, change in color or viscosity of bile)
- Late s/s: jaundice, malaise, dark urine, clay colored stools

Chronic
-leads to loss of transplant or salvage w/ plasmapheresis due to destruction and loss of bile ducts

378
Q

Liver Transplantation: Post-op care

Assessment (6)
Pulmonary (4)

A

Assessment
- Pulmonary (ABGs, pulse ox, breath sounds)
- Monitor Total body fluid vs intravascular fluid via art line, CVP, PAOP, PADOP, I & O, drains, bile totals
- Monitor Coagulopathy risk for blood loss
- Monitor Electrolytes (magnesium and potassium) — High levels= AKI; low levels = diuretics or calcineurin inhibitor (hypomagnesemia and seizures)
- Monitor or improved neurologic status i.e. resolution of hepatic encephalopathy
- Monitor LFTs (ALT, AST, ALP, total bili)

Pulmonary
- Extubated 12-24 hrs once awake and anesthesia wears off
- Prevent VAP (HOB 30 degrees, turn q2h, oral care, early mobility)
- Pulmonary hygiene after extubation (incentive spirometry; turn, cough, deep breath; CPT)
- Meds (bronchodilators, prophylactic antimicrobial)

379
Q

Liver Transplantation: Post-op care

Hemodynamic (2)
Nutrition (3)
Other (4)

A

Hemodynamic
- Reestablishment of normal body temp (hypothermia = common))—Care: rewarm w/ blankets, heating lamps, head covers
- Correct fluid w/ albumin, plasma, dopamine, prostaglandin, platelets, vitamin K

Nutrition
- check prealbumin
- TPN if oral delayed
- remove NGT when output minimal, bowel sounds return, patient extubated

Other
- Pain (analgesics may mask deterioration in mental status so do alongside nonpharmacological
- Glucose control (ideal < 150) – altered by steroids, graft function, calcineurin inhibitors, diabetes
- Kidney function (risk for AKI w/ cyclosporine, tacrolimus, poor liver function)- Manage by avoiding nephrotoxic drugs, use CKRT, hemodialysis
- Infection risk due to immunosuppression (aseptic techniques, hand hygiene; remove invasive lines as early as possible)

380
Q

Kidney Transplantation

Indication
Types (3)

A

Indications
- ESKD (DM and HTN = leading causes of ESKD)

Types
- Deceased kidney donation (DCD or DBD) and matched ABO blood type and HLA
- Living kidney donation from relative
- Living kidney paired donation (KPD)– Donation exchange w/ another living donor-recipient pair allows exchange when family members incompatible

381
Q

Kidney Transplantation: Post-op Care

  • Kidney (2)
  • Complications (5)
A

Kidney
- recipient kidney not removed
- need dialysis until kidney functional

Complications
- Hypovolemia - Care: monitor UOP and need 1:1 fluid replacement

  • Electrolytes (hypokalemia, hypomagnesemia, hypocalcemia)- care: replace as needed, Monitor q4-6h along w/ BUN and crt
  • Hemorrhage (low H/H)- Care: Monitor CBC and platelet q4-6h; blood transfusion, prevent clots
  • Bladder (bladder spasms)- Care: irrigate and aspirate foley catheter in case of clots; opiates and antispasmodics to relax bladder
  • Infection risk (i.e., Candida, PCP, CMV, EPV, HSV) - Care: aseptic technique, standard precautions, handwashing, discontinue invasive lines, limit visits, monitor subtle temp, WBC, wound drainage changes
382
Q

Kidney Transplantation: Rejection Surveillance

  • Acute s/s (6)
  • Chronic s/s (3)
A

Acute
- Increased tenderness over kidney site (flank tenderness)
- Decreased UOP (oliguria, anuria)
- Fever (> 37.8 C)
- Rapid weight gain (4-6 lb in 24 hrs) and Swelling of hands and feet– fluid retention
- increased BP
- decreased urine specific gravity

Chronic
- gradual increase in BUN and crt
- electrolyte imbalances (hyperkalemia, hyperphosphatemia, hypocalcemia
- fatigue

383
Q

Pancreas Transplantation: Procedure

General notes (2)
Types
- Enteric exocrine drainage (3)
- bladder exocrine drainage (4)

A

General
- Native pancreas not removed
- Head of pancreas placed down for exocrine drainage

Enteric (bowel) exocrine drainage
- similar to normal physiology
- Pancreatic enzymes drain into bowel and are excreted w/ stools
- Problems: peritonitis; unable to measure pancreatic enzymes

Bladder exocrine drainage
- Pancreatic enzymes excreted w/ urine
- Problems: recurrent UTI, prostatitis, urethritis, urinary catheter occlusion (more viscous urine), hematuria (urine viscous and irritating), metabolic acidosis (urine bicarb loss)
- Advantage: measurement of urinary amylase for rejection
- Care: continuous bladder irrigation

384
Q

Pancreas Transplantation

Indication (2)
Post-op care (5)

A

Indication
- type 1 DM
- allow normal glucose control w/o exogenous insulin

Post-op medical management
- ABC( oxygenation, hemodynamics, cardiac status)
- Monitor for f/e problems if done w/ kidney transplant i.e. IV fluids, I & O, Electrolytes (K, BUN, crt)
- Place NGT for 24-48 hrs post-op
- Place continuous insulin drip to prevent hyperglycemia until graft functional
- frequent blood glucose monitoring

385
Q

Older Adults: Immunity

Changes (4)
S/s of infection (5)

A

Changes
- Decreased nonspecific general and specific adaptive immunity -> more severe and frequent infections
- Cell-mediated immunity declines so less and slower recognition of pathogens
- Increase in comorbidities and frailty
- fewer neutrophils and lymphocytes -> negative TB test, no leukocytosis
- reduced antibody-mediated immunity -> reason they need boosters to generate new antibodies

S/s of infection
- acute mental status changes
- anorexia
- generalized weakness
- urinary incontinence
- falls

386
Q

Systemic Inflammatory Response Syndrome (SIRS)

What is it?
Characterization = presence of any 2 of the following (4)

A
  • Body’s exaggerated defense response to noxious stressors (massive trauma, burns, pancreatitis, Sepsis)

Characterization
- Temp > 38.3°C (101°F) or < 36°C (96.8 °F)
- HR > 90
- RR > 20 OR respiratory alkalosis
- WBC > 12,000 or < 4,000

387
Q

Define the following

  • Sepsis (2)
  • Septic Shock (2)
A

Sepsis (Leading cause of hospital death)
- life threatening organ dysfunction due to dysregulated response to infection
- All ICU are at risk esp. immunosuppressed or central lines

Septic shock
– subset of sepsis in which circulatory, cellular, metabolic abnormality and organ failure increases mortality
- hypotension requiring vasopressors after volume resuscitation to maintain MAP 65

388
Q

Sepsis and Septic : S/s

Cardiac (4)
Skin (2)
Pulmonary (3)
Fluid
Neurological

A

Cardiovascular
- DIC (platelet dysfunction)
- Decreased myocardial contractility (decreased SV and ejection fraction) from ischemia
- increased temp initially (possible hypothermia)
- hypotension (decreased cap refill

Skin
- mottling
- edema from leaky capillareies

Pulmonary
- PaO2/FiO2 ratio < 300 = ARDS
- pulmonary edema
- Hypoxia (tachypnea, low o2 sat

Fluid
- oliguria

Neurologic
- acute change in mentation

389
Q

Sepsis: Patho (6)

A
  • Microorganism enters -> inflammation/immune response activation -> systemic = uncontrolled and dysregulated so imbalance b/w oxygen supply, demand, and consumption
  • Vasodilation -> hypotension
  • increased metabolic rate
  • Endothelial damage -> Leaky capillaries -> decreased blood circulating volume (reduce preload and CO)-> worsening hypotension (microcirculatory failure)
  • Coagulation dysfunction: microscopic clotting (DIC = depleted coagulation) –> hypoxia
  • Apoptosis of immune cells -> immunosuppression, secondary infection, further inflammation
390
Q

Sepsis/Septic Shock: Labs (7)

A
  • Lactate Acidosis (> 2) due to anerobic metabolism
  • increased total bili
  • Hyperglycemia in absence of diabetes (Glucose >120) – stress response
  • increase in crt w/o hx of kidney problems (>2.0 for men) (>1.4 for women)
  • High or low WBC (bandemia i.e. left shift of neutrophils i.e. > 10% in immature forms)
  • Inflammatory markers (increased CRP and procalcitonin)
  • Positive blood culture (may not be present)
  • H/h, fibrinogen and platelets low due to DIC
391
Q

Septic Shock: Stages w/ s/s

  • Compensatory (4)
  • Progressive (5)
A

Compensatory
- Tachycardia r/t SNS, metabolic, and adrenal gland stimulation
- Widened PP (low DBP due to vasodilation; High SBP due to high CO)
- Full bounding pulse
- Skin: Pink, Warm, flushed w/o cyanosis

Progressive
- ABGs: respiratory alkalosis to metabolic and respiratory acidosis
- LOC: disoriented, confused, combative, lethargic
- UOP decreases
- Depressed WBC count
- Skin: cool, clammy, pallor, mottled, cyanosis

392
Q

Hemodynamics and Shock: Identify which shocks are they high in vs low in

  • CO/CI
  • Preload (PAOP and CVP)
  • Afterload (SVR)
  • MAP
A

CO/CI
- High: Septic
- Low: cardiogenic, hypovolemic, anaphylactic, neurogenic, obstructive

PAOP and CVP
- High: cardiogenic, obstructive
- Low: Septic, hypovolemic, anaphylactic, neurogenic

SVR
- High: cardiogenic, Hypovolemic, obstructive
- Low: Septic, anaphylactic, neurogenic

MAP
- Low: all

393
Q

Severe Sepsis: 1 hr bundle (5)

A
  • Obtain cultures before antibiotic therapy
  • Primary goal: eradicate the cause via early detection and broad spectrum antibiotics
  • Remove infection via surgical debridement of infected or necrotic tissue; drain abscesses; Remove invasive devices that may be causing problem
  • Obtain labs – Lactic acid is a gold standard (grey tube put on ice); CBC (bands, WBC), CMP, CRP, PCT, INR
  • Obtain IV or CVC for Isotonic IVF at 30 mL/kg to reverse dehydration and hypotension
394
Q

Severe sepsis/septic shock: Priorities outside 1 hr bundle

  • Pulmonary (4)
  • Other (4)
A

Pulmonary
- Intubation and mechanical ventilation w/ PEEP and low tidal volume if ARDS
- VAP prevention: HOB 45, sedation vacation,
- prone positioning
- avoid neuromuscular blocking agents

Other
- Vasopressors and inotropes if shock develops i.e. no response to fluids (norepinephrine/Levophed = gold standard after fluids)
- reassess lactate level, VS, ABC
- Lines needed: foley, art line if vasopressors
- Nutritional support (enteral w/ protein)

395
Q

Sepsis/Septic Shock: Other meds (7)

A
  • Steroids if adrenal insufficiency from stress of sepsis OR hypotensive after fluid and vasopressors to limit SIRS
  • Insulin to maintain glucose b/w 140 and 180
  • Heparin to limit inappropriate clotting and prevent excessive consumption of clotting factors
  • Blood products (plts, ffp, PRBCs, clotting factors)-if Hgb < 7
  • Platelets first to improve clotting if <100000
  • sodium bicarb if pH <7.2 (usually none for lactic acedemia)
  • stress ulcer prophylaxis
396
Q

Disseminated Intravascular Coagulation (DIC)

What is it?
Patho (4)

A
  • Consumptive coagulopathy Syndrome that arises as a complication of other serious or life-threatening conditions including Sepsis, shock, tissue injury

Patho
- excessive clotting w/ formation of thousands of small clots everywhere
- small clots use clotting factors and fibrinogen faster than they can be produced -> leads to poor CLOTTING.
- Thrombosis and fibrinolysis -> inflammation and Microvascular damage -> organ injury -> MODS
- Decreased perfusion -> hypoxia and ischemia.

397
Q

Disseminated Intravascular Coagulation (DIC)

S/s (3)
Diagnostic (2)
Treatment (2)

A

s/s
- Petechiae and ecchymoses
- Blood may ooze from the gums, other mucous membranes, and venipuncture sites and around IV catheters.
- hypoxia and ischemia from microclots

Diagnostic
- elevated fibrinogen, coagulation, D-dimer
- low platelets

Tx:
- Heparin (bolus then gtt) first b-c stops clotting cascade (target aptt 1.5-2.5x normal; normal 30-40sec,
- Fresh frozen plasma & cryoprecipitate

398
Q

Shock: Basics (3)

A
  • Acute, widespread process of impaired tissue perfusion in all body system
  • Imbalance between cellular oxygen supply and demand.
  • MAP <60 or evidence of hypoperfusion
399
Q

Shock: Stages

  • Initial (2)
  • Compensatory
  • Progressive (2)
  • Refractory (3)
A

Initial
– cardiac output (CO) ↓ = ↓ tissue perfusion but MAP compensated
- overall metabolism is aerobic

Compensatory
– the body naturally attempts to maintain CO, BP, and perfusion via SNS, RAAS

Progressive
- the body fails to meet tissue needs and compensation is ineffective
- emergency b-c apoptosis, tissue ischemic, anoxia begin

Refractory
– the body becomes unresponsive to interventions and therapy
- syndrome is considered irreversible even if MAP corrected
- progresses to MODS if 2 or more systems fail

400
Q

Shock: Types (definition and major cause)

  • Distributive (4)
  • Obstructive (2)
A

Distributive
- Abnormality in the vascular system produces maldistribution of circulating blood volume (vasodilation, pooling in venous and capillary beds, cap leaks) so ineffective organ perfusion
- Anaphylactic: severe antibody-antigen reaction
- Neurogenic-loss of sympathetic tone
- Septic-dysregulated response to microorganism -> massive vasodilation

Obstructive
- indirect pump failure: problem outside the heart impairs ability of heart to pump effectively (inadequate filling or contraction)
- Ex. cardiac tamponade, massive pulmonary embolism, tension pneumothorax, PAD, pulmonary HTN, pericarditis, thoracic tumors

401
Q

Shock: Types (definition and major cause)

  • Hypovolemic (2)
  • Cardiogenic (2)
A

Hypovolemic
- Loss of circulating or intravascular volume due to loss of intravascular integrity, increased cap permeability, or decreased colloid pressure
- Ex. Dehydration, poor clotting (hemorrhage)

Cardiogenic
- Impaired ability of the heart to pump and perfuse blood to body
- Ex. Massive MI, cardiomyopathy, dysrhythmias

402
Q

Shock: Consequences

  • Renal (2)
  • Muscular (2)
  • Hematologic (2)
  • GI (3)
A

Renal
- AKI due to vasoconstriction, hypoperfusion
- glycosuria and acetone in urine

Muscular
- muscle weakness
- loss of DTRs

Hematologic
- DIC
- impaired blood production r/t inflammation, bone marrow, kidney, liver failure

GI
- GI tract failure
- Liver failure
- Pancreatic failure

403
Q

Shock: Global indicators of perfusion and oxygenation (4)

A
  • Serum lactate (Hyperlactatemia due to inadequate oxygenation and anaerobic metabolism) - Level and duration predictive of morbidity and mortality
  • Serum bicarbonate (detected w/ serum CO2 which are low w/ metabolic acidosis b-c reflection of bicarb)
  • SVO2 levels ((mixed venous gas i.e., blood extracted after blood returns to right side of heart) = 60-80% (lower w/ poor perfusion) – need PA line
  • Base deficit from ABGs (reflects tissue acidosis and severity of shock)
404
Q

Shock: General Treatment

Major focus (1)
Assess in patients w/ (3)
Care (6)

A

Major Focus: Optimize Tissue perfusion

Assess for shock: any patient w/ change in LOC, increase in pain, or increase in anxiety

Care
- Pulmonary gas exchange (airway, mechanical ventilation, supplemental oxygen)
- fluids (crystalloids and colloids)
- Do meds (vasoconstrictors, vasodilators, inotropes, antidysrhythmic)
- Nutritional supplementation (enteral within 24-48 hrs; Parenteral after 7 days if enteral not possible)
- Glucose control (140-180 to decrease infection, renal failure, sepsis, death)
- Sodium Bicarb if pH < 7.2

405
Q

Shock: Meds

  • Vasoconstrictors (Epi, norepinephrine, dopamine, phenylephrine, vasopressin) — 4
  • Vasodilators (nitroprusside, nitroglycerin, hydralazine, labetalol) —- 4
A

Vasoconstrictors
- Increase afterload (SVR), BP, MAP via increase SVR, venous return, contractility
- Choice: Epi for anaphylaxis; Norepinephrine is gold standard for all other shocks (may add on other vasopressors)
- Risks: Chest pain (angina and ischemia); AKI and oliguria w/ high dose; Hypertension; Extravasation (vasoconstriction, tissue ischemia, tissue necrosis)
- Do not give dopamine b-c worsens tachycardia and cause dysrhythmias

Vasodilators
- Decrease preload, afterload or both
- Used in cardiogenic shock to unblock coronary arteries in AMI
- Care protect from light b-c degrades them
- Risk: systemic vasodilation and hypotension esp if nitrate w/ PDE-5 inhibitors

406
Q

Shock: Meds

  • Inotropes (dopamine, dobutamine, epinephrine, norepine, milrinone) — 3
  • Antidysrhythmics (amiodarone, adenosine, procainamide, labetalol, verapamil, esmolol, diltiazem, lidocaine) —- 3
A

Inotropes
- Increase contractility and maintain BP and tissue perfusion
- Dobutamine and milrinone seen most in cardiogenic shock
- Risk: hypertension; transient hypotension; chest pain (angina or infarction)

Antidysrhythmics
- Influence HR and rhythm by suppressing or controlling dysrhythmias
- Amiodarone used in v-fib, v-tach
- Adenosine used in SVT (short half-life so large bore IV and quick admin and connected to machine

407
Q

MODS: Cardiovascular Changes

  • Early (4)
  • Late (3)
A

Hyperdynamic (early)
- Decreased PAOP, SVR, CVP,
- Increased oxygen consumption
- Increased CO, CI, HR
- Heart failure or inadequate fluid resuscitation if unable to increase CO w/ low SVR

Hypodynamic (heart failure, cardiogenic shock, death)
- Increased SVR, CVP,
- Decreased oxygen delivery and consumption
- Decreased CO/CI, contractility, compliance

408
Q

Shock: Consequences

  • Cardiovascular (3)
  • Neurologic (2)
  • Pulmonary (3)
A

Cardiovascular
- ineffective perfusion (hypotension)
- ventricular failure
- Microvascular thrombi r/t endothelial injury from hypoxia and cytokines

Neurologic
- CNS hypoperfusion -> SNS, Cardiac, thermoregulatory, respiratory dysfunction
- Coma

Pulmonary
- ARDS
- Respiratory acidosis to respiratory alkalosis
- Acute lung failure r/t microembolic, vasoconstriction, increased pulmonary cap permeability -> cyanosis

409
Q

MODS: Management

  • Support oxygen transport and use (5)
  • identify cause and treat inflammation/infection (1)
A

Support oxygen transport:
- Establish a patent airway.
- Initiate mechanical ventilation w/ PEEP or oxygen.
- Administer fluids (crystalloids, colloids, blood, and other blood products).
- Administer meds (vasopressors, vasodilators, antidysrhythmics)
- Prone positioning

Identify underlying cause of inflammation and treat
- Remove sources of infection or contamination (Surgery: early fracture stabilization, removal of infected organ, tissue, burn excision; antibiotics)

410
Q

MODS: Risk factors (7)

A
  • Sepsis/SIRS
  • Shock
  • Trauma/burns/surgery due to ischemia-reperfusion events from hemorrhage, blunt trauma, SNS vasoconstriction
  • Acute pancreatitis
  • Aspiration
  • Multiple blood transfusions
  • 65+ due to decreased organ reserve and comorbidities
411
Q

Multiple Organ Dysfunction Syndrome (MODS)

  • Basics (3)
  • Types (2)
A
  • Progressive physiologic failure of two or more organ systems due to systemic, self-perpetuating inflammation
  • Persistent hypermetabolism causes widespread vascular endothelium and organ damage
  • Homeostasis cannot be maintained without intervention – Poor prognosis

Etiology
- Organ dysfunction may be the direct consequence of an initial insult (primary MODS) i.e. Posttraumatic pulmonary failure, thermal injuries, AKI, invasive infections
- manifest latently and involve organs not directly affected in the initial insult (secondary MODS) i.e. Liver and GI inflammation -> inflammation elsewhere due to auto catabolism

412
Q

MODS: Management

  • Decrease oxygen demand (5)
  • Prevention and monitoring for complications (3)
A

Decrease oxygen demand
- Administer sedation or paralytics.
- Temp control (antipyretics and external cooling measures)
- Pain control (analgesics
- Rest and Position for comfort
- Reduce anxiety (sedatives, education, calm, quiet environment)

Prevent and maintain surveillance for complications
- enteral nutrition to preserve organ function
- Monitor Hemodynamics, Serum lactate, Respiratory status
- Prevention: handwashing, aseptic technique, understand entrance mechanisms

412
Q

Hypovolemic Shock: Assessment

Compensatory stage (7)

A
  • Skin: pale and cool w/ delayed cap refill
  • Flat JVD
  • CNS: Thirst; slight anxiety -> anxiety, restless
  • Tachycardia
  • Postural hypotension w/ Narrow pulse pressure (increased DBP and decreased SBP)
  • Tachypnea (ABGs = respiratory acidosis to alkalosis; O2 sat 90-95%)
  • Decreased UOP w/ decreased urine sodium (but increased urine osmolality and specific gravity)
412
Q

Hypovolemic Shock: Assessment

Progressive Stage (7)

A
  • ABGs (metabolic acidosis due to high lactate, low bicarb, high base deficit)
  • Renal – Oliguria to anuria, high BUN and Crt, hyperkalemia (from anaerobic metabolism and dehydration)
  • Skin – ashen, cold, clammy w/ delayed cap refill -> cyanosis
  • CNS: thirsty, Decreased mental status/loc (sense of impending doom, confused)
  • Cardiac: Rapid weak pulse (NEED DOPPLER); dysrhythmias
  • O2 sat = 75-80%
  • Hgb/Hct (increased if fluid shift or dehydration; decreased if hemorrhage)
413
Q

Hypovolemic Shock: Assessment

Refractory stage -> MODS (6)

A
  • Skin – mottled, cyanotic, diaphoretic, cold, dusky
  • Severe lactic acidosis
  • UOP ceases
  • CNS: Pt confused and agitated -> loss of consciousness
  • Cardiac: Loss of peripheral pulses and cap refill; Marked peripheral vasoconstriction = increased SVR
  • Pulmonary: Slow shallow respirations, O2 sat < 70%
414
Q

Hypovolemic Shock: Care (6)

A
  • ABC and VS q15 min
  • Fluid resuscitation via large bore (crystalloids = 1st)
  • Meds: vasopressors (norepinephrine) intropes
  • Position: legs raised, trunk flat w/ head and shoulders above chest but no more than 30 degree
  • stay w/ pt until resolved
  • Limit fluid loss: limit blood sampling, observe for line disconnection, direct pressure to bleeding sites
415
Q

Cardiogenic Shock: Assessment

Labs (4)
Diagnostic

A

Labs
- increased BUN, crt
- increased BNP
- Increased Troponin
- ABGs (respiratory alkalosis to respiratory and metabolic acidosis)

Diagnostic: echo ( confirms cardiogenic shock; noninvasive measure of PAOP and ejection fraction

416
Q

Cardiogenic Shock: Assessment

s/s (9)

A
  • Skin: cool, pale, moist, dusky
  • Pulmonary Edema (crackles, rhonchi, dyspnea, tachypnea, JVD)
  • Chest pain
  • Dysrhythmias w/ S3, S4
  • Diminished heart tones due to decreased contractility
  • Pulse (weak, thready) w/ tachycardia
  • CNS: anxiety, delirium, decreased LOC
  • Narrow pulse pressure w/ hypotension (SBP <90
  • renal: anuria, decreased urine sodium (increased urine SG and osmolality)
417
Q

Cardiogenic shock: Management

General (7)
Invasive (2)
Nursing (2)

A

General
- Mechanical Ventilation (intubation)
- Fluids (crystalloids, colloids, blood products)
- Inotropes (milrinone, dobutamine)
- Vasoconstrictors if inflammation
- Diuretics – to reduce preload
- Vasodilators only w/ inotrope or after shock resolved
- Antidysrhythmic

Invasive
- If MI, revascularization by fibrinolytics, PCI, CABG
- Mechanical circulatory assist devices (
Intra-aortic balloon pump (IABP), Percutaneous ventricular support device (VAD i.e. Impella device), Extracorporeal membrane oxygenator)

Nursing
- Limit myocardial oxygen demand (analgesics, sedatives, positioning for comfort, meds for afterload and dysrhythmias, limit activities, calm and quiet environment, patient education)
- Enhance myocardial oxygen supply (supplemental oxygen, monitor RR, give meds, devices)

418
Q

Anaphylaxtic Shock: Basics (3)

A
  • Type of distributive shock causing fluid shift and vasodilation
  • result of an immediate Antibody-antigen hypersensitivity reaction (IgE-mediated or non-IgE mediated)
  • may be Biphasic reaction: symptoms reappear after 1-72 hrs of resolution
419
Q

Anaphylactic Shock: Assessment (6)

A
  • Skin: diaphoresis, pruritus, erythema, angioedema, warmth, urticaria
  • CNS: apprehension, syncope, doom, restless, low LOC
  • Respiratory: laryngeal edema (tightness, lump, hoarse, stridor); bronchospasms (wheeze, dyspnea); mucus plug
  • Circulatory: vasodilation (hypotension, flat JVD, reflex tachycardia)
  • Muscle: weakness
  • GI and GU: NVD, cramping, incontinence
420
Q

Anaphylactic Shock: Care

  • Remove or Prevent antigen
  • Reverse inflammatory/immune response (2)
  • Promote adequate tissue perfusion (2)
A

Remove or prevent antigen
- prevent w/ assessment of allergies & response after med, blood or blood product

Reversal effects of inflammatory/immune response
- If mild, Epinephrine (first line) via IM q5-15 min w/ 0.2 mg – 0.5 mg (0.3-0.5mL) of a 1:1000 dilution
- If severe, epinephrine titrated to maintain BP (0.05-0.1mg (1mL) of a 1:10,000 dilution IV over 5 min OR continuous if persistent hypotension,

Promote adequate tissue perfusion
- IV fluids (crystalloid or colloid) and rapid Inotropes and vasopressors via large bore IV
- Position: legs up, supine, head and shoulder above trunk

421
Q

Anaphylactic Shock: Reverse inflammatory/immune response

2nd line agents (5)

A
  • H1 antagonist -Benadryl (Diphenhydramine) via slow IVP to block histamine
  • H2 antagonist- Pepcid (Famotidine) to reduce histamine release and control cutaneous reactions
  • Corticosteroids (Methylpredisone) to prevent prolonged or delayed reaction (not used in immediate treatment)
  • IV glucagon for bronchospasm and hypotension if patient on beta blocker due to limited response to epi
  • Inhaled beta agonists for bronchospasm unresponsive to epinephrine
422
Q

Obstructive Shock: Management (2)

A
  • treat cause: pericardiocentesis for cardiac tamponade, tPA for PE, chest tube for tension pneumothorax
  • Maintain BP: fluids and vasopressors